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ABSTRACT
The dorsal raphe (DR) nucleus, located in mesencephalon, contains 5-
hydroxytryptamine (5-HT; serotonin) synthesizing neurones. This putative
neurotransmitter is recognised to have a role in many neurological disorders, such as
pain, migraine, sleep and anxiety. 5-HT1A receptors, probably located
somatodendritically, regulate an autoinhibition of 5-HT release. The effect of
phosphorylation on Ca2+ current, in the presence and in the absence of 5-HT1A
receptor activation, has been studied here using a whole-cell voltage-clamp technique
in acutely dissociated adult rat DR neurones.
In various neuronal preparations, transmitters have been shown to reduce voltage-
dependent Ca2+ currents. In DR neurones, the inhibitory action of 5-HT is incomplete,
usually around 60%, and is accompanied by a dramatic slowing of the activation. 8-
OH DPAT, a highly specific 5-HT1A agonist, also partially and reversibly reduces
high-voltage activated (HVA) Ca2+ currents and slows the activation time. It appears
that the effect is G-protein mediated and it is believed that the G-protein acts directly
on the Ca2+ channel proteins, rather than through a freely diffusible second
messenger. The action of 8-OH DPAT and GTP-y-S on both the amplitude and the
activation of the current can be relieved by a large depolarising prepulse.
A variety of data indicate that protein phosphorylation regulates the efficacy of
synaptic transmission, both by controlling the release of neurotransmitters from the
presynaptic nerve terminal and by modulating the sensitivity of receptors in the
postsynaptic membrane. Presumably, at rest, some kind of
phosphorylation/dephosphorylation balance exists. Evidence has been given that
phosphorylation is a necessary step in ion channel functioning. It appears that
inhibition of specific phosphatases, could potentiate already activated ion channel
currents.
Inhibition of protein phosphatases, by the inclusion of phosphatase inhibitors in the
recording pipette, potentiated peak Ca2+ current in 80% DR neurones tested, and, in
addition, prevented the fast decline or "run-down" of the Ca2+ current. Furthermore,
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the activation kinetics were speeded up. On the other hand, they produced no change
in the inhibition and slowing of the activation of the current caused by the external
application of 8-OH DPAT or by G-protein activation. This would suggest that
phosphorylation is not directly involved in the effect of neurotransmitters on Ca2+
channels. Phosphorylation, however, enhanced the recovery of the activation kinetics
in the presence of a prepulse or an increase in temperature.
Peak Ca2+ currents are enhanced by inhibition of dephosphorylation and increasing
the intracellular cyclic AMP. The effects are additive, together with the enhancements
induced by an increase in temperature or a prepulse.
Note: Here I confirm that the work presented is my own and that this Thesis has been
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Voltage-activated calcium currents were investigated in this study. In particular,
their modulation by the putative neurotransmitter serotonin and the effect of
inhibition of dephosphorylation in dorsal raphe neurones were examined. In this
introductory section an outline of the proposed classification of calcium channels is
given, and effect of neurotransmitters on calcium currents in other cell types is
described.
Calcium ions regulate a variety of cellular functions. In neurones, for example,
they play a role in diverse events, such as neurotransmitter release, hormone
secretion, short- and long-term changes in cell excitability, regulation of Ca-
dependent enzymes and gene expression. Calcium channels have been found in all
excitable cell types so far studied. Given the diverse nature of their function, it is
significant that several types of voltage-gated calcium channels have been described.
Development of patch-clamp methods, such as a whole-cell voltage-clamp technique
used in this study, has facilitated detailed analysis of the functional and dynamic
properties of calcium channels. In addition, parallel biochemical advances have led
to insights into their structural properties.
Classification of calcium channels has been proposed on the basis of their
biophysical and pharmacological characteristics. More specifically, calcium channels
have been differentiated according to voltage-threshold of their activation into high-
voltage activated (HVA) and low-voltage activated (LVA) (Llinas & Yarom, 1981;
Carbone & Lux, 1984). In addition, it has been shown that the HVA calcium current
consists of at least three components that possess specific properties, such as
conductance and inactivation rates. N-, L- and P-types are better characterised,
however, recent studies have suggested an existence of additional channel types (Fox
et al. 1987b; Llinas et al. 1989; Randall et al. 1993; Wheeler et al. 1994).
Electrophysiological properties of calcium channels and their presence in different
cell types are described in Chapter 1.1.
Calcium channels can also be differentiated on the basis of their pharmacological
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characteristics. A series of drugs, such as nifedipine and verapamil, used clinically
for their antiarrhythmic effects on heart and relaxation of vascular smooth muscle,
are also potent blocking agents of calcium channels. For instance, L-type channels
are shown to be sensitive to dihydropyridines (Lee & Tsien, 1983; Porzig, 1990). A
snail toxin co-conotoxin VIA is relatively specific blocker of N-type channels, and
co-Aga-IVA blocks P-type current (Kerr & Yoshikami, 1984; Plummer et al. 1989;
Mintz et al. 1992). LVA (or T-type) calcium current is resistant to these drugs, but
can be blocked by other compounds (Twombly et al. 1988; Akaike et al. 1989). The
pharmacological diversity of calcium channels are outlined in Chapter 1.2.
The following section of the introduction (Chapter 1.3) begins with the analysis
of molecular structure of calcium channels. As a result of its high sensitivity to
dihydropyridines and its relative abundance in skeletal muscle, L-type calcium
channel from this tissue is the best characterised. Its molecular properties with
oligomeric structure have been determined (Curtis & Catterall, 1984; Takahashi et al.
1987). Cloning and sequencing of cDNA encoding the arsubunit of L-type channel
have shown that this subunit probably forms the major functional part of the channel.
This was confirmed in the studies of the calcium channel reconstituted into planar
lipid bilayers (Curtis & Catterall, 1986).
The fourth section describes some of the postulated functions of calcium channels.
It has been proposed that N-type channels regulate transmitter release, L-type
channels have a part in secretion, transmitter release and gene regulation, whereas a
low-voltage activity of T-type channels suggested their role in cell excitability
(Burlhis & Aghajanian, 1987; Himing et al. 1988a; Hosey & Lazdunski, 1988). In
Chapter 1.4 it is shown that most of the functions are shared by different channel
types.
Voltage-dependent calcium channels can be modulated by neurotransmitters, see
Chapter 1.5. For instance, a whole host of neurotransmitters has been shown to
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inhibit calcium currents (Dunlap & Fischbach, 1978; Dolphin et al. 1989; Elmslie,
1992). In many neurones neurotransmitters modulate calcium currents by acting on
N-type channels, and in others by a relatively indiscriminate action on several
channel types. It has been shown that many receptors are linked to calcium channels
by GTP binding proteins (G-proteins), either directly or via second messengers or
both (Yatani et al. 1987; Kleuss et al. 1991; Meriney et al. 1994). A role of G-
proteins, their different subtypes and coupling with second messengers is described
in Chapter 1.6.
Serotonin (5-HT) is a putative neurotransmitter with an important role in regulation
of various neurologic and non-neurologic states, such as pain, sleep, migraine, anxiety
and cardiovascular activities. It is synthesised in dorsal raphe (DR) nucleus, which
then sends a large amount of serotoninergic fibres to different parts of central and
peripheral nervous system. Previous work (Penington et al. 1991;
McAllister-Williams, 1992) that was conducted into the action of 5-HT in DR on
both potassium and calcium conductance is presented in Chapter 1.7. Effects of
serotonin, in particular its modulation of calcium currents are also described here.
Many different processes in cells depend on phosphorylation. It has been suggested
that protein phosphorylation modulates synaptic transmission, both by controlling
transmitter release and receptor sensitivity. Inhibition of dephosphorylation using
specific protein phosphatase blockers has been shown to modulate calcium currents
(Hescheler et al. 1988; Frace & Hartzell, 1993). Role of phosphatase inhibitors and
changes in phosphorylation/dephosphorylation balance in cells is described in detail
in Chapter 1.8.
In the closing introductory Chapter, the aims of the investigation ofmodulation of
calcium currents in DR neurones are summarised.
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Portrait of calcium channels
Ca channels are transmembrane proteins that allow, in their open conformation, a
passive flux of Ca ions across the cell membrane. There is a strong evidence for their
existence in both vertebrate and invertebrate cells, for reviews see Reuter (1983),
Tsien (1983), Tsien et al. (1988), Bean (1989b), Hess (1990) and Catterall (1993).
One group of Ca channels, called voltage-activated channels, will be described here
in detail. They are distinguished from ligand-gated channels, which are divided into
receptor-operated channels and second messenger-operated channels (Tsien et al.
1988; Kandel & Schwartz, 1991).
Voltage-sensitive Ca channels are not restricted to classically excitable cells such
as neurones, muscle and heart cells, but also exist in non-neuronal cells, such as
invertebrate eggs, ciliates, lymphocytes, fibroblasts and GH3 pituitary cell line (Bean,
1985). They are located in the surface membrane. Many different types of voltage-
activated Ca channels have been described, but a generally accepted classification is
not yet available. However, a preliminary nomenclature based on their biophysical
and pharmacological properties will be used in this presentation. Llinas and Yarom
(1981) first pointed to the co-existence of "low-threshold" and "high-threshold" Ca
channels, in guinea-pig inferior olivary neurones. Carbone and Lux (1984)
demonstrated corresponding low-voltage activated (LVA) and high-voltage activated
(HVA) Ca currents in chick dorsal root ganglion (DRG) cells. Single-channel
recordings have confirmed this primary difference between the two groups of
channels. LVA channels were characterised as T-type (Fox et al. 1987a) and at least
three types of unitary conductances for the HVA channels were unveiled (Nowycky
et al. 1985; Llinas et al. 1989), known as L-, N- and P-types, see later. Therefore, it
seems that at least two major (LVA and HVA) classes of Ca channels exist in central
and peripheral neurones. LVA channels exhibit a low threshold of activation (> -50
mV) and inactivate quickly in a voltage-dependent manner. The other, HVA, class
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of Ca channels shows a high-threshold of activation (> -20 mV) and inactivate much
more slowly.
As described, on the basis of single-channel recordings and using specific channel
blockers, three components of the HVA Ca current were characterised, N-, L- and P-
type. N- (= neither L nor T or neuronal) type Ca channels have been recorded only
in cells of neuronal origin. Indeed, it seems that in some neuronal types only N-type
Ca currents are present (Tsien et al. 1988; Hess, 1990). N-type channels are activated
at potentials positive to -20 mV and blocked irreversibly by the peptide toxin oo-
conotoxin GVIA (w-CgTx) (Fox et al. 1987b; Plummer et al. 1989). This toxin
affects L-type current only to a minimal degree (McCleskey et al. 1987; Oyama et
al. 1987). Furthermore, N-type channels are insensitive to dihydropyridine (DHP)
drugs, unlike L-type channels. They show a unitary conductance from 12 to 15 pS,
with 110 mM Ba2+ as the charge carrier (Fox et al. 1987a; Swandulla et al. 1991).
This type of HVA current has a slower inactivation rate than for T- and faster than
for L-type current. The inactivation rate is very variable and, on average, has a time
constant, t;, of 50-80 ms (Nowycky et al. 1985; Plummer & Hess, 1991). For
example, inactivation time constant ranges from around 60 ms in chick DRG
neurones (Fox et al. 1987a) to over 500 ms in rat sympathetic neurones (Hirning et
al. 1988a), and around 800 ms in neuroblastoma cells (Docherty, 1988). Inactivation
time constants in different cells, indeed, can vary from 25 to several hundred
milliseconds (Fox et al. 1987b; Gross & Macdonald, 1987; Wanke et al. 1987).
Inactivation appears to be dependent on intracellular Ca concentration and duration
of depolarisation. The stronger the depolarisation, the more complete the inactivation.
However, in some cells even with longer test pulses of several hundred milliseconds,
N-type current does not inactivate completely and a large sustained, slowly
inactivating component is present (Plummer & Hess, 1991). There even appears to
be diversity of inactivation time constants of N-type current within a single cell type.
In frog sympathetic neurones, N-type channels can be seen that rapidly inactivate (t;=
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50 ms) with depolarisations to -10 mV in some patches, while in others there appears
to be little or no inactivation during a 320 ms test pulse (Kongsamut et al. 1989).
Other reports also described the inactivation rates of individual, otherwise identical,
channels to vary by more than a factor of ten (Cavalie et al. 1985; Rittenhouse &
Hess, 1994). Single channel recordings of N-type channel openings in rat superior
cervical ganglion neurones have suggested that not only can different types of N-type
current inactivation be seen in a single cell, but individual channels may be able to
switch between slow and fast inactivating states (Plummer & Hess, 1991).
L- (= /ong lasting) type of Ca channels can be operationally defined at the single
channel level by a combination of HVA voltage-dependence, slow or negligible
inactivation, large unitary slope conductance (20-27 pS), responsiveness to BayK
8644 and other DHP drugs and slightly larger permeability for Ba2+ than for Ca2+ ions
(Fox et al. 1987b; Bean, 1989b; Yang et al. 1993; Haack & Rosenberg, 1994). The
channels activate at relatively positive test potentials (> -10 mV) and show little
inactivation during depolarisation. The L-type current can be isolated at a holding
potential of -40 mV, where N- and T-type currents are inactivated. Openings of L-
type Ca channels are greatly enhanced by BayK 8644, a DHP Ca channel agonist,
whereas N-type and T-type Ca channels are not significantly affected (Fox et al.
1987a). However, there are some variations present among different cell types;
activation and inactivation kinetics may vary widely and, furthermore, it appears that
a small sensitivity to oo-CgTx exists, at least in some neuronal cells, see Chapter 1.2.
DHP-sensitive L-type Ca channels are found in most neurones, gland and muscle
cells (Bean, 1989b; Pelzer et al. 1990; Porzig, 1990).
Some HVA Ca channels possess different conductances and inactivation rates than
N- and L-type channels and they are oo-CgTx- and DHP-insensitive (Charlton &
Augustine, 1990). Llinas et al. (1989) discovered a novel P-type channel type in
cerebellar Purkinje cells. The channel exhibits 5-8 pS conductance in 100 mM Ca2+
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as the charge carrier. The P-type current shows a very slow rate of inactivation
during a 2 s test pulse, and in that way is similar to L-type current (Llinas et al.
1989). However, P-type channels are inactivated at holding potentials between -60
and -20 mV (Regan, 1991), which is considerably more negative than for L-type
channels (Fox et al. 1987b). Furthermore, P-type channel is sensitive to Cd2+ and
Co2+, but not to to-CgTx or DHPs (Llinas et al. 1989). The specific block of the
channel was achieved by an application of a venom toxin FTX. In cerebellar slices,
FTX blocked Ca-dependent spikes and in a squid giant synapse inhibited synaptic
transmission without affecting the presynaptic action potential. A synthetic P-type
channel blocker co-Aga-IVA has proved to be a useful tool in investigations of
putative P-type channels in different cell types (Mintz & Bean, 1993). So far, P-type
channels have been found to be abundant in cerebellar (Pearson et al. 1993;
Momiyama & Takahashi, 1994) and spinal neurones (Momiyama & Takahashi, 1994),
hippocampal CA1 region (Mintz & Bean, 1993; Momiyama & Takahashi, 1994), rat
visual cortex (Mintz & Bean, 1993), rat neocortical pyramidal neurones (Brown et
al. 1994), DRG cells (Mintz & Bean, 1993), in a smaller quantity in hippocampal
CA3 area (Mintz & Bean, 1993) while none were found in sympathetic ganglion
neurones (Mintz & Bean, 1993).
Recently, it has been suggested that some other (sub)types of HVA Ca channels
exist. Randall et al. (1993) isolated a current that was insensitive to specific channel
blockers, but was inhibited by Cd2+, oo-CgTx-MVIIC and by a large concentration of
w-Aga-IVA. In cerebellar granule cells, this novel Q-type Ca current constitutes 43%
of total Ca current. This is a HVA current and possibly has a role in synaptic
transmission, together with N-type current (Wheeler et al. 1994). It is thought that
another recently described R-type HVA Ca current also exists in cerebellar granule
cells (Wheeler et al. 1994). The R-type current appears to be sensitive to Cd2+ and




It appears that a combination of w-CgTx and DHP antagonists completely blocks
Ca current in many cell types, such as neuroblastoma cells (Narahashi et al. 1987),
but not in all. Various cells, such as rat pheochromocytoma cells (Plummer et al.
1989), DRG neurones (Regan et al. 1991; Scroggs & Fox, 1992a), hippocampal cells
(Mogul & Fox, 1991; Regan et al. 1991), spinal cord neurones, visual cortex (Regan
et al. 1991) and rat dorsal raphe neurones (Penington et al. 1991) contain other, yet
unidentified, type of HVA current. It is possible that a part of it is P-type current,
because FTX has not yet been applied to all of these cells. However, single-channel
experiments showed that this unidentified type of HVA current might exhibit, unlike
P-type current, similar unitary conductance to N- and L-type current.
LVA Ca channels such as T-type channels, have been described in a variety of
cells. There is evidence that suggests their presence in neuronal, glandular, heart and
skeletal muscle cells (Fox et al. 1987b; Liu & Lasater, 1994b). In addition to chick
(Carbone & Lux, 1984; Carbone & Lux, 1987; Fox et al. 1987a; Swandulla et al.
1991), rat (Ewald et al. 1988a; Mintz et al. 1992; Scroggs & Fox, 1992b) and mouse
(Anderson & Harvey, 1987; Kostyuk & Shirokov, 1989) DRG neurones, T-type has
also been identified in mammalian hippocampus (Tsien et al. 1988), neocortex
(Brown et al. 1994), neostriatum (Bargas et al. 1991; Hoehn et al. 1993; Surmeier et
al. 1993), retinal ganglion cells (Liu & Lasater, 1994b), spinal motoneurones (Berger
& Takahashi, 1990), cerebellar Purkinje cells (Regan, 1991; Regan et al. 1991; Mintz
et al. 1992; Bindokas et al. 1993; Hockberger & Nam, 1994), amygdala (Zhou et al.
1994), dorsal raphe (Penington & Kelly, 1990; Penington et al. 1991) and
neuroblastoma cells (Tsunoo et al. 1985; Williams et al. 1985; Narahashi et al. 1987).
There are no such apparent differences in T- (= transient) type channels in different
cell types. They share a small unitary conductance (5-8 pS), rapidly transient channel
kinetics, slow deactivation of tail currents, activation at more negative potentials (>
-60 mV) and stability of the channel activity in cell-free conditions (Carbone & Lux,
1984; Fox et al. 1987b; Bean, 1989b; Porzig, 1990; Schroeder et al. 1990). Unlike
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N- and L-type channels, T-type channels have equal unitary conductance for Ca2+ and
Ba2+ (Porzig, 1990). Electrophysiological^, T-type channels activate at more negative
potentials than the other channel types and can thus be studied in relative isolation.
This is also a some what variable aspect of T-type channels, because the voltage-
dependency of activation of T-type channels can become significant at potentials as
negative as -65 mV in sensory neurones (Carbone & Lux, 1984; Fox et al. 1987b),
but at -50 mV in heart cells (Bean, 1985). In DRG cells, the current amplitude and
the rate of decay of the current increases with stronger depolarisations until both
reach a maximum at approximately -40 mV (Carbone & Lux, 1984). Scroggs and Fox
(1991; 1992a) proposed that the density of T-type current in neurones could depend
on the cell size. In DRG neurones, T-type current was more prominent in smaller
rather than larger diameter neurones. T-type channels are more sensitive to Ni2+ and
amiloride and, in general, they are resistant to DHP drugs, although some reports
suggested that these compounds could non-specifically block T-type current (Bean,
1989b; Pelzer et al. 1990). They are more resistant to block by Cd2+ ions than L-type
channels and block by oo-CgTx is very weak and reversible (Nowycky et al. 1985;
Fox et al. 1987b). Because of the lack of specific ligands, biochemical analyses of
these channels have been sparse.
Not all cells possess both classes of Ca channels. HVA and LVA channels co-exist
in central neurones, such as hippocampal pyramidal CA3 cells (Mogul & Fox, 1991),
rat petrose ganglion neurones, rat, mouse and chick DRG neurones and mouse
cerebellar granule cells (Slesinger & Lansman, 1991a). An increase in the proportion
of HVA current with ontogenetic development has been described in hippocampus,
chick DRG cells and autonomic neuronal precursor cells (Yaari et al. 1987; Bean,
1989b; Thompson & Wong, 1991). N- and L- but virtually no T-type channels are
expressed in frog sympathetic neurones (Lipscombe & Tsien, 1987), rat myenteric
plexus neurones (Hirning et al. 1990) and superior cervical ganglion cells (Hirning
et al. 1988a). T- and L- but no N-type are reported in chick and newborn rat DRG
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neurones, rat hippocampal CA1 cells, rat petrose and nodose neurones, neuroblastoma
(N1E-115) cells, GH3 pituitary cells, cardiomyocytes from dog and frog atrium, most
muscle cells, gland cells, ciliates, fibroblasts and astrocytes (Tsien et al. 1988). Some
cells appear to express only one type of HVA channels, e.g. L-type in adrenal
chromaffin cells (Fenwick et al. 1982; but see Artalejo et al. 1994). It was suggested
that T-type current is never found in the absence of HVA current, however there are
some exceptions, as in neoplastic B lymphocytes, where only T-type channels are
present.
N-, L- and T-type channels can be further characterised by their ion selectivity and
sensitivity to inorganic blockers. N- and L-type channels are more permeable to Ba2+
than Ca2+, whereas T-type channels show equal selectivity for these two cations in
sensory, neuroblastoma, hippocampal and cerebellar granule cells (Fox et al. 1987b;
Yaari et al. 1987; Kostyuk & Shirokov, 1989; Marchetti & Robello, 1989; Slesinger
& Lansman, 1991a; Kasai, 1992). However, it has been reported that in rat
hypothalamic neurones, substituting Ba2+ for Ca2+ decreases LVA current by 40-50%
(Akaike et al. 1989). One explanation could be that these two ions have a differential
effect on Ca channel gating. Indeed, it was shown that less inactivation of HVA
current was observed in the presence of Ba2+ rather than Ca2+ (Eckert & Chad, 1984;
Sanguinetti & Kass, 1984; Kass, 1987). Specific inorganic drugs could also help to
differentiate Ca channel currents in most cell types. L- and N-type channels appear
to be more sensitive to Cd2+, whereas T-type channel is easily blocked by Ni2+ (Fox
et al. 1987b; Yang et al. 1993). In chick and mouse DRG neurones, 20-50 pM Cd2+
blocked 90% of HVA current and 50% of T-type current (Fox et al. 1987b; Gross &
Macdonald, 1987). However, in rat hippocampal cells, Cd2+ completely suppressed
both the HVA and LVA components (Yang et al. 1993). In cerebellar granule cells,
Cd2+ (1 pM) completely abolished all calcium currents (Bossu et al. 1994). Ni2+ was
more specific in its block and rather selectively reduced T-type current but not HVA
current (Fox et al. 1987b). Similar observations have been made in neuroblastoma
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cells (Narahashi et al. 1987; Twombly et al. 1988) and hippocampal cells (Mogul &
Fox, 1991). However, Akaike et al. (1989) reported that LVA current was more
sensitive to Cd2+ than Ni2+ in hypothalamic neurones, and the current was also
sensitive to Zn2+. Sensitivity of the LVA channel to Zn2+ has also been demonstrated
in amygdaloid neurones, where these currents are more sensitive to Ni2+ than to Cd2+
(Akaike et al. 1989). The trivalent cation La3+ appears to be non-selective in the
inhibition of Ca currents and blocks both HVA and LVA components in mouse DRG
(Kostyuk & Shirokov, 1989), rat hippocampal, amygdaloid and hypothalamic
neurones (Akaike et al. 1989). Another lanthanide Gd3+ blocks predominantly N-type
current with a presumably direct action on the channel, in neuroblastoma-glioma
hybrid cell line NG108-15 (Docherty, 1988).
None of the channel types have been identified exclusively with one particular
biological role. However, some evidence suggests that they might have specific
functions. T-type channels are often portrayed as generators of pacemaker activity
while L- and N-type channels could have a role in secretion and release of
neurotransmitters (Tsien et al. 1988). T-type channels have been shown to contribute
to pacemaker activity in heart cells (Hagiwara et al. 1988) and in mammalian CNS
neurones (Burlhis & Aghajanian, 1987). Ca entry through L-type channels has been
shown to link excitation to a variety of different responses: contraction in heart
(Bean, 1985), expression of c-fos in PC-12 cells (Morgan & Curran, 1986; Sheng &
Greenberg, 1990), release of substance P from DRG neurones (Rane et al. 1987) and
release of norepinephrine (NE) from undifferentiated PC-12 cells (Kongsamut &
Miller, 1986). N-type channels seem to play a dominant role in controlling transmitter
release in certain cases, e.g. NE release from sympathetic neurones, which is DHP-
resistant, but sensitive to both Cd2+ and oo-CgTx (Himing et al. 1988a). Wheeler et
al. (1994) argued that synaptic transmission between hippocampal CA3 and CA1
neurones was mediated by N-type channels. Selective inhibition of N-type Ca
currents by neurotransmitters and neuromodulators in a number of cells is also
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consistent with the blocking of synaptic function found in other studies, see Chapter
1.5.
Localization of a specific Ca channel type to a particular region of a neurone has
been proposed. There is evidence that N- and L-type Ca channels co-exist in motor
nerve terminals (Tsien et al. 1988; Stanley, 1991; Farilas et al. 1993) and in cell
bodies of sympathetic neurones (Lipscombe et al. 1988b; Delcour & Tsien, 1993;
Golard & Siegelbaum, 1993). The channels are sometimes found clustered in "hot-
spots" (Smith & Augustine, 1988). Proximity of Ca channel "hot-spots" to Ca-
sensitive mechanisms may be important for the rapid triggering of physiological
processes such as transmitter release in synaptic terminals (Tsien et al. 1988; Zucker,
1993a; Zucker, 1993b).
No interconversion between channel types has been detected (Fox et al. 1987a). It
appears that they are different but closely related proteins. A similar conclusion has
been reached in lipid bilayers studies of multiple Ca channels with different
conductances, kinetics and pharmacology. However, this hypothesis still awaits direct
stmctural analysis.
Pharmacology of calcium channels
As has been described in the previous chapter, there is still no generally accepted
classification of Ca channels. However, the existence of different types of Ca currents
could be studied on the basis of their voltage-dependency and different
pharmacological properties. The drugs that bind to Ca channels can, in general, be
described as Ca channel blockers or channel activators. In experimental and clinical
work, the most often used are 1,4-dihydropyridine derivatives (BayK 8644,
nimodipine, nifedipine and nitrendipine), phenylalkylamines (verapamil, D 600 and
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D 888) and benzothiazepines, e.g. diltiazem. Some other compounds also affect Ca
channel currents, such as co-CgTx, diphenylpiperazines (cinarizine, flunarizine) and
diphenylbutylpiperazines (pimozide, fluspirilene).
N-type Ca channels are rather specifically blocked by the peptide toxin from a
venom of the marine snail Conus geographus, co-CgTx, but not by DHP antagonists.
L-type channels are shown to be sensitive to DHPs and to various other organic
compounds. In skeletal muscle, heart and smooth muscle, L-type channels are
insensitive to oo-CgTx, whereas it is possible that similar channels from neuronal
tissue are slightly affected by the toxin (Porzig, 1990). Finally, T-type channels can
be blocked by phenytoin and amiloride and they are essentially resistant to DHPs and
to to-CgTx, for reviews see Godfraind et al. (1986), Tsien et al. (1988), Bean
(1989b), Hess (1990), Pelzer et al. (1990), Porzig (1990) and Swandulla et al. (1991).
The best characterised are L-type channels, that were first described inmammalian
cardiac cells on the basis of their electrophysiological properties (Reuter et al. 1982;
Cavalie et al. 1983). Later, it was shown that the channel could be specifically
blocked by 1,4-dihydropyridine antagonists and other drugs (Lee & Tsien, 1983).
DHP analogues have not been shown to be effective in all cell types. At
concentrations of 10 pM or more they do not modify Ca spikes in a variety of cells,
such as rat pars intermedia, rat synaptosomes and cortical slices, guinea-pig cortex
and hippocampus (Ogura & Takahashi, 1984). Nifedipine at the concentration of 10
pM had no effect on Ca current in rat superior cervical ganglion cells (Gurney et al.
1985). Furthermore, phenylalkylamines and benzothiazepines block Ca current only
at higher concentrations (10-100 pM), as in rabbit nodose ganglion cells (Kurachi et
al. 1989). This has led to suggestions that their action is non-specific. However, Ca
channel blockers, and in particular DHP compounds, have been shown to reduce the
L-type component of Ca current in many cell types (Garcia et al. 1984; Sanguinetti
& Kass, 1984; Rane et al. 1987; Akaike et al. 1989; Aosaki & Kasai, 1989; Scott &
Dolphin, 1990). Single-channel recordings showed that the DHP antagonist nifedipine
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decreased L-type channel opening probability in chick (Fox et al. 1987b) and in
mouse (Kostyuk & Shirokov, 1989) sensory neurones. It appears that the block by
DHP antagonists of the current is stronger in cardiac or smooth muscle cells than in
neurones. Bean (1989b) showed that the block is typically less than 50% of the total
current in DRG cells, whereas 100% in muscle. In neurones the block by DHPs is
never complete. Fox et al. (1987b) showed that nifedipine (10 pM) blocked 60% of
L-type current evoked from VH -40 mV, while producing no effect on current elicited
from VH -80 mV in chick DRG cells. On the other hand the same concentration of
the drug completely abolished L-type current in cardiomyocytes (Sanguinetti & Kass,
1984). This finding suggests that neuronal L-type channels have lower sensitivity to
DHPs than muscle L-type channels or that the elicited current was not completely L-
type current. Furthermore, some neurones that possess L-type channels are completely
insensitive to DHP compounds. Nifedipine and BayK 8644 did not affect Ca current
in hippocampal, cortical (Ogura & Takahashi, 1984) and rat sympathetic (Gumey et
al. 1985) neurones.
Drugs with a stimulating effect on L-type Ca channel activity, like BayK 8644,
202-791, H 160/51, have only been discovered among the DHP derivatives (Garcia
et al. 1984; Tiaho et al. 1990). The DHP agonist BayK 8644 (5 pM) enhanced the
activity of L-type Ca channels, but not that of N- or T-type channels (Nowycky et
al. 1985; Fox et al. 1987b). The tail current, which is the most consistent part of L-
type current, is found to be greatly prolonged by an application of DHP agonists
following repolarisation (Brown et al. 1983; Plummer et al. 1989; Cox & Dunlap,
1992). In electrophysiological studies, an increase in inward Ca current by Ca channel
activators was mainly due to a marked prolongation of the single-channel open state
(Brown et al. 1984; Fox et al. 1987a). Single-channel studies in DRG neurones and
rat hippocampus suggested that nifedipine (10 pM) caused fewer L-type channel
openings, and the application of BayK 8644 (5 pM) left the channels in the open
state for longer (Rosenberg et al. 1986; Fox et al. 1987a; Kostyuk & Shirokov, 1989;
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Mogul & Fox, 1991). BayK 8644 (5 pM) increased Ca current amplitudes in variety
of cells, including neuroblastoma (Docherty, 1988) and DRG (Fox et al. 1987b; Scott
& Dolphin, 1988) cells. However, it appears that DHP agonists can not open Ca
channels alone, i.e. in a voltage-independent manner. Furthermore, one group of
stereoisomers acted as activators, e.g. (-)BayK 8644 and (+)202-791, and the other
group as blockers, e.g. (+)BayK 8644 and (-)202-791 (5 pM) of the channel in
cultured rat sensory neurones (Dolphin & Scott, 1988). The effect of both the
activators and the blockers was voltage-dependent. Ca currents were potentiated only
when elicited from fairly negative holding potentials (VH -80 mV); at more positive
holding potentials, for instance above -30 mV, an inhibition of the currents rather
than an activation was observed. This effect was not seen in guinea-pig ventricular
cells (Hamilton et al. 1987), suggesting that it might be tissue dependent.
Most authors agree that these activators and blockers share a common high-affinity
DHP binding site in membrane (Williams et al. 1985; Hamilton et al. 1987). Some
toxins, like gonioporatoxin, atrotoxin and taicatoxin (Porzig, 1990) have also been
shown to interact allosterically with this DHP binding site. Gonioporatoxin and
atrotoxin are both activators, and taicatoxin is a voltage-dependent blocker of L-type
channels.
There is evidence (Porzig, 1990) to suggest that L-type Ca channels could also be
modulated indirectly, via a specific intracellular mechanisms. The author argued that
three mechanisms are predominant. The first one describes changes in receptor
density or affinity. For example, in frog ventricular cells, P -adrenergic stimulation
causes a large increase in L-type Ca current, thought to be due, at least in part, to a
recruitment of, at rest, "unavailable" channels (Bean, 1985). cAMP- and/or Ca-
mediated phosphorylation probably play a role here. The other two modulatory
mechanisms characterise an involvement of G-proteins and the effect of
phosphorylation of the channel protein by endogenous protein kinases. It has been
suggested that the effect of DHP Ca channel activators like BayK 8644, at least in
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neurones, critically depends on the presence of activated G-proteins (Scott & Dolphin,
1988). This may explain the rather unusual observation that when rat DRG neurones
are pretreated with pertussis toxin (PTX), BayK 8644 causes a decrease in Ca current,
rather than an increase. It therefore appears that BayK 8644 requires a PTX sensitive
G-protein to be able to elicit activation of Ca current. When the G-protein is
inactivated, only inhibition of the current is seen. Furthermore, Gs-mediated
amplification of the stimulatory effect of BayK 8644 has been observed in myocardial
Ca channels (Yatani et al. 1987; Yatani et al. 1988). These results suggest that G-
proteins help to maintain the Ca channel protein in an activatable state, perhaps by
stabilizing the resting or open state of the channel, see Chapter 1.6. Therefore, it was
to expect that G-proteins would antagonise the effect of Ca channel blockers, which
appear to act by stabilizing the inactivated channel state. Indeed, Scott and Dolphin
(1987) reported a loss of blocking potency for DHP antagonists, verapamil and d-cis-
diltiazem in GTP-y-S perfused DRG neurones.
Binding studies using tissue homogenates from heart, smooth muscle, skeletal
muscle and brain have shown that DHPs, phenylalkylamines and benzothiazepines,
that all act on L-type channels, occupy distinct but allosterically coupled binding sites
on the channel protein, probably located on the non-glycosylated arsubunit of the
voltage-gated L-type channel (Godfraind et al. 1986; Janis et al. 1987; Hosey &
Lazdunski, 1988). Catterall (1993) suggested that the effect of DHPs occurs some
distance away from the DHP binding site, and that DHPs are probably allosteric
modulators of L-type channel rather than simple channel blockers. One needs to be
cautious in the interpretation of the results of DHP blockers. It might still be possible
that the compounds affect either non-inactivating N-type component of HVA current
or some other, yet unidentified, neither L- nor N-type, Ca current.
N-type Ca channel current, with inactivation rates slower than in T- and faster than
in L-type currents, has been described using single-channel patch-clamp recordings
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in neuronal cells (Fox et al. 1987b). The inactivation time constant covers a broad
spectrum (50-500 ms) with conductances of 11-20 pS (Tsien et al. 1988), see Chapter
1.1. Therefore, it appears that the electrophysiological criteria are not sufficient to
characterize this type of current. An important finding was that this neuronal Ca
channel can be blocked by the snail venom oo-CgTx (Kerr & Yoshikami, 1984;
Oyama et al. 1987; Farilas et al. 1993). Many researchers (Aosaki & Kasai, 1989;
Plummer et al. 1989; Bossu et al. 1991; Regan et al. 1991; Scroggs & Fox, 1991;
Cox & Dunlap, 1992) showed that oo-CgTx blocks N-, but not L-type channels.
Previously, it was thought that oo-CgTx blocked both N- and L-components of HVA
current. This was argued by some groups working on chick DRG cells (Kerr &
Yoshikami, 1984), rat sympathetic ganglion and in hippocampal (McCleskey et al.
1987) neurones. But, when DHP antagonists became available to identify selectively
the current component exclusively carried by L-type channels, w-CgTx was shown
to be unable to block L-type current in frog and rat sympathetic ganglion neurones
(Plummer et al. 1989). In rat pheochromocytoma PC 12 cells, L-type current appears
insensitive, but w-CgTx reveals two pharmacologically distinct components ofN-type
current. One is blocked irreversibly, and the other reversibly (Plummer et al. 1989).
In agreement with that hypothesis, Kasai and Aosaki (1989) found no evidence for
persistent block of L-type channels by co-CgTx in chick DRG neurones. That was
later confirmed by Aosaki and Kasai (1989) at the single channel level. Therefore,
it appears that co-CgTx could be used to analyse the N-type component of Ca current
(Bean, 1989b; Cox & Dunlap, 1992), although L-type channels in neurones might be
slightly sensitive to the toxin (Porzig, 1990). This is additionally supported by the
fact that w-CgTx has little or no effect on the Ca currents in cardiac, smooth or
skeletal muscle (McCleskey et al. 1987) that do not contain N-type channels. It was
also suggested that the effect of co-CgTx is stronger in peripheral neurones, where
70-90% of the total current is blocked by this toxin, than in central neurones with 50-
60% block (Protti et al. 1991; Swandulla et al. 1991). In addition to that, w-CgTx,
but not DHP antagonists, strongly inhibit neurotransmitter release in central neurones
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(Kerr & Yoshikami, 1984).
Evidence for an indirect modulation ofN-type channels is also available. Specific
inhibition of N-type Ca current by transmitters was observed, as with dynorphin A
acting on K-opioid receptors in mouse DRG cells (Werz & Macdonald, 1985; Gross
& Macdonald, 1987), neuropeptide Y in myenteric plexus (Himing et al. 1988a),
adenosine in hippocampal neurones (Madison et al. 1987) and noradrenaline acting
on a-adrenoreceptors in frog sympathetic ganglia (Lipscombe et al. 1988b), see
Chapter 1.5.
Llinas et al. (1989) described P-type HVA channel, that is neither DHP nor oo-
CgTx sensitive and it is blocked by a toxin fraction from a funnel-web spider
Agelenopsis aperta venom - FTX. This channel has recently been cloned and the lack
ofDHP and oo-CgTx sensitivity confirmed (Mori et al. 1991). Originally it was found
in cerebellar Purkinje cells to constitute 90% of the HYA Ca current, and using a
synthetic P-type channel blocker oi-Aga-IVA, the current was shown to exist in other
cell types. In hippocampal CA1 neurones the P-type current component is 26% of the
total Ca current, in visual cortex it constitutes 32%, spinal cord 45%, DRG neurones
23% and hippocampal CA3 neurones 14% (Mintz et al. 1992). The block of P-type
current is voltage-dependent. The current is blocked by Cd2+ and Co2+ and showed
an unusual sensitivity to block by Ni2+ ions (Llinas et al. 1989).
The Q- and R-type channels in cerebellar granule neurones are resistant to
blockade by oo-CgTx-GVIA, nimodipine and oo-Aga-IVA at concentrations sufficient
to eliminate N-, L-, and P-type channels, respectively (Wheeler et al. 1994). The Q-
type channels are completely blocked by oo-CgTx-MVIIC and by a high
concentration of oo-Aga-IVA (100 times larger concentration than needed for the P-
type channel block). In contrast, R-type channels are little affected by either of these
treatments. The current is slowly inhibited by oo-CgTx-GVIA, unlike N-type current
(McCleskey et al. 1987; Aosaki & Kasai, 1989).
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A low-threshold, rapidly inactivating T-type Ca current has been shown in many
cells containing voltage-dependent Ca channels (Tsien et al. 1988). However, there
is a lack of reports on specific modulation of this Ca current component by dmgs and
neurotransmitters. The relevant observations from electrophysiological recordings
using a voltage-clamp or single-channel technique were able to distinguish T-type
current from L-type on the basis of voltage-dependency. Biochemical analysis showed
that T-type channel is a separate identity that consists of specific proteins, which are
different than for N- or L-type channels and also the product of different genes. For
instance, in myodysgenic mice, a mutant that lacks L-type Ca channels in skeletal
muscle cells, T-type currents are fully preserved (Bean, 1985). In spite of a lack of
a high-affinity ligand that could be used to analyse T-type channels, some drugs
inhibit T-type currents preferentially and have only low potency for L-type channels.
Phenytoin blocks transient T-type Ca current in neuroblastoma cells at concentrations
of 3-100 pM, not affecting the slowly inactivating L-type component (Twombly et
al. 1988). Flunarizine is also shown to be a potent blocker of LVA current in rat
hypothalamic neurones (Akaike et al. 1989). The same group reported an interesting
finding that BayK 8644 partially blocked LVA current in hypothalamus. Other
examples include retinoic acid and tetramethrin (Tsunoo et al. 1985) and the diuretic
compound amiloride (Tang et al. 1988; Mogul & Fox, 1991). Among the inorganic
cations, Ni2+ in low concentrations of 40 pM blocked T-type current in rabbit
sinoatrial node cells (Hagiwara et al. 1988) and in chick sensory neurones (Fox et al.
1987b). Cd2+ and Co2+ also blocked T-type channel (Hagiwara et al. 1988; Schroeder
et al. 1990).
Indirect inhibition ofT-type currents, probably via G-proteinmediated mechanisms,
has also been reported (Berger & Takahashi, 1990; Schroeder et al. 1990; Scott et al.
1990; Liu & Lasater, 1994a). In neuronal cells, a functional coupling of T-type
channels to G-protein (possibly G0) is suggested in studies with the putative
neurotransmitter neuropeptide Y. The drug inhibited T- and L-type currents in rat
DRG cells (Ewald et al. 1988b). In both cases PTX abolished this inhibitory response.
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Marchetti et al. (1986) showed that dopamine irreversibly inhibited T-type current in
chick DRG neurones. In the same experiment, HVA current showed a small and
reversible slowing of the activation kinetics.
Structure of calcium channels
Voltage-sensitive Ca channels constitute an essential link between transient changes
in membrane potential and a variety of cellular responses including secretion of
neurotransmitters and hormones, initiation of contraction in cardiac and smooth
muscle, and activation of second messenger responses in many cell types.
The L-type Ca channel is uniquely sensitive to DHP drugs and due to the high
density of DHP binding sites on Ca channels in skeletal muscle, these are the most
extensively studied and characterised, for reviews see Brown et al. (1984), Janis et
al. (1987), Campbell et al. (1988), Hosey & Lazdunski (1988), Hess (1990) and
Catterall (1993).
The reports (Curtis & Catterall, 1984; Borsotto et al. 1985; Catterall, 1988;
Catterall, 1993; Zhang et al. 1993; Bean, 1994b) describing the structure of a purified
Ca channel from skeletal muscle, showed the existence of an a-subunit (170 kDa),
a (3-subunit (50 kDa), a y-subunit (32 kDa) and S-subunit (26 kDa). All subunits
constitute integral components of the DHP receptor. The hypothesis that the DHP
receptor is composed of these subunits has been confirmed by reconstitution in lipid
bilayers. The reconstituted channel possessed the binding sites for Ca channel
blockers (Curtis & Catterall, 1986).
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It appears that the a-subunit of the DHP-sensitive Ca channel is composed of two
distinct components, the ar and the a2-subunit (Tanabe et al. 1987; Campbell et al.
1988; Ellis et al. 1988). The a,-subunit probably contains the binding sites for
dihydropyridine and phenylalkylamine (Hosey & Lazdunski, 1988; Hess, 1990) and
is also a substrate for cAMP-dependent protein kinase (Hosey et al. 1986; Hosey &
Lazdunski, 1988), Ca/calmodulin-dependent protein kinase (Hosey et al. 1986;
Takahashi et al. 1987) and protein kinase C (Campbell et al. 1988). The primary
amino acid sequence of the a rsubunit has been deduced from its cDNA and it was
shown to contain four domains of high homology and each domain is believed to
possess six, presumably a-helical, membrane-spanning segments (S1-S6) (Tanabe et
al. 1987). The S4 segment contains a pattern of positive charges and appears to be
a voltage sensor of the Ca channel (Tanabe et al. 1987). The DHP binding site is
located at the interface between domains S3 and S4, and may affect domain-domain
interactions that are important determinants of activation gating (Catterall et al. 1993).
Kinetic properties, such as inactivation kinetics, appear to be determined by a
sequence of amino acids in the S6 segment of the first repeat of the arsubunit
(Zhang et al. 1994). Furthermore, the arsubunit has a higher degree of homology to
the a-subunit of the voltage-activated Na+ channel (Tanabe et al. 1987; Williams et
al. 1992).
The a2-subunit and the 5-subunit form an a26 complex. The a2-subunit is easily
identified following treatment of a2d complex with sulfhydryl reducing agents. When
treated with sulfhydryl reducing agents this complex undergoes a reduction in
molecular mass. This is probably due to the dissociation of an additional protein
component, the 6-subunit (Takahashi et al. 1987). It has been reported that the a2-
subunit consists of a large glycosylated extracellular domain and a relatively small
transmembrane domain (Takahashi et al. 1987; Williams et al. 1992). This subunit
is not phosphorylated and does not contain binding sites for DHP or




The 6-subunit contains a hydrophobic transmembrane domain. The functional role
of the S-subunit is not known.
The P-subunit of the DHP-sensitive Ca channel has been shown to be a substrate
for cAMP-dependent protein kinase and protein kinase C (Curtis & Catterall, 1986;
Ishikawa et al. 1993). It is tightly associated with an intracellular domain of and
possibly facilitates coupling between movement of the voltage sensors and opening
of the channel pore (Bean, 1994b). A monoclonal antibody to the P-subunit affects
the current magnitude and activation and inactivation kinetics of the Ca channel
reconstituted into planar lipid bilayers (Hymel et al. 1988). This result and the
presence of phosphorylation sites on the P-subunit, suggest that the peptide may play
a part in regulation of Ca channel activity.
There is evidence to suggest that the y-subunit has both extracellular and
transmembrane domains and, so far, is shown to be unique to skeletal muscle (Curtis
& Catterall, 1984; Borsotto et al. 1985; Campbell et al. 1988). The y-subunit appears
to be a tightly associated regulatory subunit of the Ca channel.
The oligomeric subunit structure of the skeletal muscle channel, shows that the a r
subunit is the major transmembrane component of the receptor and the a2-subunit is
the major glycoprotein. The P-subunit is mostly cytoplasmic protein, but may be
tightly associated to the membrane or other subunits. Finally, the y-subunit is a part
of the membrane and is a glycoprotein. The association of the four subunits appears
to be very tight and highly specific (Campbell et al. 1988). Takahashi et al. (1987)
proposed a model for the subunit stmcture of the DHP-sensitive Ca channel in
skeletal muscle, see Figure 1.1, in which the a,-subunit forms the ion channel and
is surrounded by the a2- and y-subunits. The P-subunit is probably attached non-
covalently to the cytoplasmic side of ctj, whereas the 6-subunit forms a complex with
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the a2-subunit. The a28 complex extends to the external surface and contains
glycosylation sites. Similar model has also been suggested by other researchers
(Catterall, 1988; Hosey & Lazdunski, 1988).
It is still not clear whether other Ca channels are similar to the skeletal DHP
sensitive channel. Antibodies raised against the S3 - S4 loop of the a,-subunit of the
DHP sensitive skeletal muscle channels cross react with DHP insensitive channels in
neuroblastoma cells (Reeve et al. 1994). Nevertheless, mice that lack skeletal muscle
DHP receptors, have normal levels of DHP binding sites in heart and sensory
neurones (Tanabe et al. 1991; Mori et al. 1993; Tanabe et al. 1993), which is an
indication that there are differences between DHP sensitive channels in different
regions. In addition, the unitary conductance of skeletal DHP channels is lower and
they activate around ten times slower than DHP channels elsewhere (Rosenberg et
al. 1986). It is possible that different genes code for the channels in different tissues.
There are certain similarities with recently cloned human neuronal L-type channel.
This channel was shown to possess most of the predicted voltage and
pharmacological properties (Williams et al. 1992). Interestingly, this group reported,
that the arsubunit does not pass current in the absence of the p-subunit.
Functions of calcium channels
There is a strong body of evidence to suggest that different types of Ca channels
regulate important functions, such as transmitter release, pacemaker activity, secretion
and gene expression (Miller, 1987; Tsien et al. 1988).
Selective modulation of Ca channels by specific drugs is the technique most often
used to assess the contribution of individual channel types to the overall function of
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a cell. Such studies show that, in most cases, the biological function is rarely
associated exclusively with an individual channel type.
The mechanism of transmitter release triggered by Ca entry into neurones has been
studied by recording presynaptic Ca concentration with Ca-sensitive dyes and by
controlling the levels of internal Ca with photosensitive Ca chelators. At fast
synapses, it is suggested that [Ca]; decays slowly (in seconds) after presynaptic action
potentials, whereas transmitter release lasts for only a few milliseconds after each
spike. Simulations of Ca diffusing from Ca channels opened during action potentials
suggest that neurotransmitter is released by a brief, localized increase in [Ca];
reaching about 100 pM (Augustine, 1987; Zucker, 1993b).
N-type current appears to represent a major component of voltage-dependent Ca
current in neuronal cells. There is a strong evidence showing that the release of
catecholamines in nerve terminals and sympathetic neurones is predominantly
controlled by voltage-dependent Ca entry through N-type channels (Tsunoo et al.
1985; Himing et al. 1988a; Lipscombe et al. 1988b). The depolarisation-induced
secretion of the neurotransmitter is not, or only partially, reduced by organic blockers
of L-type channels. 5-HT release in the hippocampus during electrical stimulation of
the dorsal raphe (DR) area is blocked by cadmium, but not by dihydropyridine
antagonists (Sharp et al. 1990). Other laboratories have pointed to a possible
involvement of L-type channels during neurotransmission. Pharmacological studies
of high potassium-induced transmitter release from cultured neurones (Hirning et al.
1988a) implicate N-type channels, e.g. norepinephrine release from sympathetic
cultures or L-type channels, e.g. substance P release from DRG cultures, role in a
transmitter release. Furthermore, oo-CgTx, a blocker of N-type channels, inhibited
transmission at the frog neuromuscular junction but not at the same site in the mouse
(Anderson & Harvey, 1987). The release of a putative neurotransmitter substance P
from embryonic chick dorsal root ganglia and rat sensory neurones is inhibited by
nifedipine, a blocker of L-type channels, in a voltage-dependent manner (Perney et
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al. 1986; Rane et al. 1987). Catecholamine release from undifferentiated PC 12 cells
can be almost completely abolished by dihydropyridines (Garcia et al. 1984; Ogura
& Takahashi, 1984). However, dihydropyridines do not appear to affect substance P
release from slices of adult rat spinal cord (Miller, 1987).
Furthermore, Wheeler et al. (1994) reported that, together with N-type channels,
a novel Q-type channels might have a role in glutamatergic synaptic transmission at
hippocampal CA3 - CA1 synapses. These results support the idea that
neurotransmitter release may depend on multiple types of Ca channels under
physiological conditions (Wheeler et al. 1994). Himing et al. (1988a) proposed that
Ca entry via N-type channels may dominate the release of small vesicles that contain
only "classical" transmitters (such as catecholamines), whereas Ca influx through L-
type channels can release larger vesicles containing peptides (such as substance P).
The kinetic properties of the two channel types differ, so regular action potentials
could allow an activation of N-type channels and promote a release of small vesicles,
while intermittent bursts of impulses of high frequency might favour an activation of
L-type channels and exocytosis from larger vesicles.
A role of DHP-sensitive L-type channels in contraction of cardiac and smooth
muscle has been shown (Godfraind et al. 1986; Janis et al. 1987; Hosey & Lazdunski,
1988; Pelzer et al. 1990; Porzig, 1990). In many cases, Ca entry via L-type channels
is required for hormone secretion in endocrine cells. Artalejo et al. (1994) examined
the effect of Ca channels on secretion from chromaffin cells. Ca influx through the
three types of Ca channels (N-, P- and L-type) triggered secretion individually, but
P- and N-types were far less efficient, compared to L-type. In rat anterior pituitary
cells, that possess both L- and T-type channels, depolarisation-induced Ca influx and
hormone secretion was blocked with nanomolar concentrations of nimodipine,
nisoldipine and nifedipine (Enyeart et al. 1985) and stimulated by the L-type channel
activator BayK 8644 (Enyeart et al. 1985). However, these results certainly do not
prove an exclusive role for DHP-sensitive channels in stimulus-secretion coupling.
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It has been reported that synaptic stimulation is able to rapidly activate several
transcription factor genes, such as c-fos, that are believed to be involved in
modulation of gene expression that underlie neuronal plasticity (Sheng & Greenberg,
1990). In rat cerebral cortex, the expression of several transcription factor genes, such
as c-fos, fos-b and jun-B, is suppressed in medium containing DHP antagonists,
whereas BayK 8644 leads to an increased expression (Murphy et al. 1991). It is
possible that a target for the transcription factor genes might be the expression of L-
type channels. Further work is needed to clarify this interesting hypothesis.
T-type Ca channels are associated with current activation at relatively negative
membrane potential and rapid inactivation (Fox et al. 1987b). This activation with
relatively weak depolarisations has led to the suggestion that T-type current may be
involved in pacemaker activity in spontaneously active neurones (Llinas & Yarom,
1981; Burlhis & Aghajanian, 1987). Hagiwara et al. (1988) showed that T-type
current contributes importantly to the generation of pacemaker activity in
spontaneously active neurones, such as in rabbit sinoatrial node. In line with this
observation, it is possible that the bursting behaviour of various neurones in the
mammalian CNS involves regenerative Ca current passing through T-channels
(Burlhis & Aghajanian, 1987; Miller, 1987; Tsien et al. 1988; Bean, 1989b).
Furthermore, in some cells, such as adrenal glomerulosa cells (Cohen & McCarthy,
1987), fibroblasts and smooth muscle cells (Chen et al. 1988), T-type channels appear
to constitute a major voltage-gated Ca influx pathway and, therefore, might be
essential for contractile and secretory events in these cells.
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Effect of neurotransmitters on calcium currents
Introduction
There are many observations that support the hypothesis that neurotransmitters
modulate Ca channel currents (Dunlap & Fischbach, 1978; Reuter, 1983; Lipscombe
& Tsien, 1987; Madison et al. 1987; Bean, 1989a; Dolphin et al. 1989; Penington et
al. 1991; Elmslie, 1992; Menon-Johansson et al. 1993). This is a very substantial
finding, because it means that neurotransmitters can alter many functions of Ca
channels, and in this way affect plasticity of the transmission of signals in neuronal
and non-neuronal cells.
These studies indicated that neurotransmitters can affect Ca channel currents in
many mammalian central and peripheral neurones. At least two typical effects of
neurotransmitters on Ca current have been reported in the majority of neurones. First,
neurotransmitters can produce a change in the size of Ca current amplitude and,
second, they can alter Ca current kinetics.
A fundamental question that had to be answered was whether a neurotransmitter
modulates Ca channel current in the same way as Cd2+. Cd2+ directly blocks Ca
channels from the outside of the pore, whereas it was suggested that agonists reduce
Ca current by acting through one or more transducing molecules (Catterall, 1993;
Yang et al. 1993). If that is the case, the onset of the action of an agonist might be
expected to be slower than that for Cd2+. Surprenant et al. (1990) tested this
hypothesis in guinea-pig submucosal neurones by comparing the latency of the action
of NE and Cd2+, when both were applied transiently with a pressure pipette. The
group showed that a decrease in the Ca current amplitude was first observed with the
depolarising pulse given 15 ms after the start of the Cd2+ ejection. In the presence of
NE, a decreased current amplitude was detected with the stimulus given 220 ms after
the first NE pulse. These observations suggested that Cd2+ and NE used different
pathways to modulate Ca channel current.
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Moreover, in sympathetic neurones NE probably selectively inhibits N-type Ca
current rather than causing an overall reduction of Ca influx (Cox & Dunlap, 1992).
Kongsamut et al. (1989) showed that the inhibitory effect of NE on Ca current is
different from the effect of Cd2+. NE eliminated a decaying component and partially
inhibited a sustained component of Ca current in a voltage-dependent fashion. The
inactivation time of NE-sensitive component was consistent with the kinetic
properties of N-type channels. In contrast, Cd2+ inhibited Ca current without affecting
the time course of the current decay. The same result was reported by Akasu et al.
(1990) in rabbit vesical parasympathetic ganglion neurones.
Many studies suggested that a number of neurotransmitters modulate Ca current,
see Table 1.1. In vertebrate neurones Dunlap and Fischbach (1978) showed that a
number of transmitters, such as norepinephrine, GABA, 5-hydroxytryptamine,
dopamine, enkephalin and somatostatin, but not acetylcholine or glycine, reduced Ca
current in chick DRG neurones. Some of these actions of transmitters have been
confirmed, e.g. NE's action on a-adrenergic receptors in rat superior cervical
ganglion cells and enkephalin-induced inhibition of Ca current in mouse DRG cells
(Werz & Macdonald, 1985). A common finding is that this inhibition is incomplete,
and is usually between 30-60%, even at supramaximal concentrations of the
neurotransmitters (10-100 pM), (Lipscombe & Tsien, 1987; Dolphin et al. 1989;
Penington et al. 1991). The incompleteness of this effect raises questions concerning
which type of Ca current is affected following transmitter application and whether
different transmitters modulate different channel types.
In sympathetic ganglion neurones only 5-15% of Ca current is contributed by
dihydropyridine sensitive L-type current (Boland & Bean, 1993). In the presence of
3pM nimodipine, 3 pM oi-CgTx blocked 97% of the remaining current. In this
study, LHRH inhibited w-CgTx sensitive but not nimodipine sensitive current, and,
furthermore, had no effect on BayK 8644-enhanced Ca current. Therefore, it appears
that LHRH inhibited N-type, but not L-type current. LHRH also had no effect on the
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slowing of the tail current induced by BayK 8644 application, whereas it inhibited
a fast component of the tail current. A similar conclusion was reached by Caulfield
et al. (1992), when they examined the action of NE and acetylcholine on Ca current
in neuroblastoma x glioma hybrid NG108-15 cells. NG108-15 cells contain three
types (N-, L- and T-type) of Ca channels. Both ligands blocked Ca currents and the
effect was not occluded either by an application of nifedipine, an L-type channel
blocker, or Ni2+, which is more selective for T-type channels. More conclusively, in
the presence of co-CgTx the modulation of Ca current was completely abolished.
Carbone and Lux (1987) examined the modulation of dopamine on Ca currents, in
rat DRG neurones. Dopamine drastically inhibited Ca current. Similar effects of
dopamine were observed in chick sympathetic neurones (Marchetti et al. 1986) and
in clonal AtT-20 pituitary cell line (Brown et al. 1984). Both of these cell types lack
T-type channels and AtT-20 cells possess only L-type channels. This latter result
suggested that dopamine can act on L-type channels, rather than on N-type channels.
This view is strengthened by the observation that the effect of dopamine was
insensitive to changes in holding potential. Modulation of N- and L-type Ca channels
by oxotremorine acting on muscarinic receptors was studied together with NE acting
on a-adrenergic receptors in superior cervical ganglion neurones (Mathie et al. 1992).
It was shown that NE inhibited only N-type current, whereas oxotremorine
additionally depressed a DHP-potentiated tail current. In single-channel recordings,
oxotremorine reduced the probability of opening of single N- and L-type channels,
and acted via a diffusible second messenger. It appears that the compound activated
two different pathways, one a diffusible second messenger signalling pathway
inhibited both N- and L-type Ca channels, whereas a pathway activated by both
oxotremorine and NE inhibited only N-type Ca current. This modulation of L-type
Ca channels by oxotremorine was observed with 0.1 mM BAPTA, a potent chelator
of intracellular Ca, in internal solution, whereas in the presence of 20 mM BAPTA
the effect was abolished. With the higher level of BAPTA, the effect on N-type
current was seen, with both NE and oxotremorine. This mechanism of action may
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also be involved in the action of TRH mediated inhibition of HVA current in GH3
cells, and kainate in hippocampal neurones (Nistri & Cherubini, 1991).
There have been reports of transmitters decreasing T-type current (Marchetti et al.
1986; Carbone & Lux, 1987; Schroeder et al. 1990; Schroeder et al. 1991). This may
involve the activation of protein kinase C, since when activated by phorbol esters,
this kinase was observed to selectively inhibit T-type current in rat DRG cells
(Schroeder et al. 1990). T-type current has also been observed to be increased by
neurotransmitters in spinal cord neurones (Berger & Takahashi, 1990) and
hippocampal interneurones (Fraser & MacVicar, 1991).
Golard and Siegelbaum (1993) applied both NE and somatostatin simultaneously
to chick sympathetic neurones to test whether the Ca current inhibition was additive.
Initial application of somatostatin alone inhibited Ca current by 51%, whereas NE
inhibited the current by 31%. When both compounds were applied together, the Ca
current was inhibited by 41%, which was less than the inhibition seen with
somatostatin alone. Thus, the inhibition was not additive, suggesting that the drugs
acted possibly on the same population of Ca channels. It is possible that the two
ligands activated the same population of inhibitory molecules that mediated the effect.
The inhibitory molecule might be an activated G-protein. If this is so, NE and
somatostatin may interacted with the same population of G-proteins. Alternatively,
the compounds activated separate G-proteins, which then interacted with a common
effector - a proposed inhibitory molecule. From the observations by Taussig et al.
(1992) in hybrid rat-mouse NG108-15 cells, one could argue that these transmitters
interacted with distinct G-proteins to inhibit Ca current. Indeed, in rat pituitary GH3
tumour cell line somatostatin and muscarine have been shown to modulate DHP
sensitive Ca current through two distinct subtypes of PTX sensitive G0-protein
(Kleuss et al. 1991).
As described, it is clear that a single application of many neurotransmitters
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modulates Ca current. However, subsequent applications of the ligands desensitise Ca
current (Huganir & Greengard, 1990; Elmslie et al. 1992). Desensitisation appears to
be persistent, since the responses does not fully recover after washout of the drugs.
Moreover, rather surprisingly the desensitisation is homologous and does not affect
Ca current inhibition induced by other agonists (Elmslie, 1992). Bley and Tsien
(1988) showed that the LHRH-induced inhibition of Ca current in a representative
sympathetic neurone was subsequently weaker, following regular applications of the
dmg over a period of time. Interestingly, the response desensitised only when the
neurones were examined using a perforated patch technique, but not in the whole-cell
configuration. In perforated patch studies the cells are not dialysed with artificial
pipette solution and the intracellular milieu is mostly preserved, whereas in the
whole-cell studies, the pipette solution perfuses into the cell. Therefore, a mechanism
of desensitisation involving an intrinsic "desensitisation factor" has been proposed
(Ikeda & Schofield, 1989). However, there is still a disagreement whether a
"desensitisation factor" exists in cells or not. Clearly, more studies are needed to
understand this mechanism.
Modulation of voltage-activated Ca currents by different neurotransmitters appears
to be voltage-dependent. Stronger block of Ca currents is observed at negative
potentials, and it is largely removed at more positive membrane potentials (Marchetti
et al. 1986; Bean, 1989a) or by a conditioning, strong depolarisation (Elmslie et al.
1990; Penington et al. 1991; Boland & Bean, 1993; Elmslie et al. 1993; Golard &
Siegelbaum, 1993). Boland and Bean (1993) suggested that LHRH inhibited Ca
current at all tested potentials, but the inhibition was much greater for small to
moderate depolarisations than for large depolarisations. The group showed that a peak
Ca inward current elicited by steps from VH -90 mV to the test potential of -10 mV
was inhibited by 28%, whereas Ca current evoked at the test potential of +130 mV
was inhibited by only 11%. LHRH had no effect on the reversal potential. Voltage-
dependency of LHRH-induced inhibition of N-type current could be analysed in more
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detail using tail currents to assay the extent of the channel activation during test
pulses to different voltages. In control experiments, using test pulses of 15-30 ms
duration to activate Ca currents, the tail current was best fit by a single Boltzmann
function. However, in the presence of LHRH, the tail current following small or
moderate depolarisations decreased more than the one following larger
depolarisations. The fit by a single Boltzmann function was inadequate in the
presence of the transmitter and the best fit was a sum of two functions. Bean (1989a)
gave additional evidence to support this theory by showing that in frog sensory
neurones NE inhibited 54% of Ca current following small and moderate
depolarisations, compared to 15% inhibition following test pulses to +130 mV.
However, other reports contradict this view. Dolphin and Scott (1987; 1989)
described an equal potency of inhibition of Ca current by baclofen following
moderate and large depolarisations in rat sensory neurones. To explain this
discrepancy, Beech et al. (1992) suggested that there may be at least two different
fast pathways of modulation, one that is responsible for voltage-dependent and
another one for voltage-independent modulation.
Many neurotransmitters produced a substantial slowing of the activation kinetics
(Dunlap & Fischbach, 1978; Lipscombe & Tsien, 1987; Ikeda & Schofield, 1989;
Jones et al. 1992; Golard & Siegelbaum, 1993). For example, Bean (1989a) showed
that NE reduced Ca current amplitude and slowed the activation kinetics of the HVA
channels in frog DRG cells. In the presence of NE, the activation curve was biphasic.
However, an unexpected observation was made by Elmslie (1992), that in frog
sympathetic neurones, the application of a variety of transmitters (LHRH, NE,
muscarine, substance P) had no effect on the activation kinetics. The time constant
of activation was identical to that in control experiments, i.e. in the absence of the
drugs (Elmslie, 1992). This is in contrast with the results reported by Boland and
Bean (1993) in the same cells. On the other hand, other groups have also observed
the same effect as Elmslie on peripheral (Dunlap & Fischbach, 1981; Forscher et al.
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1986; Ewald et al. 1988b), and central (Toselli et al. 1989; Sah, 1990) neurones.
Neurotransmitter-induced slowing of the activation kinetics of Ca current can be
substantially relieved by large depolarising prepulses, applied just prior to the test
pulses. This has been reported in many systems, such as in chick, rat and frog
sympathetic neurones (Ikeda & Schofield, 1989; Boland & Bean, 1993; Elmslie et al.
1993; Golard & Siegelbaum, 1993), DRG neurones (Macdonald et al. 1986;
Tatebayashi & Ogata, 1992), spinal cord neurones (Sah, 1990), dorsal raphe neurones
(Penington et al. 1991), chromaffin cells (Artalejo et al. 1992a; Gandia et al. 1993)
and NG108-15 cell line (Kasai, 1992).
With an addition of a prepulse the activation kinetics was usually completely
restored, but the inhibition was never 100% relieved. Transmitter-induced inhibition
of Ca current is generally best fit with a double exponential. The recovery from the
block following the prepulse application was best fitted by a single exponential, as
in control experiments. Similar changes in the activation kinetics are observed in
different neuronal types (Ikeda & Schofield, 1989; Sah, 1990; Artalejo et al. 1992a;
Boland & Bean, 1993; Elmslie et al. 1993). In a few cases longer prepulses fully
restored the amplitude of Ca current to the control value (Kasai & Aosaki, 1989;
Kasai, 1992).
Gray and Johnston (1987), among others (Takahashi & Berger, 1990), recorded not
a reduction, but a potentiation of Ca current in the presence of a neurotransmitter.
The group have shown that NE and the (3 -adrenoreceptor agonist isoprenaline,
increased voltage-dependent Ca currents by 37%, in acutely dissociated granule cells
from guinea-pig hippocampus. In this experiment, single-channel recordings
demonstrated an enhancement of an inactivating 14 pS channel by these agonists. The
fact that this effect of NE is mediated by P-adrenoreceptors is in contrast to the
reduction of N-type current which seems to be a 2-adrenoreceptor related (McFadzean
et al. 1989). The described action of NE and isoprenaline could be mimicked by a
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forskolin-induced activation of adenylyl cyclase or by a direct application of a
membrane-permeable analogue of cAMP. The potentiation of Ca current may be
analogous to the (3 -adrenoreceptor-induced increase in L-type current observed in
heart cells, that probably involves cAMP-dependent phosphorylation of L-type
channels (Bean, 1985; Hagiwara et al. 1988; Hartzell et al. 1991). This finding
suggests that an intracellular second messenger might have a role in modulation of
Ca channels.
An involvement ofG-proteins in the transmitter-induced modulation of Ca currents
has been strongly indicated, see Chapter 1.6. Most neurotransmitters reported to
inhibit HVA Ca current are thought to require an activation of GTP-binding proteins
(Holz et al. 1986; Dolphin & Scott, 1989; Porzig, 1990; Cox & Dunlap, 1992;
Campbell et al. 1993; Dolphin et al. 1993), for review see Dolphin (1990; 1991a;
1995). The slow tum-on of Ca current in the presence of neurotransmitters might
merely reflect a time- and voltage-dependent uncoupling of G-proteins from HVA
channels at depolarised membrane potentials. Thus, whether slowing of Ca channel
activation and Ca current depression reflects a singular mode of action or two
independent actions on two pharmacologically distinct Ca channels remains to be
seen.
One idea, supported by Dunlap (Dunlap & Fischbach, 1978; Cox & Dunlap, 1992)
is that the slowing of HVA current activation kinetics is associated with some, but
not all, G-proteins, and that differences in transmitter effects on the current kinetics
reflect the selectivity of receptor-G-protein interactions. Dunlap and Fischbach (1978)
argued that NE reduced the number of functional calcium channels in the cells. In
contrast with that hypothesis, Bean (1989a), has suggested that the inhibition of Ca
currents is primarily due to a transmitter-induced change in the voltage-dependency
by which the channels are opened. There is little or no change in the number of
functional channels activated by very large depolarisations. His argument is that in
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the control cells, i.e. in the absence of neurotransmitters, at any time the majority of
the channels are in the "willing" mode to open and that a neurotransmitter increases
the fraction of channels in the "reluctant" mode.
Role of G-proteins and second messengers
Neurotransmitters bind to membrane receptors that can be classified into twomajor
groups. These two receptor groups differ in transmembrane topology, oligomeric
structure and in the molecular mechanisms by which they transduce signals, for
review see Huganir and Greengard (1990). One group of the membrane receptors
includes GABAa, nicotinic acetylcholine, NMDA, glycine and kainate receptors.
These receptors contain a receptor binding site, as well as an ion channel that
transduces signals, and all but NMDA receptor possess fast activation kinetics. The
second group of receptors are associated with GTP-binding (G) proteins, which
possess slower kinetics and consist of a-adrenergic, p-adrenergic, dopamine,
muscarinic acetylcholine, some serotonin and many neuropeptide receptors, for
reviews see Reuter (1983), Gilman (1987), Dolphin (1990; 1991a; 1995), Hess
(1990), Pelzer et al. (1990), Taylor (1990) and Clapham (1994).
There is a strong evidence for the presence of G-protein-coupled receptors that
modulate Ca currents. For example, cardiac L-type Ca channels, appear to be
modulated by Gs and Gi? via their control of adenylyl cyclase activity (Cachelin et al.
1983; Hescheler et al. 1987). There are also suggestions that Gs could interact directly
with L-type Ca channel to increase its open state probability (Yatani et al. 1988).
Andrade (1993) showed that an activation of Gj by 5-HT or GABAb receptor




Signal transducing G-proteins consist of a-, 0- and y-subunits. The diversity
among the three better characterised G-protein subtypes, Gs, Gf and G0, is basically
dependent on different a-subunits. This subunit probably represents an active part of
G-proteins, whereas a role of py-complex is less clear.
Direct confirmation for the involvement of G-proteins in Ca current modulation
comes from the experiments where neuronal cells were treated with pertussis toxin
(PTX), cholera toxin (CTX), antisense oligonucleotides and GTP-y-S. PTX prevents
receptor-mediated effects by interaction on mainly G0 and G,, while CTX opposes
GTP hydrolysis by ribosylating Gs. It has been reported (Hescheler et al. 1987;
McFadzean et al. 1989; Menon-Johansson et al. 1993) that the a-subunit of G0, Ga0,
is involved in transducing signals from a number of different receptors to Ca channels
in neurones and secretory cells, and other researchers have shown Ga, also to be
effective (Surprenant et al. 1990). Therefore, if the action of neurotransmitters is
regulated by G0, in the presence of PTX the effect will be abolished. Indeed, in the
presence of the toxin, the opiate agonist DADLE had no effect on Ca current in
NG108-15 cells. However, intracellularly injected G0, and to a lesser degree Gi5
restored the inhibitory effect of this agonist on Ca current. Since G0 was ten-fold
more effective, it was suggested that it is probably G0 that couples 6-opioid receptors
to Ca channels (Hescheler et al. 1987). Ewald et al. (1988b) reported a similar
finding. They examined the effect of neuropeptide Y (NPY) in DRG cells, and
proposed that G0 mediated the inhibitory effect of NPY on Ca current. This effect on
Ca channels appears to be voltage-dependent; the block was stronger during
hyperpolarisation and decreased with larger depolarisations (Tsunoo et al. 1986).
However, PTX does not prevent the action of bradykinin on Ca current in
neuroblastoma cells (Taussig et al. 1992) and its differential actions are also shown
in rat superior cervical ganglion cells. In these neurones the action of acetylcholine
was completely abolished, but NE-induced inhibition was only partially reduced
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(Song et al. 1989).
Gs, a G-protein that supposedly stimulates adenylyl cyclase, potentiated the
stimulatory effect of BayK 8644 on Ca current in myocardium (Yatani et al. 1987;
Yatani et al. 1988). This effect was abolished in the presence of CTX. Furthermore,
the opening probability of Ca channels from skeletal muscle Mubules, reconstituted
into lipid bilayers, was enhanced by activated Gs protein or by its a-subunit in the
presence of BayK 8644 (Yatani et al. 1988). Second messengers, such as cAMP,
appeared not to be involved in this modulation. Therefore, it appears that G-proteins
help to maintain the Ca channel protein in an "activatable" state, possibly by
stabilizing the resting or open state of the channel. However, if this is true, G-
proteins should be expected to antagonise the effects of Ca channel blockers which
act by stabilizing the inactivated state of the channels. Such a loss of blocking
potency has, indeed, been observed. L-type channel blockers verapamil and d-cis-
diltiazem had no inhibitory effect on Ca current in the presence of internal GTP-y-S,
in dorsal root ganglion neurones (Scott & Dolphin, 1987).
GDP analogues inhibit G-proteins and oppose the response to neurotransmitters.
It was an interesting observation that their inclusion increased the peak amplitude of
Ca current in DRG neurones, with a specific effect on the transient component of the
current (Scott & Dolphin, 1986; Dolphin & Scott, 1987). This led to a suggestion that
under basal conditions G-proteins maintain a fine balance between activatable and
inactive state.
Another way to identify G-proteins involved in modulatory effects on Ca current
is to use antisense oligonucleotides to abolish expression of G-protein a-subunits and
then test the action of an agonist. By intranuclear injection of antisense
oligonucleotides that have complementary sequences to Ga0 and Goq, into rat
pituitary GH3 cells, Kleuss et al. (1991) suggested that G0l and Go2, but not Gis
mediated Ca current inhibition following activation of muscarinic and somatostatin
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receptors, respectively. Studies by Campbell et al. (1993) have identified G0, but not
Gj, to be responsible for GABAb receptor coupling to voltage-sensitive Ca channels
in cultured rat DRG neurones. The effect was studied in a preparation where GABAb
receptors are selectively coupled to N-type channels. However, it is too early to
conclude that G0 couples to a specific type of Ca channels, and since there are no
dihydropyridine sensitive channels in this cell line, it is unclear whether G0 can
couple to neuronal L-type channels.
In many cell types, neurotransmitter-induced modulation of Ca currents following
activation of G-proteins, can be mimicked by an intracellular administration of
guanosine 5'-0-(3-thiotriphosphate), GTP-y-S. GTP-y-S is a non-hydrolysable GTP
analogue that permanently activates G-proteins. GTP-y-S, included in a recording
pipette, reduced Ca current amplitude and caused a marked slowing of the activation
kinetics (Lewis et al. 1986; Dolphin & Scott, 1987; Penington et al. 1991).
Furthermore, there has been some controversy whether G-proteins interact
exclusively with one or more types of Ca channels. Researchers argued that by a
stimulation of G-protein predominantly N-type current was inhibited, as discussed
earlier. On the other hand, other groups showed that G-proteins also acted on L- and
possibly T-type Ca current. For example, studies have suggested that the effect of L-
type Ca channel activators, such as BayK 8644, was strongly enhanced following
intracellular application of GTP-y-S. The effect was abolished in the presence of
PTX (Scott & Dolphin, 1988).
There have been fewer studies of the modulatory effect of neurotransmitters
following G-protein activation on the LVA Ca current. It was described that
dopamine and the adenosine agonist 2-chloroadenosine (2-CA) inhibited T-type
current in chick and rat DRG neurones (Forscher et al. 1986; Scott & Dolphin, 1987).
Scott et al. (1990) observed that a photorelease of 10-20 pM GTP-y-S intracellularly
from a photosensitive nitrophenylethyl ester of GTP-y-S inhibited only T-type current
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in rat DRG cells, whereas a lower concentration of GTP-y-S, increased the current.
As described, there are examples where an activation of various G-proteins resulted
in different actions on Ca channels, but it appears that, at least in some neuronal
types, an activation of different G-proteins can induce identical changes in Ca
channel gating. Elmslie (1992) reported that in bullfrog sympathetic neurones NE and
LHRH inhibited Ca current. An application of LHRH occluded the response to NE,
but, LHRH was still effective following application of NE. Furthermore, a PTX
treatment of the cells or dialysis with the A-protomer of PTX, markedly reduced the
effect of NE, but not that of LHRH on Ca channel current. This suggested that more
than one G-protein was involved in modulation of the current, although both drugs
showed similar effect, that was an inhibition of Ca current. It appears that the
adrenergic receptor preferentially couples to the PTX sensitive G-protein, while the
LHRH receptor can interact with a PTX insensitive G-protein(s). It is possible that
different G-proteins modulate the same Ca channels, because each transmitter
inhibited more than 50% of the current, and the effect of two neurotransmitters
applied simultaneously was partially additive. In addition, Ca currents evoked were
kinetically identical. Very similar observation was reported by Taussig et al. (1992).
This group suggested that different G-proteins regulate modulation of N-type Ca
current in NG108-15 cell line. These cells contained a PTX resistant mutant of GoA.
Leu-enkephalin, NE and somatostatin all inhibited Ca current and the effect was o>-
CgTx sensitive. PTX blocked the action of somatostatin, but not that of leu-
enkephalin or NE. Thus, while NE and leu-enkephalin's actions were probably
mediated via GoA, somatostatin acted via a different PTX sensitive G-protein. It
appears that each G-protein is highly specific in the choice of the receptor and that
different G-proteins can activate a common effector upon their activation.
Dolphin (1991a; 1991b) hypothesised that two mechanisms could be involved in
the G-protein regulation of Ca channels. Upon activation, G0 or G; interacted with the
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Ca channels in their resting state, resulting in a voltage-dependent inhibition. The
slow activation rate could then be explained as a function of the slow dissociation,
or unbinding, of this complex and the subsequent opening of the channels upon
depolarisation (Dolphin et al. 1989; Grassi & Lux, 1989). In favour of this model, it
was shown that a slow activation could be speeded up by a brief depolarising
prepulse. The second reason for the reduction of the amplitude of Ca current by
neurotransmitters can be due to an involvement of a freely diffusible second
messenger. Possibly, G; activation and a consequent inhibition of adenylyl cyclase,
resulted in a reduced cAMP-dependent Ca channel phosphorylation. It was shown that
in heart and skeletal muscle Ca channels were possible substrates for cAMP-
dependent phosphorylation on the ar and (3-subunits (Takahashi et al. 1987; Hartzell
et al. 1991; Andrade, 1993). This resulted in a potentiation of Ca currents and in an
increase of the open probability and the number of functional Ca channels (Rosenberg
et al. 1986; Fox et al. 1987a). However, the response to cAMP in neuronal Ca
channels is less clear.
There is an evidence to suggest that at least in some cells a modulation of Ca
current by neurotransmitters imply a direct interaction between G-proteins and various
Ca channels. However, this appears not to be a general rule. Some groups have
already proposed (Dolphin, 1990; Bernheim et al. 1991; Dolphin, 1991b; Braha et al.
1993; Sculptoreanu et al. 1993; Netzer et al. 1994; Rosenmund et al. 1994), that
binding of a ligand to G-protein activates another, highly specific intracellular
mechanisms. Bernheim et al. (1991) showed that muscarinic, but not a-adrenergic,
action on Ca channels is mediated by a diffusible second messenger.
The potential mechanisms responsible for modulation of Ca current in the presence




2. activation of phospholipase C and PKC
3. other second messengers (e.g. arachidonic acid)
4. direct G-protein - Ca channel interaction
First, neurotransmitters could stimulate and/or inhibit adenylate cyclase, by
activation of Gs or G,, respectively. For example, norepinephrine increases Ca current
and the effect results from the coupling of (3 -receptors with Gs, that triggers cAMP-
dependent phosphorylation of L-type Ca channel (Cachelin et al. 1983; Kameyama
et al. 1986; Sculptoreanu et al. 1993). A similar mechanism was described for a
regulation of L-type channels in other cells (Armstrong & Eckert, 1987), but whether
all L-type channels are sensitive to elevations of intracellular cAMP remains unclear.
However, Hartzell et al. (1991) showed that in frog, rat and guinea-pig ventricular
myocytes, an increase in Ca current was due to cAMP phosphorylation, without G-
protein activation.
Chad and Eckert (1986) and other researchers (Hill & Dolphin, 1984; Dolphin,
1991b; Dolphin, 1992) also observed that other compounds, such as forskolin,
increased cAMP levels and enhanced Ca current in rat DRG neurones. However,
forskolin was not able to prevent the inhibitory effect of neurotransmitters (Akaike
et al. 1989; Dolphin, 1991b; Frace & Hartzell, 1993).
Secondly, as a hypothesis, neurotransmitters could activate phospholipase C,
possibly by a distinct G-protein (Gq). In most cases, a PTX insensitive mechanism
is involved in such modulation. This evidence mostly relies upon the use of the PKC
activators phorbol esters and diacylglycerols. Activation of PKC is thought to
underlie the inhibition of Ca channels by NE in chick DRG neurones and NPY in rat
DRG cells (Rane & Dunlap, 1986). In rat hippocampal cells PKC activation also
inhibited Ca current (Doemer et al. 1988). Activation of PKC has been reported to
increase (Dosemeci et al. 1988; Lacerda et al. 1988) or decrease (Lacerda et al. 1988)
DHP sensitive Ca current in cardiac and smooth muscle cells. In contrast, there is a
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strong evidence that inhibitory actions of many other putative transmitters do not
appear to involve PKC, since PKC activation does not produce the characteristic
voltage-dependent inhibition of Ca current (Wanke et al. 1987; Bley & Tsien, 1988;
Akaike et al. 1989; Dolphin et al. 1989; Kasai & Aosaki, 1989; Plummer & Hess,
1991). Inhibitors of PKC, like H-7, a non-specific PKC and protein kinase A (PKA)
inhibitor, polymixin B (PKC blocker) and staurosporine (a potent non-specific kinase
inhibitor) were unable to prevent the reduction of Ca currents caused by
neurotransmitters (Penington et al. 1991; Dolphin, 1992). Therefore, it is most likely
that in these cells PKC activation is not necessary for the neurotransmitter-induced
reduction of Ca current.
It might be possible that some other second messengers regulate modulation of Ca
current; it was proposed that an eicosanoid, arachidonic acid, mediated the inhibition
of Ca currents in Aplysia sensory neurones (Brezina et al. 1987; Schacher et al.
1993). The effect was regulated by a PTX sensitive G-protein. However, in other
cells, as in DRG (Dolphin et al. 1989) and DR (Penington et al. 1991) neurones this
action of arachidonic acid was not observed.
On the other hand, evidence is mounting to suggest that, at least in some cells, a
coupling between transmitters and G-proteins can directly modulate Ca channels.
Data in support of such a direct G-protein-ion channel modulation is based on several
observations. First, a number of studies have failed to identify any second messenger
that mimics the action of neurotransmitters. Second, transmitter-dependent inhibition
of Ca current can be quite rapid, with an onset occurring in 50 ms, which is faster
thanmost known second messenger-mediated events (Bean, 1989a). Third, application
of a transmitter to the bath fails to inhibit Ca current in cell-attached patches, arguing
against a freely diffusible second messenger and supporting a membrane-delimited
mechanism of G-protein action (Forscher et al. 1986; Lipscombe et al. 1988b).
A direct interaction between G-proteins and Ca channels has already been proposed
in cardiac myocytes (Yatani et al. 1987). With that in mind, Kasai and Aosaki (1989)
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discussed the data obtained in chick sensory neurones. The adenosine analogue 2-CA
selectively reduced to -CgTx sensitive Ca channel current via G-protein activation.
cAMP, cGMP, PKC or eicosanoids were unable to prevent the neurotransmitter
effect, suggesting that the G-protein acted directly on the channel. A similar idea is
supported by Kozlowski et al. (1994). They described a direct interaction of Gs with
L-type Ca channels in cardiac myocytes.
Boland and Bean (1993) proposed a model that assumes that the inhibition by
transmitters results from direct interaction between G-protein(s) and Ca channel. This
model is based on two assumptions: a) that G-protein stabilizes closed gating states
(see above) and b) activation of G-protein-bound channels destabilizes the binding
of the G-protein to the channel. The model acknowledges the previous hypotheses
(Bean, 1989a; Elmslie et al. 1990) that there might be two, "reluctant" and "willing",
modes of gating of Ca channels and that conversions between the two modes
represent binding and unbinding of G-proteins. In Bean's view, there is a possibility
that the "reluctant" mode represents gating of channels modified by direct binding of
activated G-proteins to Ca channel. This is in opposition to the model proposed by
Kasai and Aosaki (1989) and Kasai (1992), which is based on a speculation that
gating states of Ca channels reflect slow gating transitions in a channel which is
continuously modified by G-protein binding.
Serotonin and calcium currents in dorsal raphe neurones
Serotonin (5-hydroxytryptamine, 5-HT) is a putative neurotransmitter, that was
discovered by Rapport et al. in 1948. It has been shown that the compound plays a
major role in multiple neurologic and non-neurologic states, such as pain, sleep,
migraine, appetite, anxiety, depression and aggression (Stembach, 1991).
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The largest density of serotoninergic neurones is found in dorsal raphe (DR)
nucleus. Other areas of the brain with an abundancy of 5-HT receptors are septum,
hippocampus, entorhinal cortex, cerebral cortex, thalamic and hypothalamic nuclei
and interpeduncular nucleus (Steinbusch, 1981; Bowker et al. 1983; Montone et al.
1988; Ma et al. 1991; Matsuzaki et al. 1993). The DR nucleus, located in the
periaqueductal grey in the mesencephalon, sprouts a large amount of both ascending
and descending fibres, for review see Steinbusch (1981). The ascending bundle
divides and forms the dorsal and ventral serotoninergic pathways. These fibres
terminate in basal ganglia and other centres in diencephalon and telencephalon
(Matsuzaki et al. 1993). The descending bundle of DR nucleus ends in cerebellum,
nucleus of the solitary tract, lower sections ofmedulla and spinal cord, such as spinal
trigeminal nucleus and dorsal hom of spinal cord (Li et al. 1993).
There is a strong body of evidence to suggest that in the descending serotoninergic
nerve terminals 5-HT co-exists with one or more other putative neurotransmitters,
such as substance P, enkephalin, thyrotropin-releasing hormone, GABA and
catecholamines. For example, immunohystochemical studies using specific antibodies
to serotonin and the peptides, showed that a large majority of raphe neurones
projecting to the spinal cord are serotoninergic and that about half of them contain
substance P immunoreactivity. Only a few neurones contained 5-HT alone (Bowker
et al. 1983). It is possible that an interaction in the release of these substances finely
tunes important physiological processes, such as sleep and modulation of pain
sensation. Moreover, these neurones with such widespread distribution at both higher
and lower levels of the nervous system also control specific behavioural and
autonomic activities, such as food intake, arousal, innervation of respiratory muscles
and regulation of cardiac function, in association with other neuronal groups.
Approximately 90% of the neurones in DR region possess 5-HT1A receptors (Verge
et al. 1985; Lawrence et al. 1989). 5-HT1A receptors, first cloned by Kobilka et al.
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(1987), appear to be localized on the cell bodies and dendrites of DR neurones. Their
role in autoinhibition of the 5-HT release has been proposed (Verge et al. 1985;
Becquet et al. 1990; Wu et al. 1991). This hypothesis is supported by biochemical
(Hjorth et al. 1982), lesion (Verge et al. 1985) and electrophysiological (Sprouse &
Aghajanian, 1988; Penington & Kelly, 1990) studies. The 5-HT agonist 8-hydroxy-2-
(di-n-propylamino)tetraline, 8-OH DPAT, binds with a high affinity (K; of 1.45 nM)
and specificity (KD of 24 nM) to 5-HT1A receptors (Verge et al. 1985). The binding
of the drug decreased dramatically after deliberately induced degeneration of 5-HT
cell bodies with 5,7-dihydroxytryptamine (Verge et al. 1985). This has been
confirmed by demonstration of a close correlation between [3H]8-OH DPAT binding
and 5-HT1A mRNA in situ hybridisation histochemistry in DR cells (Chalmers &
Watson, 1991).
DR neurones exhibit pacemaker potentials (Aghajanian & VanderMaelen, 1982;
Burlhis & Aghajanian, 1987; Penington et al. 1991). Electrophysiological studies
demonstrated a slow, regular firing pattern which was maintained by addition of ax-
adrenoreceptor agonists (VanderMaelen & Aghajanian, 1983). 8-OH DPAT also
affected the DR firing rate by increasing potassium conductance, mimicking the effect
of 5-HT (Sprouse & Aghajanian, 1988; Hecimovic et al. 1992). This increase in
potassium conductance can be blocked by an application of (-)-propranolol, a 5-HT1A
receptor antagonist (Sprouse & Aghajanian, 1986). Intracellular current-clamp
recordings of DR neurones in vivo (Aghajanian & VanderMaelen, 1982) as well as
in vitro (Pan et al. 1989; Penington et al. 1992), unveiled a large
afterhyperpolarisation after each action potential followed by a slow decay during the
interspike interval. Burlhis and Aghajanian (1987) suggested that these spikes arise
from depolarising ramps, rather than from excitatory postsynaptic potentials.
Spontaneous action potentials in these cells measured 70-100 mV and they can also
be evoked by depolarising steps positive to -60 mV. Application of tetrodotoxin
(TTX) onto depolarised DR cells uncovered low- and high-threshold calcium-
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dependent spikes. The low-threshold spike was inactivated by holding potentials
positive to -50 mV (Penington et al. 1991). The membrane potential of DR neurones
is in the range of -40 to -60 mV.
It was also described that 5-HT and the 5-HT agonist d-lysergic acid diethylamide
(LSD) had an inhibitory effect on the repetitive firing of DR cells, possibly through
a proposed "somatodendritic 5-HT1A autoreceptor" (Aghajanian & VanderMaelen,
1982; VanderMaelen & Aghajanian, 1983). Both drugs hyperpolarised the neurones
as shown in current-clamp recordings, due to an increase in an inwardly rectifying
potassium conductance (Williams et al. 1988; Kelly et al. 1991; Pan et al. 1993). 8-
OH DPAT has a similar depressant effect on DR firing rate as LSD and 5-HT, as
does ipsapirone, another selective 5-HT1A ligand (Sprouse & Aghajanian, 1986). The
actions of both dmgs have also been shown to increase a potassium conductance
similar to that mediated by 5-HT.
In recent studies (Penington & Kelly, 1990; Penington et al. 1991) on acutely
isolated adult rat DR neurones, intra- and extracellular solutions were made to isolate
Ca current. At a holding potential of -100 mV a peak Ca current amplitude was
obtained with a voltage step to -10 mV. At the end of a 150 ms long test pulse, the
peak current was only partially inactivated. Most of the HVA Ca current is blocked
by ca-CgTx and possessed properties typical for N-type current. Switching the
holding potential from -100 mV to -50 mV, the peak Ca current had smaller
amplitude, showed little or no inactivation and was partially DHP sensitive, having
some of the properties of L-type current (Penington et al. 1991). Depolarisation jumps
from VH -80 mV to the test potentials of -50 to -35 mV, elicited a small inward
current that rapidly inactivated, characteristic of T-type Ca current seen in dorsal root
ganglion cells (Fox et al. 1987a; Fox et al. 1987b; Bean, 1989b; Schroeder et al.
1990).
The presence of different Ca current types in DR neurones was confirmed in
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whole-cell and single-channel recordings. There is evidence to suggest an existence
of at least four types of Ca current in DR neurones. Channel openings with a slope
conductance of 8 pS with small depolarisations were consistent with T-type channels.
Larger depolarisation steps elicited openings with larger conductance of 23 pS and
the application of BayK 8644, a DHP agonist, prolonged the opening time. The third
channel had a conductance of 15 pS and was ca-CgTx sensitive (Penington et al.
1991).
It appears that the peak current evoked from a holding potential of -100mV to -10
mV has both N- and L-type components of Ca current. Studies with co-CgTx and
DHPs have been performed to examine this. However, an administration of 1 pM co-
CgTx blocked 40% of the peak Ca current and the addition of 1 pM nimodipine, a
DHP antagonist, further reduced the current by only 4% (Penington et al. 1991). This
result shows that a significant amount, -50%, of the HVA current was not of N- or
L-type. It is, therefore, possible to conclude that DR neurones possess N-type current,
a small and variable L- and T-type components and a significant amount of Ca
current that is co-CgTx and DHP insensitive.
As described, in many neurones it has been shown that neurotransmitters modulate
Ca current (Sah, 1990; Fraser & MacVicar, 1991; Elmslie, 1992; Gandia et al. 1993).
However, the exact mechanism is still unclear. 5-HT and 8-OH DPAT inhibited the
peak Ca current in DR neurones by 50% and 27%, respectively, and it appears that
HVA, but not LVA current is affected by these compounds (Penington & Kelly,
1990). The drugs also produced a dramatic slowing of the activation of the current.
The effect was blocked by the 5-HT1A antagonist l-(2-metho-oxyphenyl)-4-[4-(2-
phthalimmidobutyl]piperazine (NAN 190), suggesting this action was mediated by the
5-HT1a receptor subtype (Glennon et al. 1988; Rydelek-Fitzgerald et al. 1990). It,
therefore, appears that the same autoreceptor causes both hyperpolarisation via an
increase in potassium conductance, and inhibits HVA Ca current, and both of these
actions have been shown to occur simultaneously in the same cell (Penington et al.
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1992). A similar observation was reported by Koike et al. (1994) who described that
8-OH DPAT reversibly inhibited N-type current in acutely isolated ventromedial
hypothalamic neurones. Ciranna et al. (1993) used porcine pituitary intermediate lobe
cells and showed an inhibition of Ca current by 5-HT and to a smaller degree by 8-
OH DPAT. They suggested that the effect was mediated via G-protein and proposed
a direct interaction between the G-protein and Ca channels, because no diffusible
second messenger was identified. On the other hand, Berger and Takahashi (1990)
unexpectedly showed that 5-HT increased Ca current and acted mainly on LVA
channels in neonatal rat spinal motoneurones.
It is still too early to conclude which type of Ca current is inhibited by an
application of the 5-HT1A agonists in DR neurones. In the presence of oo-CgTx the
inhibition of the peak Ca current amplitude was reduced from 50% to 40%
(Penington et al. 1991). The percentage of the inhibition was not substantially
affected by the change in holding potential from -100 mV to -50 mV. It appears that
both co-CgTx sensitive and insensitive Ca currents were modulated. Complexity of
the modulatory action of neurotransmitters on Ca current has also been described in
other neuronal types.
The inhibition of the peak Ca current by 8-OH DPAT in DR neurones is sensitive
to a prepulse application. A brief and strong depolarising prepulse to 40 mV, applied
just prior to the test pulse, partially relieved this inhibition (Penington et al. 1991).
Such pulses have little or no effect on control currents.
Various reports suggested that the action of agonists on 5-HT1A receptor is
mediated by G-protein, probably G0 or G; subtype (Innis et al. 1988; Penington et al.
1991). For example, intraventricular injection of pertussis toxin eliminated the 5-HT
evoked hyperpolarisation in hippocampus (Andrade & Nicoll, 1987). GDP-P-S
abolished the 5-HT induced hyperpolarisation in DR neurones. Moreover, GTP-y-S
mimicked the action of 5-HT and produced a sustained hyperpolarisation (Andrade
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& Nicoll, 1987; Innis et al. 1988). Intracellular perfusion of DR neurones by GTP-y-
S had the same effect as 5-HT and reduced the peak amplitude of Ca currents
(Penington et al. 1991; McAllister-Williams, 1992). Therefore, it appears that the 5-
HT action is G-protein mediated. Electrophysiological studies were unable to give
strong evidence that changes in [Ca2+]j and in cAMP levels mediate the 5-HT action
on Ca currents. H-7, phorbol esters, 8-Br-cAMP and arachidonic acid were ineffective
in preventing the inhibitory effect, suggesting that protein kinases are probably not
involved (Penington et al. 1991). Furthermore, 5-HT applied externally, in cell-
attached single-channel recordings, had no effect. It appears that the inhibition of the
peak Ca channel currents by 5-HT in DR neurones is mediated via 5-HT1A receptor
coupled to a PTX-sensitive G-protein, without the involvement of a freely diffusible
intracellular messenger.
The inhibitory effect on the peak Ca current and slowing of the activation kinetics
following activation of 5-HT1A receptor in DR neurones, are similar to the action of
various other neurotransmitters on different cells (Kasai & Aosaki, 1989; Boland &
Bean, 1993). It is physiologically significant that 5-HT modulates Ca channel
currents. Release of 5-HT from the nerve terminals of DR neurones is under
autoinhibitory control (Becquet et al. 1990; Wu et al. 1991). Thus, the entry of Ca
ions into raphe terminals could trigger a release of 5-HT and other substances and,
with a negative-feedback mechanism following an activation of somatodendritic 5-
HT1A receptors, 5-HT might regulate this release. For example, 5-HT applied to the
DR causes a rapid inhibition of the release of 5-HT from axonal nerve endings at
sites distant to the DR (Becquet et al. 1990). This is highly significant, since 5-HT
can be synthesized and released in the DR nucleus itself. 5-HT-mediated
hyperpolarisation decreases DR firing rates, and possibly reduces both local and distal
release of 5-HT. In some other neuronal types it has already been proposed that 5-HT
could inhibit transmitter release by acting on 5-HT1A receptors (Sharp et al. 1993) or




Inhibition of dephosphorylation in different cell types has been shown tomodulate
Ca currents (Hescheler et al. 1988; Artalejo et al. 1990; Dolphin, 1992; Berlin &
Preston, 1993; Braha et al. 1993; Elmslie et al. 1993; Frace & Hartzell, 1993; Ono
& Fozzard, 1993; Werz et al. 1993; Betz & Henkel, 1994). Thus, clearly, an
investigation of this dependence of Ca channels on phosphorylation could aid a better
understanding of the mechanism involved in the regulation and expression of Ca
currents in various cell types.
Protein phosphatase 1 and 2A inhibitors
Okadaic acid (OA), microcystin-LR (MC) and calyculin-A are shown in
biochemical experiments to inhibit specifically protein phosphatase 1 (PP1) and 2A
(PP2A), with different potencies (Ingebritsen & Cohen, 1983; Nishiwaki et al. 1990).
These analogues belong to the OA group of compounds, but have structural and, to
a certain extent, functional diversities. For that reason, they will be introduced
separately.
Okadaic acid
Okadaic acid is a polyether compound isolated from a black sponge Halichondria
okadai (Bialojan & Takai, 1988). The drug binds to protein phosphatase 1 and 2A,
and inhibits their activity. This inhibition leads to a prolonged phosphorylation of
proteins in the cells (Nishiwaki et al. 1990; Fujiki & Suganuma, 1993). It appears
that the carboxyl group, as well as the four hydroxyl groups at C-2, C-7, C-24 and
C-27 of OA, are important for its function. It has also been evaluated as possible
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tumour promoter, for review see Fujiki and Suganuma (1993).
Chemical stmcture of OA was determined by Tachibana et al. (1981) and Bialojan
and Takai (1988) reported that OA acted as a non-competitive or mixed inhibitor on
the OA-sensitive protein phosphatases. Therefore, the binding site for OA might be
different from that for the substrate. OA probably interacts directly with a catalytic
subunit of the protein phosphatases (Nishiwaki et al. 1990).
Furthermore, the drug is -50-100 times more potent in blocking PP2A than PP1
(Haystead et al. 1989; Fujiki & Suganuma, 1993). The order of potency for other
related compounds for the inhibition of PP2A is: OA > MC > calyculin-A. The
reverse is tme for the inhibition of PP1; MC and calyculin-A appear to be the most
potent. The proposed order of potency is: MC > calyculin-A > OA.
So far, there has been no strong evidence given to explain this difference in the
potency of inhibition of PP1 and 2A. One speculation is that the effect reflects
different catalytic subunits of the two phosphatases. However, in the opposition to
this theory is the observation that the two phosphatases have a striking sequence
homology between their catalytic subunits. Another possibility is that the non-
catalytic subunits make the catalytic subunit less accessible to OA (Nishiwaki et al.
1990). It was described earlier that the OA site and the substrate site are different,
and, possibly, the affinity of OA for the phosphatase is considerably decreased in the
presence of a substrate (Nishiwaki et al. 1990).
When OA inhibits the protein phosphatases that presumably leads to an activation
of serine/threonine group of protein kinases (Sassa et al. 1989). It appears that the
action of protein phosphatase 1 and 2A on the phosphorylate kinases is slightly
different. It is postulated that PP1 dephosphorylates P -subunit of a phosphorylase
kinase, whereas PP2A preferentially dephosphorylates the a-subunit (Ingebritsen &
Cohen, 1983).
The exact protein kinase(s) that mediate this process are yet to be identified. Frace
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and Hartzell (1993) were unable to observe an involvement of protein kinase A,
protein kinase C, tyrosine kinases and calcium-calmodulin kinase II in the modulation
of Ca currents in cardiac myocytes in the presence of OA. They suggested that OA
and the tested kinases all activated different biochemical pathways.
The present understanding of the OA pathway is still very hypothetical. There is
an evidence to suggest that OA binds to PP1 and PP2A in the cell membrane and is
incorporated into the cells. Intracellularly, OA inhibits activities in the cytosol and
nucleus, which leads to an increase in phosphorylation of proteins, such as
hyperphosphorylation of intermediate filaments and possibly regulatory proteins of
different membrane channels. Furthermore, in the nucleus, the presence of OA results
in a sustained activation of gene expression, as well as in a hyperphosphorylation of
a suppressor gene products (Foulkes et al. 1983; Ingebritsen & Cohen, 1983;
Ingebritsen et al. 1983; Haystead et al. 1989; Cohen et al. 1990; Nishiwaki et al.
1990; Fujiki & Suganuma, 1993).
Microcvstin
Microcystin-LR (MC) was isolated from colonial and filamentous algae and
cyanobacteria (Fujiki & Suganuma, 1993). It is a member of the OA class of
compounds, but its chemical structure is, to a certain degree, different than that of
OA and calyculin-A. Unlike OA, MC appears to be equally effective in blocking PP1
and PP2A. As explained above, MC is slightly more potent in blocking PP1 in
comparison to OA and calyculin-A (IC50 for the inhibition of PP2A by MC is 2 nM).
Moreover, the compound also shows a minimal inhibitory potency towards protein
phosphatase 2B (PP2B) or calcineurin. There is also evidence that MC is a tumour
promoter and that it could induce tumours in rat liver, initiated with
diethylnitrosamine (Fujiki & Suganuma, 1993).
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Biochemical analyses have shown that MC binds to the same binding site as OA.
In the studies with lipid bilayers OA and MC have been tested whether they permeate
the cell membrane. It was shown that while OA was freely permeable, MC was
membrane impermeable. Supposedly, this can be an advantage in the present work
using a whole-cell technique, where MC, included in the recording pipette, will be
in the concentration applied. On the other hand, over a period of time, OA could leak
out of the cell and partly disintegrate to its by-products, that could, in turn, reduce
its action on protein phosphatases (Frace & Hartzell, 1993).
Calvculin-A
Calyculin-A, is a substance isolated from a marine sponge Discodermia calyx. The
drug binds to the OA binding site on protein phosphatase 1 and 2A with equal
potency, IC50= 2.5 nM (Fujiki & Suganuma, 1993). In comparison to the action of
OA, calyculin-A is slightly more potent blocker of PP1, but less potent on PP2A.
1-norokadaone
Another member of the OA group of analogues is 1-norokadaone (1-NO). 1-NO
is a synthetic compound that binds to the OA binding site and has similar chemical
structure to OA. However, the major difference between these two compounds is that
1-NO has no effect on protein phosphatases. Therefore, it is used in investigations as
an inactive analogue of OA.
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Protein phosphatase 2B (calcineurin) inhibitors
Protein phosphatase 2B (PP2B) or calcineurin, is completely dependent on Ca2+ for
its activity, in the presence or absence of calmodulin (Cohen, 1989). It has been
proposed that Ca2+ ions enter the cytosol via Ca channels, bind to calmodulin and this
complex activates PP2B. It appears that this phosphatase then activates
Ca2+/calmodulin-dependent protein kinase II (Ca2+-CaM-PKII) (Liu et al. 1991;
Brewis et al. 1993). PP2B is practically insensitive to OA and MC and for its action
does not require Mg2+, unlike protein phosphatase 2C (Brewis et al. 1993).
A high concentration of PP2B in the brain suggests that this phosphatasemay have
a number of substrates there. However, the exact function of calcineurin and its
pathway in regulation of intracellular processes is still not understood.
It has been reported that some putative immunosuppressant drugs act as potent and
specific blockers of PP2B (Schreiber, 1991; Neuhaus et al. 1994). Tacrolimus or FK
506 has been shown to be specific inhibitor of PP2B (Liu et al. 1991; Jayaraman et
al. 1992; Schreiber & Crabtree, 1992). Moreover, it has been shown that the action
of FK 506 to block calcineurin, depends on the presence of the immunophilin FK-
binding protein (FKBP) (Liu et al. 1991).
Effect of protein phosphatase inhibitors
It is known that many different processes in cells depend on phosphorylation.
There is a strong indication that protein phosphorylation regulates the efficacy of
synaptic transmission, both by controlling the release of neurotransmitters from
presynaptic nerve terminals and by modulating the sensitivity of receptors in the
postsynaptic membrane (Smith & Augustine, 1988; Huganir & Greengard, 1990;
Sihra, 1993; Anholt, 1994; Chavez-Noriega & Stevens, 1994). Presumably, at rest,
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a state of phosphorylation/dephosphorylation balance is maintained (Armstrong &
Eckert, 1987; Hescheler et al. 1988; Artalejo et al. 1992a; Frace & Hartzell, 1993).
It appears that this balance depends on many factors and much of its complexity is
not yet understood. It is possible that this equilibrium is kept at two levels. Firstly,
some researchers have pointed out to the existence of basally active phosphatase(s)
and, subsequently, protein kinase(s). Indeed, some evidence has been given in support
of such idea, see later. Secondly, reports have indicated that an inhibition of specific
phosphatases potentiates already activated Ca currents (Hescheler et al. 1988; Artalejo
et al. 1992a; Frace & Hartzell, 1993; Werz et al. 1993; Wang et al. 1994).
Thus, it was important to examine if there really is any basal activity of protein
kinases in cells, and, secondly, whether ion channels have to be in a phosphorylated
state in order to open. As it will be shown, the evidence is very often confusing and
controversial, depending on the cell population and the protocols employed in the
study. Mironov and Lux (1991) used acutely isolated rat hippocampal pyramidal
neurones and applied the whole-cell patch-clamp technique. In control conditions,
several minutes of perfusion with the intracellular solution were needed for a full
development of HVA Ca current. The group argued that, at rest, the HVA current
was masked, due to the activity of basally active phosphatases. When they blocked
PP1 and 2A with OA, the development of Ca current occurred faster. A similar
phenomenon was observed in the presence of the calcineurin inhibitor trifluoperazine.
That would imply that PP1, PP2A and/or PP2B at rest suppress the HVA currents in
these neurones.
Further evidence that a basally active phosphatase maintains the equilibrium in
cells was shown by Frace and Hartzell (1993). In cardiac myocytes the basal Ca
current reflects basal phosphorylation activity, suggesting that the channel can pass
current when in the dephosphorylated state. They went on to show that PKA was not
responsible for the phosphorylation of Ca channels under basal conditions. Internal
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perfusion with PKI, a protein kinase A inhibitor, had no effect on basal Ca current.
It is, however, possible that other basally active protein kinase(s) mediate this action.
Unfortunately, they were unable to identify the protein kinase. They showed that
PKA, PKC, tyrosine kinases and calcium-calmodulin kinase II were not involved in
the process. It appears that identification of the kinases will be a very complicated
task. Hunter (1987) argued that mammalian cells are capable of expressing over fifty
different serine/threonine kinases. Therefore, it is indeed possible that other, yet
unknown, kinases are involved in the modulation of the ion channels.
Potentiation of Ca current by OA or MC in cardiomyocytes was interpreted as an
effect of phosphorylation as it depended on intracellular ATP. In the absence of ATP
no effect of OA or MC on the Ca current was observed. Frace and Hartzell showed
that calcineurin, a calcium dependent phosphatase, was not involved, because the
internal Ca was well buffered.
Furthermore, PKA had no effect on the enhancement of Ca current amplitude
induced by OA or MC. Forskolin and cAMP produced an additional increase of the
current amplitude in the presence of saturating doses of MC and OA (Frace &
Hartzell, 1993).
Several hypotheses emerged from these observations: (1) Is it possible that OA
increases Ca current via a different mechanism and does not involve inhibition of
dephosphorylation. This is probably not true, because, other groups (Hescheler et al.
1988; Chen et al. 1990; Elmslie et al. 1993) have also shown that the effect of OA
and MC is lost in the absence of ATP. However, so far there is no firm evidence to
show that these two compounds have a direct effect on protein kinase activities. (2)
The potency of the drugs might be influenced by their accessibility to the
phosphatases. It was shown that MC is slightly more potent than OA. This
observation might be due to their differences in binding affinity (Bialojan & Takai,




Unlike Frace and Hartzell, other scientists (Reuter, 1983; Chad & Eckert, 1986;
Armstrong & Eckert, 1987; Chen et al. 1990) have reported that phosphorylation is
a "conditio sine qua non" for Ca channels opening. In intact cardiac myocytes
(Reuter, 1983) and dialysed molluscan neurones (Chad & Eckert, 1986) it was
observed that dephosphorylation of Ca channels leaves the channels in a state from
which they do not open in response to membrane depolarisation. The first group to
give stronger evidence that Ca channels require to be phosphorylated to open, was
that of Armstrong and Eckert (1987). They used cell-free membrane patches in GH3
cell line from a mammalian pituitary tumour. Using a single-channel recording
technique, they exposed the cytoplasmic surface to purified enzymes in the absence
of a complex intracellular regulatory mechanism and activated two classes of Ca
channels. It was clearly shown that at least one group of the channels, the
dihydropyridine sensitive class, had to be phosphorylated to open, following the
membrane depolarisation. Furthermore, they observed that the decrease of the channel
activity over time was smaller in the presence of 1 mM ATP. Biochemical studies
have previously shown that the putative protein of the DHP sensitive Ca channel,
purified from skeletal muscle, contains a protease- and phosphatase-sensitive cAMP-
dependent phosphorylation site on one of its subunits. They suggested that because
cAMP-dependent kinase in brain tissue is often membrane bound, it was possible that
ATP prevented the loss of the channel activity by serving as a substrate for an
endogenous cAMP-dependent kinase isolated with the patch.
Furthermore, Armstrong and Eckert (1987) proposed that dephosphorylation of that
site, and not voltage, leaves the channel in inactivated state in the absence of
rephosphorylation. GH3 cells are rich in calcineurin, which is possibly membrane
bound and associated with the cAMP-dependent kinase, and its activity may be
important for channel regulation. In molluscan neurones calcineurin dramatically
accelerated inactivation of the Ca current (Chad & Eckert, 1986).
Interesting observation was reported by Artalejo et al. (1992a). In bovine
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chromaffin cells, this group characterised a novel Ca current, which is normally silent
but can be activated by large pre-depolarisations or by repetitive depolarisations to
physiological potentials. The current could be additionally stimulated by an activation
of PKA; H-7, a non-specific PKA and PKC antagonist, and PKI 14-24 amide, a more
specific PKA blocker, partially reduced Ca current. It appears that these compounds
did not block the current directly, because in its presence, BayK 8644, a DHP
agonist, still potentiated the current. On the other hand, the Ca current was
suppressed in the presence of inhibitors of protein phosphorylation or by an injection
of phosphatase 2A into the cells. However, when the cells were dialysed with OA,
the current was dramatically potentiated, but was not additionally increased in the
presence of prepulses. The phosphorylation of the channels was voltage-dependent
and could be one of the mechanisms by which membrane potential modulates ion
channel activity. These observations suggest that prepulses or repetitive
depolarisations can recruit Ca channels by promoting their phosphorylation. Recovery
from facilitation involved a dephosphorylation step. It appears that although PKA can
potentiate Ca current, it is not directly involved in the action of prepulses. There is
a possibility, that an "unidentified kinase" and PKA act on the same site on the Ca
channel that is phosphorylated during the prepulse application. The group proposed
a model suggesting that depolarisation may change the conformation of the Ca
channel, making it a better substrate for protein kinase.
As described earlier, a number of groups (Kodama et al. 1986; Hescheler et al.
1988; Elmslie et al. 1993; Frace & Hartzell, 1993; Ono & Fozzard, 1993; Werz et
al. 1993; Wang et al. 1994) have shown that OA applied to many different cell types
modulated Ca currents. Actions of the drug on the currents are various. In heart
muscle, OA increased the duration of the action potentials and enhanced the
contractions of cardiac papillary muscle (Kodama et al. 1986). The positive inotropic
effect of OA was not abolished following a treatment with TTX or ryanodine.
Moreover, OA increased the amplitude of the end-plate potential at frog
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neuromuscular junction (Abdul-Ghani et al. 1991), and modulated synaptic
transmission (Swain et al. 1991). Elmslie et al. (1993) suggested that phosphorylation
of the channels was necessary to maintain the G-protein mediated inhibition of Ca
current following an application of norepinephrine. Hescheler et al. (1988) and Werz
et al. (1993) reported that OA potentiated Ca current, increased inactivation kinetics
and slowed "run-down" of the current in guinea-pig cardiomyocytes and frog
sympathetic ganglion neurones, respectively.
Abdul-Ghani et al. (1991) suggested that phosphorylation could regulate the release
of neurotransmitters. Addition of 1 pM OA into the extracellular solution doubled
the amplitude of the end-plate potential at frog neuromuscular junction. The effect
was presynaptic and the transmitter release reversibly increased following the nerve
stimulation. At the lobster neuromuscular junction, OA increased both excitatory and
inhibitory synaptic responses following nerve stimulation. OA had no effect on the
membrane potential in either preparation. Similar observations were reported by
Swain et al. (1991) at crayfish neuromuscular junction where the effect of OA was
dependent on its concentration. At lower doses (0.5-5 pM) the effect was exclusively
presynaptic and an increase in transmitter release was observed. However, with higher
doses of OA the effect was postsynaptic. This might suggest that transmitter release
is constantly regulated by phosphorylation of the membrane proteins on the nerve
terminals.
It appears that phosphorylation of channel proteins is necessary to preserve a
neurotransmitter-induced modulation of Ca current by norepinephrine. A simple
analysis suggests that if an activated G-protein acted directly on the Ca channel,
coupling of the receptor with the channel should require only GTP. However, there
is an evidence to suggest a requirement for the presence of intracellular ATP. During
long intracellular recording the preservation of Ca current modulation by NE was
sustained only in the presence of both ATP and GTP in the recording pipette in frog
sympathetic neurones (Elmslie et al. 1993). A need for both ATP and GTP suggested
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the existence of an intracellular phosphorylation step that occurred simultaneously or
around the time of receptor-channel coupling.
In many different cell types OA had no effect on the inhibition of Ca current
induced by neurotransmitters. For example, OA did not prevent the inhibition of Ca
current by NE (Elmslie et al. 1993; Werz et al. 1993) in sympathetic neurones. In the
same neurones, inactivation was stronger in the presence of OA (Werz et al. 1993).
However, Yakel (1992) showed a reduction in the inactivation rate in the presence
of OA in snail Helix aspersa neurones. The effect was not observed with 1-
norokadaone, an inactive OA analogue.
Calcineurin may also play a role in the modulation of Ca currents. A train of
depolarising pulses increased Ca current in smooth muscle cells. The strong and
reversible potentiation of the current was independent of cAMP stimulation, unlike
in adrenal chromaffin (Artalejo et al. 1990) or cardiac (Reuter, 1983) cells, and H-7
had no effect. However, 10 mM BAPTA included in the pipette solution or the
inclusion of the calmodulin inhibitory peptide, RS20, blocked the augmentation of Ca
current. This observation showed that the potentiation of Ca current can possibly be
mediated by the activation of calmodulin-dependent protein kinase II (McCarron et
al. 1992).
Armstrong and Eckert (1987) suggested that the dephosphorylation of Ca channels
by calcineurin is responsible for the inactivation of L-type channels. Frace and
Hartzell (1993) perfused frog cardiomyocytes with the calcineurin inhibitory peptide,
CNIP, and did not observe any particular effect. Very high, nonspecific,
concentrations of the drug slowed an increase in Ca current amplitude, accompanied
with an increase in inactivation. Yakel (1992) used the same PP2B inhibitor and
recorded a significantly reduced rate of inactivation of Ca current in neurones from
the snail Helix aspersa.
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In summary, it appears that strong evidence already exists to suggest that protein
phosphatases 1, 2A and 2B are involved in a modulation of Ca current. However, it
is unclear whether these phosphatases have a role in maintaining basal
phosphorylation/dephosphorylation equilibrium. Furthermore, not all Ca channels have
to be phosphorylated in order to open. It appears that in many cell types the
inhibition of dephosphorylation up-regulates Ca current. On the other hand, it is not
clear whether the regulatory pathway for phosphatases is identical to that used by
neurotransmitters to modulate Ca current.
Purpose and aims of Thesis
The main aim of this study was to examine Ca channel currents in dorsal raphe
neurones, together with their modulation following activation of the 5-HT]A receptor.
Previously, Ca currents in DR neurones have been characterised to some extent
(Penington et al. 1991; McAllister-Williams, 1992) and the procedure has been
validated here. The work presented confirms the previous observations and examines
additional properties and modulation of Ca currents by the 5-HT1A agonist 8-OH
DPAT and G-proteins. This study gives the first detailed report of the role of
phosphorylation of Ca channels in DR neurones, and of the voltage and temperature
sensitivity of Ca current kinetics, in the presence and in the absence of 5-HT1A
receptor activation. In addition, the possible involvement of second messengers in
modulation of Ca current is touched and briefly discussed.
Following Chapter 2, which describes procedures and techniques performed, there
are four Chapters which describe the results obtained in this study and their analysis.
The first, Chapter 3, describes the basic properties of DR neurones, membrane and
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action potentials, together with the characterisation of peak Ca currents and their
block by cadmium. It has been shown that a whole range of neurotransmitters
modulate Ca current in a number of neuronal preparations (Tsien et al. 1988; Kasai
& Aosaki, 1989; Cox & Dunlap, 1992; Boland & Bean, 1993). This action of
neurotransmitters results in changes in Ca current amplitude, usually accompanied
with a change in the current kinetics. Modulation of the peak Ca current and its
kinetics following 5-HT1A receptor activation in DR neurones is described in this
Chapter.
There is a strong evidence to suggest that G-proteins mediate the action of
neurotransmitters on calcium currents in many cell types. For example, it was shown
that the GABAb agonist baclofen inhibited Ca current via G-protein in cultured dorsal
root ganglion neurones (Campbell et al. 1993). In DR neurones the effect of G-
protein on the peak Ca current was also tested, and its temperature-dependency. The
peak current kinetics in control cells, and in the cells perfused with either 8-OH
DPAT or GTP-y-S are analysed in detail, and fitted using mathematical functions,
see Chapter 4.
Multiple phosphorylation sites on calcium channels have been shown to exist, and
it is possible that the effects of transmitters are mediated by a change in the
phosphorylation state. Specific inhibitors of dephosphorylation were used, and their
effect on the peak Ca current studied, as shown in Chapter 5. During the whole-cell
voltage-clamp recordings performed in this study, a slow and inevitable "run-down"
of Ca currents occurred. This means that calcium current amplitude gradually and
irreversibly decreased during recordings. The effect of phosphatase inhibitors on "run¬
down" was examined, and analysis of Ca current kinetics in the presence and in the
absence of 5-HT1A receptor activation was performed, see Chapter 6. In addition, the
phosphatase inhibitors were tested in the presence of 5-HT1A receptor activation to
investigate whether they modulate the same pathway as 8-OH DPAT. Furthermore,
more data is obtained to show whether second messengers are involved in the 8-OH
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DPAT-induced modulation of the currents in DR neurones or if this is a membrane-
delimited pathway.
In the last part of this study, in Chapter 7, the results are discussed, and further
ideas are proposed about the nature of modulatory pathways of calcium currents.
Finally, conclusions about the effects of 5-HT1A receptor activation and role of
phosphorylation on calcium currents in DR neurones are drawn.
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Figure 1.1: Proposed model for calcium channel structure. Calcium channel with
subunit structure is schematically shown in an open configuration. Sites for cAMP-
dependent phosphorylation (P), disulfide bond, glycosylation and interaction with the
membrane are illustrated. Picture is modified from Catterall et al., Ann.N.Y.Acad.Sci.
560, 1-14 (1989), and described in the text.
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Table 1.1: Modulation of calcium currents by putative neurotransmitters and other
substances.











































Caulfield et al. 1992
Toselli et al. 1989
Jones et al. 1992
Wanke et al. 1987
Kasai & Aosaki, 1989
Dolphin et al. 1986
Elmslie, 1992
Gandia et al.1993
Hescheler et al. 1987
Hescheler et al. 1987
McFadzean & Docherty,
1989
Marchetti et al. 1986
Surprenant et al. 1990
Bean, 1989
Sah, 1990
Gross & McDonald, 1987
Deisz & Lux, 1985
Grassi & Lux, 1989
Cox & Dunlap, 1992
Dolphin & Scott, 1987
Zeilhofer et al. 1993
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GTP-y-S +++ AtT-20 Lewis et al. 1986
+++ bullfrog SG Elmslie, 1992
+++ chick DRG Grassi & Lux, 1989
Kasai & Aosaki, 1989
Marchetti & Robello, 1989
+++ chromaffin cell Gandia et al. 1993
+++ rat DRG Dolphin & Scott, 1987
Dolphin & Scott, 1989
+++ rat DRN Penington et al. 1991
+++ rat SCG Ikeda & Schofield, 1989
Leu-enkephalin +++ NG108-15 Tsunoo et al. 1986
LHRH +++ frog SG Bley & Tsien, 1990
++ frog SG Boland & Bean, 1993
Elmslie et al. 1990
Met-enkephalin ++ guinea-pig SMN Surprenant et al. 1990
Muscarine +++ bullfrog SG Elmslie, 1992
Noradrenaline ++ bullfrog DRG Bean, 1989
++ chick DRG Forscher & Oxford, 1985
Holz et al. 1986
Marchetti et al. 1986
Cox & Dunlap, 1992
++ chick SG Golard & Siegelbaum, 1993
++ frog SG Lipscombe et al. 1989
Bley & Tsien, 1990
++ guinea-pig SMN Surprenant et al. 1990
++ NG108-15 McFadzean & Docherty,
1989
Caulfield et al. 1992
++ rat SG Galvan & Adams, 1982
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Penington & Kelly, 1990
Penington et al. 1991
Sah, 1990
Koike et al. 1994
Luini et al. 1986
Tsunoo et al. 1986
Sah, 1990
Ikeda & Schofield, 1989
Meriney et al. 1994
Golard & Siegelbaum, 1993
Surprenant et al. 1990
Elmslie, 1992
*- degree of inhibition of Ca current: (+++) strong; (++) medium; (+) slight.
Abbreviations: DADLE: D-Ala, D-Leu-enkephalin; DPDPE: D-Pen-enkephalin; DRG:
dorsal root ganglion; DRN: dorsal raphe nucleus; LHRH: luteinizing hormone
releasing hormone; SC: spinal cord; SG: sympathetic ganglion; SCG: superior
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Chapter 2 Methods
Preparation of dorsal raphe neurones
Dorsal raphe nucleus, located in a brain stem, contains a large number of
serotoninergic neurones with 5-HT1A receptors (Lawrence et al. 1989). Dissociation
of the DR cells in the present experiments was based on the method first described
by Kay & Wong (1986), with some variations. DR neurones were acutely isolated,
which sometimes has an advantage over cultured cells, where various conditions
during the cell growth can affect the expression of calcium channels (Boland &
Dingledine, 1990; Allen et al. 1993), in addition to possible alterations in the release
of neurotransmitters (Kasai, 1992).
Adult male Cob Wistar rats (200-250 g) were decapitated by a guillotine and the
cranium removed. Cranial nerves were exposed and dissected and the whole brain
was rapidly removed and placed into a continuously oxygenated ice-cold artificial
cerebrospinal fluid (aCSF). The tissue was then transferred onto a filter paper and
moistened with the cold aCSF solution. The cerebral hemispheres together with the
cerebellum were removed with a razor blade. On the remaining part of the tissue a
rostral cut was made just caudally of the superior colliculus and that side of the brain
was put onto a plastic platform and fixed with a cyanoacrylate glue. To support the
ventral surface of the brain, a 4% agar block was glued just behind it and the caudal
surface was exposed upwards. This part of brain was then transferred into the
plexiglass chamber of a vibroslice (Campden Instruments) and submerged in aCSF
bubbled with 95% OJ5% COz mixture and chilled to 4°C. The tissue was carefully
sliced using the vibratome in a caudo-ventral direction at the mesencephalic level of
the brain stem. The size of the aqueduct of Sylvius, the superior colliculus and the
decussation of the superior cerebellar peduncles were additional markers for the
localization of DR nucleus. Three to four 400 pm coronal slices were obtained and
rapidly placed on an agar base that was moisted with aCSF. The area of grey matter
2x2 mm, just below the cerebral aqueduct and dorsal to the decussation, containing
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the clearly visible DR nucleus, was now dissected from each slice using a razor
blade. This whole procedure of isolation of the pieces of brain tissue containing DR
nucleus took on average 7-10 min. Sometimes, to provide more tissue for the
experiments, two rats were used in rapid succession.
The pieces of grey matter containing DR nucleus were isolated and rapidly
transferred into 10 ml of a piperazine-N,N'-bis-[2-ethanesulfonic acid] (PIPES)
buffered solution and enzymatically treated with 5000 units/ml (0.07%) of trypsin
(Type XI). The solution was bubbled with a pure oxygen and the tissue stirred using
a magnetic stirrer at a rate just sufficient to keep the pieces of tissue suspended. The
incubation lasted for 90 min at 33° C exactly. The pieces of tissue were then washed
in the same solution, to remove the trypsin, and kept at room temperature (18-22° C)
for at least 60 min while bubbled with 100% 02. Just prior to the use of the DR
neurones (1-8 hours later), two to three pieces of tissue were withdrawn and triturated
with three fire-polished Pasteur pipettes in turn with end tips of decreasing size of
approximately 1 to 0.5 mm in diameter in Dulbecco's modified Eagle's medium
(DMEM). Neurones, now bathed in DMEM, were transferred to a 35 mm Petri dish
(Coming) and allowed to settle on the bottom of the dish for 15-20 min. The dish
was placed in a specially designed holder on the stage of an inverted phase contrast
Nikon Diaphot microscope, see Figure 2.1.
Electrophysiology of dorsal raphe neurones
DR neurones that settled on the bottom of the dish and were "phase-bright" with
short dendrites and soma diameter of at least 20 pm were chosen for the
experiments, see Figure 2.2.
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Borosilicate glass electrodes (Clark Electromedical Instruments) with a filament
and standard wall and inside and outside diameter of 0.86 mm and 1.5 mm,
respectively, were made using a List-Medical L/M-3P-A puller. For a number of
experiments the tips of the electrodes were fire polished. They were mounted on the
headstage and lowered to the Petri dish. With the tip of the electrode submerged into
the extracellular solution, an Axoclamp-2A amplifier (Axon Instruments) was turned
on in the "bridge mode" and the electrode resistance measured. The resistance of the
electrode filled with the internal solution, was, on average, 6-11 MQ (mean= 8.7+0.1
MQ), n= 129. The tip potential was balanced before bringing the electrode tip in the
contact with a cell. Junction potentials, measured in the presence and in the absence
of the drugs differed by less than 2 mV.
The tip of the electrode was moved towards the chosen neurone using a Burleigh
patch-clamp micromanipulator PCS-250. With a continuous application of current
pulses of 0.03 nA and 10 ms in duration at a frequency of 10 Hz, a small voltage
deflection was seen when the tip touched the cell. Negative pressure was immediately
applied by mouth or with 1 ml syringe to the suction electrode until a seal between
the electrode glass and the soma membrane was formed. The seal resistance was on
average of 5.8+0.4 GQ (n= 113). At that point a few cells went into a whole-cell
formation spontaneously, n= 16. In other cells a further pulse of negative pressure
was required to disrupt the cell membrane and convert the mode from the cell-
attached to the whole-cell configuration. It was observed that the "gigaohm-seals"
were obtained more easily in an external solution containing calcium and for that
reason a calcium Tyrode solution was used. When the whole-cell configuration was
obtained the calcium Tyrode solution was replaced with a standard external
(recording) solution. Immediately after obtaining a stable whole-cell voltage-clamp
mode, hyperpolarising current was applied to hold the membrane potential at -100
mV. At that holding potential, the cell was held for 5 min before any further
manipulation was done to equilibrate and the content of the patch pipette dialysed the
81
Chapter 2 Methods
neurone. Capacitance neutralisation, gain and phase controls were adjusted to produce
optimal clamp efficiency. Under these conditions, a clamp gain of between 1 and 2.8
nA/mV was achieved. One agarose bridge (a 1 mm diameter glass tube containing
4% agar in 3 M KC1) connected the ground well with the main chamber. The
reference "ground" electrode was connected to a Ag/AgCl pellet at the bottom of a
small well filled with 3 M KC1. In all experiments shown here, test pulses that
evoked peak Ca currents were applied from VH -100 mV to -10 mV, for 150 ms, at
a frequency of 0.05 Hz. In the experiments with a prepulse application, the prepulses
were intermittently applied 10 ms prior to the test pulse, from the same holding
potential of -100 mV to 40 mV, for 100 ms.
Recordings were made with a high input impedance amplifier Axoclamp 2A.
Single-electrode voltage-clamping (SEVC) with this amplifier allows both current
passing and voltage recording using the same microelectrode. The electrode, after it
penetrates the cell, records voltages Ve (the voltage developed on the microelectrode
resistance and capacitance by the current Iq) and Vm (change of the membrane
potential compared to the resting potential) and samples them in amplifier Al, see
Figure 2.3. The sample-and-hold amplifier (SHI) produces the sampled value Vms,
that becomes an input to another amplifier A2. When the switch SI is in the current
passing position, the output of A2 flows to a CCS unit (controlled current source),
which then injects current into the electrode. This current is dependent and directly
proportional to the CCS input voltage, and is not influenced by the electrode
resistance.
In the current-passing period, T;, the current pulses cause Ve to rise and the process
is dependent on the capacitance of the wall of the glass microelectrode to the solution
and the capacitance at the input of the buffer amplifier. At the end of the current-
passing time, SI switches to the "voltage-recording" position. An input to the CCS
unit is zero now, and, therefore, the output is also zero. During this period, the
microelectrode records voltage. The amplifier A2 provides negative feedback to
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clamp Vms to a value almost equal to the command voltage, Vc. As shown in Figure
2.3 (B), Vms slightly changes around the average value, due to the system, electrode
and membrane "noise" sources. Therefore, the difference between Vms(ave) and Vc
is a common error of the voltage clamp, that mainly results from the open-loop
transfer conductance (GT). This conductance is a product of the transfer conductance
of the CCS unit and the voltage gain of A2.
The circuit could also be switched to the "current clamp" position with the S2
switch. This mode was used to make a "gigaohm-seal" formation and to enter a
whole-cell configuration. In that mode, during the current-passing period the CCS
unit gets input from a current-command voltage (VJ and injects the current Iq into
the electrode. Vms is a reliable measure of the changes in the membrane potential
during current clamp.
Open-loop transconductance (GT), the switching period (T), the duty cycle (D),
electrode tip resistance, Re, and the transmural capacitance can all be optimally set
up. To some extent, the operation of the system also depends upon the resistance (RN)
and capacitance (CN) of the membrane that is clamped. There are some practical steps
that were taken in the experiments: it was necessary to keep Re as low as possible,
although that might affect a resistance seal, furthermore, a smaller volume of solution
in the Petri dish usually helped, and compensating for residual Ce and other
capacitance in the system, was done by the capacity compensation (CC) dial. The
cycle frequency (1/T) was also adjusted; the range of sample rates was, on average,
8.5-19 kHz with a mean of 14.3+0.26 kHz, n= 129.
The operation of the SEVC could also be described by a series of equations (Finkel
& Redman, 1984). As described earlier, each cycle of a period T consists of a period
Tj, during which the current is applied to the electrode, and Tv, when no current is
applied and voltage is recorded. Thus





where D is the duty cycle.
Figure 2.3 shows the clamp operation during the n'th cycle. At the end of the
cycle, a sample of membrane potential Vms(n) is stored, as explained previously. The
electrode current I(n) flowing during Tj(n) is dependent on the amplifier error voltage
€i(n-l) at the end of the previous cycle, and by the open-loop transfer conductance
Gx. When Vc is the command voltage, then there is:
I(n)= Gx Gl(n-1)
e,(n-l)= Vc - Vms(n-1)
The minimum value of T is limited by the response speed of the microelectrode
and of the electronic circuity. The following equation allows a steady-state
"equivalent electrode resistance" (Ra) to be defined, where Ra= Ve(°°)/I(°°). Thus
Re (l-e"DT1) * e"(1"D)T1
1 - e"T1
where Ra is "equivalent electrode resistance"; Re is electrode resistance; and D is the
duty cycle.
The steady-state error can be reduced by increasing the duration of the current-
passing period and by increasing Gx with other stability requirements. If D-0, and
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Temperature analysis
A temperature controller was used to test the effect of temperature on Ca currents.
A small Petri dish on the microscope stage was surrounded by a heat sink with two
peltiers, see Figure 2.4. These peltiers regulated the temperature of the heat sink and,
consequently, heated and cooled the recording solution with DR neurones. When the
outside temperature was more than 5°C warmer than the set temperature, ice-cold
water was passed through the copper tubing, which was in a tight contact with the
heat sink.
This specially designed temperature manipulator, Peltier Temperature Controller,
allowed a smooth transition from heating to cooling and prevented development of
any sudden switching events that could cause electrical spikes in the vicinity of the
electrode. Also, the control unit was connected to dry cell batteries to eliminate the
introduction of 50 Hz mains "noise" into the Faraday cage. The temperature controller
was calibrated with a bipolar thermometer (Comark) with the reference thermistor
placed in boiling tetramethylsilene and the test thermistor in the centre of the Petri
dish under normal operating conditions. The central area of the dish was kept at a
fairly constant temperature. In a map produced by Medical Systems Corp., with a set
temperature at 20°C, a variation in temperature of no more than 0.5° C in the central
area of the dish occurred. The majority of the experiments presented here were done
at 20° C exactly, and a number of neurones were additionally held at a range of
temperatures from 15° to 30° C. Increases in temperature of 5°C, which was the
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minimal step used in the experiments, can be performed in less than 1 min, while
decreasing a temperature by 5°C, lasted, on average, 1-4 min. This depended on the
room temperature and whether or not ice-cold water was passed across the heat sink.
Recordings were normally made 2-3 min after the temperature settled at a new level.
Solutions and drug application
Most solutions used for the dissociation of DR neurones are as in the method
described by Kay and Wong (1986) and tested by other workers (Penington et al.
1991; McAllister-Williams, 1992). The composition of the solutions used in the
present experiments is shown in Table 2.1. A peristaltic pump was used to deliver an
external solution into the Petri dish that contained DR neurones with a rate of 1
ml/min exactly. A "bubble trap" was made in the line to minimise the pulsatile flow
and electrically isolate the dish from the pump. The level of solution in the Petri dish
was kept constant by a suction device connected to a vacuum pump. This output was
placed diagonally opposite the input line that brought the bathing solution into the
dish. In addition, 100% 02 was continuously blown across the dish at a rate of 100-
150 ml/min.
As described earlier, calcium Tyrode solution was used to establish the whole-cell
mode. Immediately upon obtaining a whole-cell mode, the extracellular perfusion was
switched to a standard recording solution that was designed to isolate Ca currents.
Sodium was replaced by tetraethylammonium (TEA) and a contribution of sodium
currents was additionally eliminated by tetrodotoxin (TTX, see Table 2.2).
Furthermore, potassium currents were completely blocked by TEA and also by the
addition of 4-aminopyridine (4-AP) to prevent the appearance of the A-current that
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these cells exhibit (Burlhis & Aghajanian, 1987; Aghajanian et al. 1990). Barium ions
were used as the main charge carriers, instead of calcium. That has certain advantages
and disadvantages. The main reason was that in the presence of Ba2+, the "run-down"
process, studied in these experiments, was smaller (Dolphin & Scott, 1989).
Furthermore, there was no activation of calcium-dependent activities, such as an
activation of calmodulin-dependent cAMP phosphodiesterases, activation of ion
channels and other intracellular processes in the neurones. Ba2+, additionally,
contributed to the inhibition of potassium current (Brown, 1990). On the other hand,
the calcium channel kinetics might be affected by the presence of Ba2+ (Zhang et al.
1994). It has been reported that inactivation of L-type channels is slowed when Ba2+
replaced Ca2+ in cardiac cells (Sanguinetti & Kass, 1984; Kass, 1987), smooth muscle
cells (Lang et al. 1991), pituitary cells (Williams et al. 1991) and hippocampal
neurones (Kay, 1991), but not in mouse cerebellar neurones (Slesinger & Lansman,
1991b; Slesinger & Lansman, 1991a; Haws et al. 1993) or rat DRG cells
(Tatebayashi & Ogata, 1992). Akasu et al. (1990) recorded faster tail currents kinetics
when using Ba2+ ions. For that reason, it is important that the results shown are
viewed in that prospective. It should also be clear that where ever "calcium currents"
are referred to in the presentation of the results, they were actually "barium currents".
In the initial experiments, that were designed to study basic properties of DR
neurones, intracellular solution contained (mM): K+ gluconate 84, HEPES 10, MgATP
2, KC1 38, EGTA 11, KOH 33, CaCl2 1, GTP 0.3, and pH was of 7.3. In all other
experiments, a standard intracellular solution was made in a fashion to optimize Ca
current isolation, to block the remaining potassium and possibly sodium currents and
to minimise "run-down". TEA was included in the internal solution to eliminate
potassium current and MgATP to help to reduce "run-down" (Elmslie et al. 1993).
This group also reported that MgATP, together with GTP, helped to maintain the
modulation of Ca current by norepinephrine in sympathetic ganglion neurones.
Therefore GTP was also added to the solution. Intracellular calcium was buffered by
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the inclusion of ethyleneglycol-bis-( P -aminoethyl ether)-N,N,N',N'-tetraacetic acid
(EGTA). EGTA, as a chelator, might not be as fast and sensitive to pH as another
buffer l,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid (BAPTA), but that
appeared not to affect the experiments (McAllister-Williams, R.H. - personal
communication). Potassium was replaced by trizma, a large impermeant ion, that was
more suitable to minimise "run-down", than a more conventional caesium based
solution. The recording pipettes also contained phosphate as the main anion, rather
than chloride. Chloride is known to have several disadvantages, such as an interaction
with proteins that stabilize plasma membranes (Inoue et al. 1976). Another advantage
was that with phosphate included in the standard internal solution, the recordings
were more stable and lasted for up to 90 min.
The standard intracellular solution was usually made at the beginning of a week
and used for that week only. Ca Tyrode and standard recording solutions were made
fresh every day, or every second day. When they were stored overnight, they were
kept refrigerated at 4°C. No deterioration or the presence of particles in the solutions
were noticed. On the day of an experiment, the solutions were taken out of the
refrigerator and left at a room temperature. The standard intracellular solution was
kept in a deep-freezer until 3 hours prior to the recordings, drawn up into a 1 ml
syringe and kept on an ice bed. The syringe with the filling was allowed to warm up
to room temperature 10 min before the cells were tested and then returned to the ice
bed. The recording pipettes were filled via a 0.1 pm filter (Acrodisc, Gelman
Sciences) that was put in between the syringe and a fine tube pulled with heat to
inject the solution into the pipette.
An optimal cell viability was achieved with a pH of the standard recording solution
of 7.3, whereas for the standard intracellular solution pH was adjusted to 7.2.
Osmolality was finely adjusted with sucrose. The recording solution was calibrated
to 320 mOsm and internal to 310 mOsm. Hypoosmotic pipette solution probably
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helped to reduce cell swelling. On some occasions DR neurones did swell; that was
observed visually when the cell suddenly became spherical, and sometimes an
increase in the current amplitude occurred. When a cell became spherical due to
swelling it was lost or the recording was stopped and not included in the analysis.
Drugs were added either to the internal solution or perfused into the external
solution, see Table 2.2. Guanosine 5'-0-3-thiotriphosphate (GTP-y-S) and guanosine
5'-0-2-thiodiphosphate (GDP- P -S) were included in the pipette solution at the time
it was made up. Okadaic acid, 1-norokadaone, microcystin-LR, calyculin-A,
staurosporine, H-7, forskolin, FK 506 and FK binding protein were dissolved in an
anhydrous N,N-dimethyl-formamide (DMF) and deep frozen. All compounds were
diluted to their final concentration and added to the pipette solution just prior to the
start of recordings. In a few experiments, OA was placed in the back of the recording
pipette ("back filling") and the tip of the pipette was filled with a standard internal
solution. This method was used to test the time OA needed to dialyse the neurones.
DMF (0.5%) has several advantages over more often used dimethyl sulphoxide
(0.5%, DMSO) and ethanol (0.2%). Control experiments in DR neurones showed that
DMSO and, to a lesser degree, ethanol, significantly potentiated the peak Ca currents
in the absence of any other application, see Figure 2.5. On the other hand, DMF did
not affect the peak Ca current amplitude, or the effect of forskolin to increase
intracellular cAMP, see Figure 2.6. In control experiments, forskolin, dissolved either
in DMF or in DMSO, was shown to stimulate cAMP levels in a protein-binding assay
(Armstrong et al. 1985).
5-HT, 8-OFI DPAT and cadmium were dissolved and applied into the standard
external solution. All were made up as stock solutions at 10 mM and kept frozen.
Each day, the drug was diluted to its test concentration with the external solution. A
short and rapid administration of agonists was possible via a broken glass pipette,
with a tip diameter of about 5 pm, positioned 50-100 pm from the cell. The pipette
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was placed in a holder and slight positive pressure was produced. It was possible to
view the solution flowing out of the pipette to the studied cell. In the experiments
where only the external solution was perfused in the same way to the vicinity of the
neurones, no change in Ca current was recorded. When the compounds, e.g.
cadmium, had to be applied for a longer time, the drug was included into the external
solution and perfused into the Petri dish with DR neurones. The externally applied
drugs were removed from the bath by a withdrawal of the pipette and simultaneous
bath perfusion with drug-free external solution.
A reduction and enhancement of Ca current is expressed as a percentage of the
change of the control Ca current amplitude (100%) obtained in the standard recording
solution and in the absence of any drugs. All results are expressed as the means ±
S.E.M. For evaluation of the statistical significance of the results, Student's f-test was
used with a level of significance as p< 0.05.
Data analysis
Currents were measured in respect to the zero current level and Ca current was
evoked as a peak inward current. Ca channel currents ran down slowly with time. As
described earlier, after obtaining a whole-cell voltage-clamp mode, a neurone was
perfused in Ca Tyrode solution for 5 min and held at holding potential of -100 mV,
without eliciting currents. Correspondingly, the time course of the peak Ca current
amplitudes shown in the graphs is shown with no currents evoked in the first 5 min
after establishing the whole-cell mode. Thereafter, every second peak is shown in the
graphs. An inevitable "run-down" that occurred during recordings was measured from
the time the peak Ca current amplitude was recorded to 30 min later. It is also
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sometimes shown as a percentage of "run-down" per minute, although this is not an
optimal reference, because the "run-down" was not linear. However, the data were
not analysed if "run-down" was rapid and the same cell lost during the first 30 min
of recording.
Current and voltage data had a direct input, after filtering at 1 kHz, onto a video
cassette recorder Sony SL-F30 via a Sony PCM-701 digital audio processor. The data
were then digitised at 5 kHz and transferred to a DELL PC386 IBM-compatible
computer, using CED 1401 Electrophysiology Package V6.0 - Current and Voltage
Clamp Analysis (Cambridge Electronic Design, Cambridge). Linear components of
capacitance and leak currents were subtracted digitally from all records shown. Leak
and capacity subtraction was calculated from small test pulses that elicited no active
current, and then scaled linearly. Leak sweeps consisted of ten hyperpolarising (10
mV) test pulses that were later averaged. The leak currents were scaled to the
appropriate size and then subtracted from the individual current records. Data was not
accepted unless voltage errors from series resistance remaining after partial
compensation were less than 5 mV. To eliminate residual capacity artifacts after leak
subtraction, current data points 0.4-0.6 ms following a depolarising voltage step have
been left blank in the figures. Moreover, because of an incomplete capacitance
subtraction and sensitivity of the clamp system, the first few tenths of milliseconds
of tail currents were difficult to analyse and there was a possibility of making a
considerable error in measuring current kinetics. It was, therefore, decided that the
tail current amplitudes and kinetics will not be included in the presentation. For the
same reason, fast activation kinetics with time constants of less than 1 ms were not
suitable for analysis. All voltage traces shown here are as recorded.
Ca current activation, inactivation and deactivation were fitted using theoretical
curves in a Newfit V3.0 programme, partially written in our laboratory
(McAllister-Williams, 1992). Fitting of theoretical curves was by means of the
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iterative "Amoeba" algorithm (Press et ah, 1992) utilising the downhill simplex
method in multidimensions of Nelder and Mead (1965). This algorithm involves
creating a multidimensional object with one more vertex than unknown constants,
whose volume represents the sum of the squares of the difference of the data points
from the estimated curve on that iteration. The procedure adjusts the vertices to
minimise the volume. Once a minimum is reached, values for the constants are
returned. To prevent the detection of false local minima, values obtained were
multiplied by 0.1 and 10 and returned to the procedure as starting points for a re-run.
This continued until the final sum of the squares of the difference of the re-run varied
from the previous one by less than 0.001%. This usually took 2-4 runs of the
procedure, though occasionally no definite minimum could be found, and so a
maximum of 8 mns was set to prevent the programme being in endless calculations.
Fitting of the curves was averaged to every second point to mostly reduce "noise"
and number of iterations. This did not affect the time constants obtained. As an
example, a current trace was digitised at 5kHz and forward averaged every 2 points.
The calculated activation time constant was of 2.35 ms for a single exponential. If
the same data were digitised at the same frequency and all 824 points of the current
trace included in the analysis, the time constant for a single exponential was 2.36 ms.
The difference was not significant and the error was no more than 0.5%. To double
check possible variations all calculated curves were superimposed onto the real data
and visually examined to exclude false fitting points.
The current kinetics were fitted with both single and double exponentials. The data
were compared and the time constant with the best fit recorded. Single exponential
function has the form
Im(t)= A + B*exp(t/T)
whereas a double exponential was calculated using the following equation
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Im(t)= A + B*expl-t/T(f)1 + C*exp["t/T(s)]
Im(t) is the membrane current at time t\ A, B and C are constants; t, Tf and ts are
time constants.
Furthermore, the activation of Ca currents was also fitted using Hodgkin and
Huxley m1 - m4 models (Hodgkin & Huxley, 1952).
ut)= Imax * [L-(I«-I0)*exp("t/T)]x
1^ is the maximum inward current; I„ and 10 are the final and initial values of Imax;
x is an integer that describes the fits to this equation as m1, m2, m3 or m4.
93
Chapter 2 Methods
Figure 2.1: Schematic view of a Petri dish placed on the stage of the Nikon Diaphot
microscope. Petri dish is positioned on the centre stage of the microscope. Elements
for temperature control and tubing for gas and solutions are shown here and described
in the text. 1. copper tubing, 2. Petri dish, 3. Ag/AgCl pellet and ground well, 4.





Figure 2.2: A phase contrast photomicrograph of a typical dorsal raphe neurone.
Dorsal raphe neurones were isolated using mechanical and enzymatic dissociation.
Healthy cells with triangular "phase-bright" somas and the shortest diameter of at
least 20 pm were used for the whole-cell recordings. Dendrites were short and
truncated to obtain an optimal space clamp. Bar represents 50 pm. (Kindly provided
















Figure 2.3: Scheme of the operation of a single-electrode voltage-damp. A block
diagram (A) and timing diagram (B) describe the principle of current passing and
voltage recorded events. Switch SI is closed during the current passing period. The
microelectrode voltage (Ve) is shown as an exponentially increasing voltage during
the current-passing, and an exponentially decreasing during the voltage-recording
period, when SI switch is grounded. The membrane potential (Vm) increases linearly
during the voltage recording period. The sum of Ve and Vm is sampled at the times
indicated in (B). Vms is compared with the command voltage (Vc), and Vms (ave) is









Figure 2.4: Scheme of a cross-section view of Peltier temperature controller.
Temperature controller was used to test the effect of temperature on Ca channel
current. The scheme of the controller, mounted on the Nikon Diaphot microscope
stage, is described in the text. 1. copper tubing, 2. lid, 3. Petri dish, 4. perfusion tube,












Figure 2.5: Differential effects of DMF and DMSO on the peak calcium current. In
a typical DR neurone, DMF was included in the recording pipette and had no effect
on the peak current, n= 3 (A). With inclusion of DMSO in the recording pipette, the
peak current was enhanced, on average, to 109% of control, n= 3 (B). The peak
current was elicited with a voltage step to -10 mV from a holding potential of -100
mV, for 150 ms (lower panel). Currents are leak and capacity subtracted. Standard









Figure 2.6: Effect of DMF and DMSO as vehicles for forskolin-induced cAMP
production in rat cerebral cortical neurones. Forskolin stimulated cAMP production,
that was measured using a protein-binding assay, see text. Dose response curves for
forskolin dissolved in either DMF (•) or DMSO (■) are shown. The final
concentration of both DMF and DMSO was 3.3%, and the neurones were incubated
for 5 min at 37° C. Data represent the mean + SEM of four experiments. (Kindly
performed by Mr. H. Ito).
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Table 2.1: Table of solutions used in the experiments for dissociation and recordings
of dorsal raphe neurones.
aCSF PIPES Ca Tyrode External Internal
NaCl 126 120 138
KC1 5 5 1
MgS04 2
MgCl2 1 1
CaCl2 2 1 5
NaHC03 26
NaH2P04 1.25
glucose 10 25 10 10










PH 7.4 7.0 7.4 7.4 7.2
w/95% OJ
5% C02





















TTX Sigma 5 x 10"7 M
5-HT creatinine sulphate Sigma 10^ M
8-OH DPAT RBI 10"5 M
Calyculin-A RBI 10* M
FK 506 Fujisawa 10"8 M
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FKBP Fujisawa 10A M
Forskolin RBI 10'5 M
Microcystin-LR Sigma 10"6 M
1-norokadaone Calbiochem 10* M
Okadaic acid Calbiochem 10* M
Staurosporine Calbiochem io-6 M
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Basic properties of dorsal raphe neurones
Dorsal raphe neurones were acutely isolated and studied using a whole-cell
voltage-clamp technique (Hamill et al. 1981; Kay & Wong, 1987). Basic properties
of the neurones, such as membrane and action potential, were examined, with K+
gluconate containing recording pipettes (see Methods). Healthy cells fired
spontaneous action potentials under current-clamp conditions, prior to the addition of
TTX, see Figure 3.1 (A). This observation confirms the finding (Burlhis &
Aghajanian, 1987; Sprouse & Aghajanian, 1988; Pan et al. 1989; Pan et al. 1993) that
DR neurones recorded in vitro from raphe midbrain slices, exhibit a slow, regular
discharge pattern, suggesting that the cells may have tonic pacemaker properties in
the absence of synaptic inputs.
In this experiment, the spontaneous action potentials measured between 70-100mV
in amplitude. Additional action potentials could be elicited by depolarising pulses
positive to -60 mV. The frequency of the action potentials varied from cell to cell,
and the neurones usually fired at a rate of 5-10 Hz. On an expanded time scale, as
in Figure 3.1 (B), note that each action potential consisted of an initial depolarisation,
a small shoulder during repolarisation, followed by hyperpolarisation. Thus, it is
possible that spikes arose from depolarising ramps, rather than from excitatory
postsynaptic potentials (Burlhis & Aghajanian, 1987). TTX (0.5 pM), added to the
external solution, abolished the fast component of the action potential and uncovered
high- and low-threshold Ca2+ action potentials, as shown and discussed before
(Penington et al. 1991). The membrane potential of the dissociated DR neurones
ranged from -40 to -60 mV.
Penington and Kelly (1990) have shown that at least four types of Ca currents are
present in DR neurones. Most of the characterised current is carried through the N-
type channels (-40%), and a smaller proportion via L- (-0-20%) and T-type
channels. It has been reported so far that many neurones, such as cerebellar granule
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neurones, hippocampal CA1 and CA3 neurones, spinal cord and dorsal root ganglia,
but not sympathetic neurones, also contain P-type Ca current (Mintz et al. 1992;
Mogul et al. 1993; Pearson et al. 1993; Protti & Uchitel, 1993; Bossu et al. 1994).
It is important to keep in mind that at VH -50 mV, where all T-type Ca current is
inactivated, an application of OJ-CgTx (1 pM) and DHP antagonist nimodipine (1
pM) into the bath, blocked only -45% of Ca current. Thus, -55% of the Ca current
remains unblocked (Penington et al. 1991).
With 5 mM Ba2+ in a recording pipette, as the charge carrier, weak depolarisations
from VH -100 mV to -40 mV for 150 ms, produced a small, -0.2 nA, rapidly
decaying current that almost completely inactivated by the end of the test pulse (data
not shown). This was LVA current and had characteristics of T-type Ca current (Fox
et al. 1987b; Bean, 1989b; Dolphin, 1991a; Liu & Lasater, 1994b). The size of the
current was variable and, in some cells absent. If it was present to a significant
degree, a small shoulder was recorded on the I-V relationship. T-type current is also
present in other neurones, such as chick (Marchetti et al. 1986; Fox et al. 1987b;
Swandulla et al. 1991) and rat (Swandulla et al. 1991; Bossu et al. 1994) sensory
neurones, rat cerebellar granule cells (Dolphin, 1991a; Bossu et al. 1994), turtle
retinal ganglion cells (Liu & Lasater, 1994a), but in some neurones, such as in rat
and frog sympathetic neurones, its presence is variable. Stronger depolarisations
elicited larger, high-voltage activated Ca current. In all experiments shown here, only
HVA Ca current in DR neurones was studied (n= 129).
Figure 3.2 shows current-voltage relationship in one, representative, DR neurone.
Ca currents were elicited from a holding potential of VH -100 mV to various
depolarising potentials for 150 ms, at a frequency of 0.05 Hz. It is assumed that at
VH-100 mV, all available Ca current is de-inactivated. Ca current activation was first
observed at test potentials to -40 mV. From this threshold the current gradually
increased and from potentials greater than -30 mV the increase in current amplitude
was very much steeper. Peak amplitude was always recorded at around -10 mV and
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the potential reversed at about 50 mV.
In guinea-pig submucosal neurones and some other neurones, the peak Ca current
was recorded at more positive potentials (Surprenant et al. 1990), but not in bullfrog
sympathetic ganglion neurones (Boland & Bean, 1993). Furthermore, it was not
possible to record the current at test potentials more positive than 80 mV. If the
current was elicited with strong depolarising test pulses, to more than 80 mV, large
leak currents occurred and the clamp was no longer stable. This might be due to the
use of Ba2+ as the charge carrier and the use of TEA and not Cs+, in the pipette
solution. In other preparations (Boland & Bean, 1993), where Cs+ was used in the
pipette, a large outward current was recorded, at potentials positive to 40 mV. This
group argues that this outward current is carried primarily by Cs+ ions flowing
through Ca channels, because the current was effectively blocked by co-CgTx and
Cd2+.
"Run-down" of calcium currents
During whole-cell recordings inmany different cell types a slow "run-down" of Ca
current occurs (Fenwick et al. 1982; Belles et al. 1988; Dolphin et al. 1989; Elmslie
et al. 1993; Tiaho et al. 1993). "Run-down" is defined as a slow, but permanent,
decrease of Ca current.
"Run-down" is illustrated as a function of time in Figure 3.3. The peak current was
elicited with voltage steps from VH -100 mV to -10 mV for 150 ms, every 20 s.
During the first 5 min in a whole-cell mode, the peak current gradually increased and
was maximal, on average, in 5-13 (mean= 7.6) min after establishing the whole-cell
mode. In that period, the cell was presumably dialysed and outward currents were
blocked. Then, the inward current stabilised on average at 1.82+0.08 nA and
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gradually, over the time of recording, decreased. It has been shown that the presence
of ATP and GTP are crucial to the preservation of the Ca currents during long term
recordings (Chen et al. 1990; Elmslie et al. 1993). With Mg-ATP (3 mM) and GTP
(0.3 mM) in the recording pipette, the rate of "run-down" in the present experiments
was on average 17 ±4.3%, 30 min after obtaining the maximal peak amplitude, i.e. a
decrease of 0.57%/min in the peak current. The recordings were relatively stable and
lasted for periods of 30-90 min. Without ATP in a recording pipette, "run-down" was
much faster. Furthermore, the recording time was also shorter and lasted for only
-10-22 min, n= 3. During these experiments, the peak Ca current decreased to near
zero and the leakage current irreversibly increased, which, presumably, led to a "loss"
of the cells.
Ca current was measured at 20° C exactly, and during a voltage step from VH -100
mV to -10 mV, the peak Ca current was on average 1.82+0.08 nA (n=34). The
current consisted of two components, see inset. A transient one with a fast activation
constant was followed by a slowly decaying component that represented the
inactivation of the current. In majority of DR cells, the amplitude of the current at
the end of the test pulse, 1.75+0.05 nA, was similar to that of the transient
component. A prepulse was applied 10 ms before the test pulse for 100 ms, from a
holding potential of -100 mV to 40 mV. The effect of the prepulse varied. In DR
neurones, there is no significant increase in the current amplitude, and sometimes the
peak amplitude of the current is slightly smaller than in control experiments, i.e. in
the absence of the prepulse. The same phenomenon was reported in guinea-pig
submucosal neurones (Surprenant et al. 1990), chick sympathetic neurones (Golard
& Siegelbaum, 1993) and bullfrog sympathetic neurones (Elmslie, 1992), but Artalejo
et al. (1992a) showed an increase in Ca current amplitude following strong repetitive
depolarisations. Mean amplitude of the peak current following the prepulse
application in DR neurones was, on average, 1.86±0.07 nA, (i.e. 102±3.6% compared
to control).
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Kinetics of the peak Ca current were unaltered following a prepulse. Therefore, in
DR neurones, it appears that the prepulse had no effect on the peak amplitude nor
activation kinetics in control experiments.
Effect of cadmium on calcium currents
Cadmium, Cd2+, recognized as a relatively specific blocker of Ca channels, was
also used to characterise the current. Cd2+ is known to compete with Ca for binding
to Ca channels (Surprenant et al. 1990; Yang et al. 1993). As described earlier, Fox
et al. (1987b), Dolphin (1991a) and other groups (Allen et al. 1993; Yang et al. 1993)
have shown that HVA channels are more sensitive to Cd2+, than LVA channels. For
example, Allen et al. (1993) has reported that in acutely dissociated magnocellular
cholinergic basal forebrain neurones of rat, Cd2+ at low concentrations (< 1 pM)
markedly inhibited HVA, but not LVA current. However, at higher doses of Cd2+ (3-
200 pM), this selectivity was lost and all components of Ca channel current were
blocked, with an IC50 value of 2 pM.
In the present experiments, internal and external solutions were designed to isolate
the current carried through Ca channels, and the peak current was elicited with
standard voltage pulses. When the amplitude of the current stabilised, as shown in
Figure 3.4, Cd2+ (0.1 mM) was applied externally to the cell for 7 min. The dmg
blocked, on average, 81 ±2.8% of the peak Ca current, n= 3. Following wash-out of
Cd2+, partial recovery occurred. It was, to some extent, unexpected to observe that
this concentration of Cd2+ did not completely abolish the peak current. This might be
due to the flow artifacts when Cd2' was superfused over cells, or that DR neurones
are somehow less sensitive to the dmg, when compared to the chick sensory neurones
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and rat forebrain neurones where the block was fast and complete (Swandulla &
Armstrong, 1988).
Figure 3.5 shows the current elicited with a voltage step from VH -100 mV to -10
mV for 150 ms. The current peaked in control solution at 1.82+0.08 nA and
following an application of 0.1 mM Cd2+ it peaked at 0.35+0.04 nA, as illustrated in
Figure 3.4.
When Cd2+ was applied in the same fashion, but in a higher concentration (1 mM)
the inhibition was almost complete, and averaged 98.3 + 1.2%, n= 3. Following wash¬
out only partial recovery was achieved.
Effect of temperature on calcium currents
As some groups have already demonstrated, Ca current amplitude and kinetics are
temperature-dependent (Byerly et al. 1984; VanLunteren et al. 1993). VanLunteren
et al. (1993) reported that activation and inactivation of Ca currents were more rapid
at higher temperatures. In bullfrog sympathetic neurones, they found that the voltage
required to elicit the peak Ca current shifts ~5 mV to the left, when the temperature
is increased from 20° to 30° C. A very detailed study of the effect of temperature on
the HVA Ca currents in DR neurones has been performed by McAllister-Williams
(1992).
InMcAllister-Williams experiments, it was observed that in DR neurones the HVA
current was less stable at higher temperatures and, as a consequence, long term
recordings were not possible. For that reason, in the present experiments DR neurones
were held at 20° C and then stepped to the desired temperatures for short periods. An
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accurate temperature controller was used that allowed relatively fast temperature
changes. Usually, it took a few more minutes to lower the temperature than to
increase it. Because of the "run-down" of Ca current, it was difficult to obtain precise
and comparable data for analysis. Therefore, when the temperature was returned to
20° C from a test temperature, a 10% change from the previous control current
amplitude at 20° C was taken as acceptable. When the current stabilised at the new
control level at 20° C a new temperature step was instigated.
In Figure 3.6, the time course of changes in the peak Ca current amplitude is
shown, in a typical cell where the temperature was stepped in a range from 15°C to
30° C. The peak current stabilised at 20° C and the temperature increased to 25° C.
The size of the current increased dramatically to 168% of the control peak current at
20° C. The temperature was then returned first to 20° C and then to 15°C. At 15°C,
the current peaked at 81% of the control amplitude at 20° C. The current was
stabilised at 20° C again and the temperature stepped to 30° C, where, as expected,
the current was significantly larger, and peaked at 191% of the control peak current.
"Run-down" process was much faster at higher temperatures. At 25° C, the current
decreased 11% over a 3 min period. At 30°C, the decrease after 3 min was 14%,
while only 3.6% over 3 min when holding the cell at 15°C. In all cells tested, the
result followed that pattern (n= 4). The data show that Ca channels functioning is
strongly dependent on temperature and confirm reports from other laboratories
(Byerly et al. 1984; VanLunteren et al. 1993).
In Figure 3.7 Ca current amplitude at different temperatures is plotted against
voltage. At all temperatures tested (15°, 20° and 25°C), Ca current was voltage-
dependent and peaked at around -10 mV. Furthermore, the biggest difference in the
current amplitudes was observed at around the peak amplitudes. At more depolarising
test potentials, the size of the current was less temperature-dependent. The reversal
potential was 50 mV at all temperatures.
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The data was averaged from 4 neurones. Only the cells in which a complete range
of temperatures was tested (from 15° to 25°C) are included in the analysis. In 2/4
recordings, the Ca current at 25°C peaked at slightly more negative potentials, close
to -20 mV. Other workers, McAllister-Williams (1992) and VanLunteren et al.
(1993), have also observed this shift in the peak potential to the left. The present data
could be similar, but the potentials were stepped at 10 mV intervals, and could only
be approximate for the peak current obtained.
A change in temperature, in most cells, affected both, transient and slowly
decaying, components of the peak Ca current (Figure 3.8). In majority of neurones
both components were potentiated at the higher temperature, that is best seen when
the current obtained at 20° C is subtracted from that obtained at 25°C, see inset in
(A). In other cells, only transient, possibly N-type current was modulated, as in (B).
Modulation of calcium currents by 5-HT1A agonist
Inhibition of calcium currents by neurotransmitters has been described inmany cell
types, such as chick sensory neurones (Dunlap & Fischbach, 1978), cerebellar granule
neurones (Pearson et al. 1993), chromaffin cells (Gandia et al. 1993), frog
sympathetic neurones (Elmslie et al. 1992; Boland & Bean, 1993; Elmslie et al.
1993), Helix aspersa (Hill-Venning & Cottrell, 1992), rat dorsal root ganglion (Bean,
1989a; Dolphin et al. 1989; Menon-Johansson et al. 1993), rat hypothalamic neurones
(Zeilhofer et al. 1993), guinea-pig submucosal neurones (Surprenant et al. 1990) and
DR neurones (Penington et al. 1991).
In DR neurones, Penington et al. (1991) and McAllister-Williams (1992) reported
that 8-OH DPAT, a potent 5-HT1A agonist, partially inhibited the HVA Ca current.
Ill
Chapter 3 5-HT,A receptor activation and L..2'
The action was blocked by the putative 5-HT1A antagonist l-(2-methoxyphenyl)-4-[4-
(2-phthalimmido)butyl] piperazine (NAN-190).
In Figure 3.9 the peak Ca current is plotted against time. After establishing the
whole-cell mode, the peak Ca current initially increased and then stabilised. A
second, small glass pipette with a broken tip was lowered into the standard external
solution and 8-OH DPAT perfused from the pipette into the vicinity of the cell. The
bath flow was stopped and known final concentration of the drug was achieved. 8-OH
DPAT was used rather than 5-HT since it is not involved in the process of neuronal
uptake and is more stable and suitable for testing at different temperatures.
Invariably, Ca current was only partially blocked with a supramaximal dose of 8-
OH DPAT (50 |iM), on average, by 34.3+3.8%. This is a smaller percentage of
inhibition than reported for 5-HT by Penington et al. (1991). One explanation could
be that the concentration of 8-OH DPAT was not optimal or that the cell did not see
the full dose of the drug. Another, more likely, possibility is that while 5-HT is a full
agonist on 5-HT1A receptors, 8-OH DPAT is, arguably, only a partial agonist (Sprouse
& Aghajanian, 1988; Sprouse et al. 1993). In hippocampal neurones, the lower
potency of 8-OH DPAT, compared to 5-HT, was attributed to lower reserves of 5-
HT1A receptors, to explain its action as a partial agonist at 5-HT1A receptors (Andrade
& Nicoll, 1987; Sprouse & Aghajanian, 1988; Sprouse et al. 1993).
The inhibition of the current was variable across cells. The reason might be that
the perfusion of the cells by 8-OH DPAT was not adequate or the wash-out of
intracellular components occurred. Another possibility was a difference in the cell
population. This is probably unlikely, because, Lawrence et al. (1989) showed that
-90% of DR neurones contain 5-HT1A receptors, and 8-OH DPAT had no effect in
-8% of the cells (4 out of 51). Moreover, DR neurones have a very small variation
in the cell diameter, so differences in responses can not be attributed to a different
size in Ca currents that appear to depend on cell diameter, as proposed by others
(Scroggs & Fox, 1992b).
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The current recovered slowly after removal of 8-OH DPAT from the standard
external solution. In a minority of DR neurones, as in the cell shown, the post-
application Ca current peaked at a higher amplitude. Similar "overrecovery" has also
been observed in other neurones (Boland & Bean, 1993).
Control Ca current at various potentials is compared with Ca current elicited in the
presence of 8-OH DPAT, see Figure 3.10. The currents were evoked from VH -100
mV to the indicated test potentials. The presence of 8-OH DPAT did not change the
voltage-dependency of Ca channels and the potential at which the Ca current peaked.
Kasai and Aosaki (1989) showed that 2-chloroadenosine (2-CA) inhibited Ca channel
current in chick sensory neurones most prominently at the onset of depolarisation,
and the inhibition slowly reached a steady level. This group observed no depression
of the current at potentials more positive than 30 mV. Surprenant et al. (1990)
reported no effect of the action of noradrenaline in guinea-pig submucosal neurones
on membrane potential. In DR cells, block of Ca current started at depolarising
potential of -50 mV, and the maximal inhibition was seen at -10 mV. At negative test
potentials, -40 mV, -30 mV, -20 mV and -10 mV, the current was blocked by 15, 23,
29 and 34%, respectively. At more positive potentials, the inhibition was less and at
0, 10 and 30 mV it was 25, 14 and 4%, respectively. At around 40 mV, no block was
observed. The reversal potential was not affected, and occurred at 50 mV. The
inhibition at more positive potentials was not examined, but others (Bean, 1989a;
Boland & Bean, 1993) showed that the inhibition by transmitter ligands was much
smaller at larger depolarisations. In bullfrog sympathetic ganglion neurones, LHRH
inhibited Ca current evoked with a voltage step to -10 mV by 28%, whereas the
current elicited with a step to 140 mV was blocked by only 11% (Boland & Bean,
1993).
In Figure 3.11 the peak current traces of control Ca current, during an application
of 50 pM 8-OH DPAT and recovery are shown. 8-OH DPAT inhibited the peak Ca
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current and prolonged the activation time (A). In the inset, the inhibited part of the
current is shown following subtraction. Both, a fast transient and slowly decaying
components were inhibited by 8-OH DPAT. Note the "overrecovery" that occurred
after the removal of the drug. In the same cell the full process of recovery after
wash-out of the drug is shown in (B) by superimposing repetitive current traces.
Recovery of both components was fast and simultaneous.
A number of groups (Artalejo et al. 1992b; Elmslie, 1992; Kasai, 1992; Boland &
Bean, 1993; Elmslie et al. 1993; Gandia et al. 1993; Golard & Siegelbaum, 1993;
Zeilhofer et al. 1993) have shown that a prepulse can partially relieve the inhibition
of Ca current caused by an agonist. As described earlier, in DR neurones a prepulse
did not change the size of the peak current in the absence of 5-HTiA receptor
stimulation. During the presence of 8-OH DPAT, a prepulse to 40 mV from VH -100
mV, 10 ms before a test pulse was applied and shown to substantially relieve the
inhibition of Ca current, on average, by 61%, see Figure 3.12.
The peak current, elicited in the presence of 8-OH DPAT, was blocked by Cd2+,
see Figure 3.13.
Modulation of calcium currents by GTP-v-S
In many cell types it has been reported that inclusion of GTP-y-S in a pipette
modulate Ca current (Dolphin et al. 1989; Kasai & Aosaki, 1989; Elmslie, 1992;
Golard & Siegelbaum, 1993; Netzer et al. 1994) and intracellular dialysis with GTP-
Y-S, mimics the effect of extracellularly applied ligand, for review see Dolphin
(1991a). This suggests that G-proteins are involved in the coupling of activated
receptors to the Ca channels.
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GTP-y-S (200 pM), a non-hydrolysable analogue ofGTP that irreversibly activates
G-proteins, was included in a recording pipette. Ca current, elicited with standard
voltage steps from VH -100 mV to -10 mV, at 20° C, peaked at 1.02+0.04 nA,
significantly lower than in control DR cells (1.82+0.08 nA, p<0.001), see Figure 3.14.
Another difference was that the peak current reached its maximal amplitude some
what later than in control experiments. With GTP-y-S in the recording pipette, the
maximal peak current was seen in 9-15 min (mean= 11 min, n= 16) after obtaining
a whole-cell mode, compared to 7.6 min in control cells. At 20°C, "run-down" of the
current was smaller and the peak current decreased by 5.6+2.3%, 30 min later.
The assumption was that the effect of 8-OH DPAT on Ca channel current was the
result of G-protein activation. Therefore, it was to expect that when the G-protein was
already fully and irreversibly activated by GTP-y-S, no further change either in the
current amplitude or activation kinetics would occur with the addition of 8-OH
DPAT. The current recorded in addition of 8-OH DPAT (50 pM), peaked at
0.98+0.03 nA, n= 4, thus not significantly different from the result obtained in GTP-
Y-S treated cells. The second application of 8-OH DPAT, onto GTP-y-S-dialysed DR
neurones, also produced no significant effect. Therefore, it is difficult to relate the
suggestion made by Elmslie (1992), that the action of GTP-y-S is gradually lost over
time, as in sympathetic ganglion neurones. He also observed that LHRH and NE
reversibly inhibited Ca currents, even in the presence of the GTP analogue.
From times (1) and (2) in Figure 3.14, the peak Ca currents are shown as traces
in the inset. The currents were obtained in the presence of GTP-y-S (200 pM) and
GTP-y-S + 8-OH DPAT (50 pM). GTP-y-S inhibited the peak Ca current, and the
other striking effect produced was the slowing of the activation kinetics. At the end
of the test pulse (150 ms), the current was still not fully activated in most neurones,
and no inactivation of the current was observed. 8-OH DPAT had no significant
effect in the presence of GTP-y-S. In experiments with GTP-y-S, the best fit was
obtained by a double exponential function, as in 8-OH DPAT cells. In control
experiments, the activation followed a single exponential function.
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It was interesting to test whether the HVA Ca current in the presence of GTP-y-S
is also temperature dependent. Figure 3.15 shows the effect of temperature on a GTP-
y-S dialysed cell. At 20° C, the current peaked at 1.02+0.04 nA. When the
temperature was stepped to 25° C the peak current was dramatically enhanced to
1.68 ±0.05 nA, p<0.001. This effect of temperature was completely reversible.
In Figure 3.16, two superimposed peak Ca currents are shown as traces at 20° C
and 25°C, respectively. At 25° C, the peak current was larger than at 20° C, and the
current was fully activated during the test pulse.
Several groups of researchers have shown that the application of a brief,
depolarising prepulse, shortly before the test pulse could partially reverse the effect
of G-protein activation on Ca currents (Penington et al. 1991; Gandia et al. 1993;
Golard & Siegelbaum, 1993). For example, Golard and Siegelbaum (1993) showed
a partial recovery of the inhibition of Ca current by GTP-y-S, following an
application of a 15 ms long prepulse from VH -80 mV to 100 mV. In the presence
of GDP-p-S, the prepulse had no effect on Ca currents.
In DR neurones dialysed with GTP-y-S, a prepulse to 40 mV for 100 ms, 20 ms
prior to the test pulse, potentiated Ca current and the peak was, on average, at
1.11+0.02 nA, see Figure 3.17. So, the prepulse partially relieved the inhibition of
the peak Ca current at 20° C, and also restored the activation kinetics. At 25° C, the
effect of the prepulse was similar, see Figure 3.18.
Therefore, the result obtained in the presence of GTP-y-S is similar to the effect
of the prepulse application on the peak current in cells bathed in 8-OH DPAT.
Current-voltage relation of Ca current amplitudes at 20° and 25° C is shown in
Figure 3.19. The current activated around potentials positive to -40 mV, and, at both
temperatures, peaked at around -10 mV. Reversal potential was at 50 mV, as in
control cells. As explained earlier, the current amplitude was larger at 25° C and the
biggest difference in the current amplitude occurred at the potential that evoked peak
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amplitudes. At potentials more positive than 10 mV, there was no significant
difference in the current size at the two temperatures.
As a control for the action of GTP-y-S, 2 mM of GDP-fl-S was added to the
standard internal solution. Peak current amplitudes are plotted against time and shown
in Figure 3.20. The current peaked, on average, at 1.89+0.04 nA, n= 4. This was not
significantly different from the peak Ca current in control experiments, 1.82 ±0.04 nA.
"Run-down" of the peak Ca current was also similar to control cells and 20 min after
obtaining the maximal peak amplitude, it measured 14+2.1%.
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Figure 3.1: Action potentials recorded from acutely dissociated PR neurone. (A)
Whole-cell current-clamp recording showed many neurones to fire spontaneous action
potentials. The potentials measured between 70-100 mV and could also be evoked by
depolarising pulses positive to -60 mV (A). In (B) the same potentials are shown on
an expanded time scale. Each of them consisted of an initial depolarisation, a small
shoulder during repolarisation (arrow) and a hyperpolarisation. K+ gluconate (120
mM) in internal solution and standard external solution with no TTX were used. Cell
1906922.
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Figure 3.2: Current-voltage relationship of calcium currents recorded in a typical PR
neurone at 20° C. Ca currents were elicited by voltage steps from a holding potential
of -100 mV to a series of depolarised test potentials for 150 ms, as indicated. The
relation between the test potentials and transient (#) and slowly decaying (a) Ca
current components is shown. At test potentials positive to -40 mY, the current
increased and peaked at around -10 mV. The reversal potential was at 50 mV. Note
that strong inactivation of the current occurred only at the peak amplitude. The curve



























10 15 20 25
Time (min)
30 35 40
Figure 3.3: "Run-down" of the peak calcium current with time and the effect of
prepulse. Peak amplitude (•) of the HVA Ca current evoked by a voltage step from
VH -100 mV to -10 mV at a frequency of 0.05 Hz and at 20° C exactly, is plotted
against time. Maximal amplitude of the peak current was obtained, on average, in 7.6
min. The peak Ca current stabilised, on average, at 1.82 nA and 30 min later it was
17% smaller, n= 34. Every second peak is plotted. A prepulse (*) applied
intermittently 10 ms prior to the test pulse, from VH -100 mV to 40 mV and 100 ms
in duration, produced no significant change in the current amplitude, that peaked, on
average, at 1.86 nA, n= 16. The inset shows superimposed Ca current traces in the
presence and in the absence of a prepulse. Currents are leak and capacity subtracted.
Standard internal and external solutions were used. Cell 0902932.
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Figure 3.4: Time course of block of the peak calcium current by cadmium. Peak
calcium current (•) evoked by a standard voltage pulse is plotted against time. At
indicated time "0", the peak current stabilised and 0.1 mM of Cd2+ was applied
externally for 7 min (horizontal bar) to the cell. The drug reduced the peak Ca
current on average by 81 %, n= 3. Cadmium was perfused by a broken glass electrode
with 3-5 pm tip diameter into the vicinity of the neurone. Standard internal and
external solutions were used. Currents are leak and capacity subtracted. Cell 2001932.
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Figure 3.5: Inhibition of the peak calcium current by various concentrations of
cadmium. Cd2+ was applied externally to the vicinity of the neurone and
superimposed peak Ca current traces are shown. In the concentration of 0.1 mM, Cd2+
reduced the peak Ca current by 81%, n= 3 (A), and 1 mM almost completely
abolished the current by 98%, n= 3 (B). The inhibition was partially reversible,
following wash-out of Cd2+ (W). Standard internal and external solutions were used.
The peak Ca currents were evoked with standard voltage pulses and leak and capacity
subtracted. Voltage trace is shown in the lower panel. Cell 2001933.
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Figure 3.6: Effect of temperature on the peak calcium current. Temperature-
dependency of the peak Ca current in DR neurones is shown over a period of time.
At 20°C (•) the peak current stabilised and with a temperature step to 25°C (a)
increased to 168% of control. The current then equilibrated at 20° C and the
temperature was lowered to 15°C. At 15°C (□) the current peaked at 81% of the
control amplitude observed at 20° C. The temperature was returned to 20° C and then
jumped to 30° C (*), where the current peaked to 191% compared to the control
amplitude, n= 4. "Run-down" was faster at higher temperatures, see text. Standard
voltage protocol was employed and standard internal and external solutions were
used. Cell 2201931.
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Figure 3.7: Current-voltage relationship of calcium currents recorded at various
temperatures. Calcium currents were elicited with voltage steps from a holding
potential of -100 mV to indicated potentials in a representative DR neurone. At all
tested temperatures, that is at 15°C (□), 20°C (•) and 25°C (a) the current was
voltage-dependent, peaked at around -10 mV and reversed at 50 mV. The current
amplitudes were best differentiated at the peak potential. Note that at more
depolarising potentials the currents were less temperature-dependent. The curve was
fitted by a cubic spline routine. Currents are leak and capacity subtracted. Standard
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Figure 3.8: Effect of temperature on the peak calcium currents at 20° and 25° C. Ca
currents elicited with a standard voltage steps peaked, on average, at 1.82 nA (n= 34)
and 3.05 nA (n= 4), at 20° and 25° C, respectively. In most neurones both transient
and slowly decaying components of the peak current were affected by an increase in
temperature (A), although in minority of DR neurones only transient part of the
current was potentiated (B). The insets show Ca current when the current obtained
at 20° C was subtracted from that obtained at 25° C. Currents are leak and capacity
subtracted. Standard internal and external solutions were used. Cells 2701932 (A) and
1102931 (B).
125





















5 10 15 20 25
Time (min)
Figure 3.9: Time course of 8-OH DPAT-induced inhibition of the peak calcium
current. Peak Ca current (•) was evoked using standard voltage protocol in a typical
DR neurone. The current stabilised and 8-OH DPAT (50 pM, □) was applied
(horizontal bar) externally via a broken tip capillary glass close to the neurone. The
compound led to a large (34.3%) but incomplete reduction of the peak current, n= 22.
The inhibition was reversible and following wash-out of 8-OH DPAT the peak Ca
current fully recovered. In a number of cells an "overrecovery" was observed, see
text. Currents are leak and capacity subtracted. Standard internal and external
solutions were used. Cell 2204931.
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Figure 3.10: Current-voltage relationship of calcium currents recorded in the
presence and in the absence of 8-OH DPAT. From a holding potential of -100 mV
jumps to the indicated test potentials were used to evoke and compare control Ca
currents (•) with the currents elicited in the same fashion, but in the presence of 8-
OH DPAT (50 pM, □). Currents evoked in both conditions were voltage-dependent.
The inhibition of Ca currents started at potentials at around -50 mV, with the
maximal block at -10 mV. The inhibition was weaker at positive test potentials and
the current reversed at around 50 mV, as in control situation. The curve was fitted
using a cubic spline routine. Currents are leak and capacity subtracted. Standard
internal and external solutions were used. Cell 2403931.
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Figure 3.11: Inhibition of the peak calcium current by 8-OH DPAT. Control Ca
current (1) peaked, on average, at 1.82 nA (n= 34) and following the application of
8-OH DPAT (50 pM, 2) significantly decreased and peaked, on average, at 1.21 nA
(n= 22, p< 0.001). The 5-HT1A agonist was applied into the standard extracellular
solution close to the DR neurone. Following wash-out (3) of 8-OH DPAT, recovery
of the current amplitude was complete (A). Inset shows the inhibited component of
the current. In (B) a full process of recovery (■••) following removal of 8-OH DPAT
is shown by superimposing current traces. Both transient and slowly decaying
components of the current recovered simultaneously. Currents are leak and capacity
subtracted. Standard internal and external solutions were used. Cell 0903932.
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1 - control
2- 8-OH DPAT
3- 8-OH DPAT + prepulse 1 nA
50 ms
Figure 3.12: 8-OH DPAT-induced reduction of the peak calcium current is
significantly relieved by a prepulse. The peak Ca current (1) was blocked by 8-OH
DPAT (50 pM, 2) on average by 34%, n= 22. During continuous presence of the 5-
HT1A agonist in the external solution, a prepulse (3) applied to 40 mV from VH -100
mV, 10 ms prior to the test pulse, substantially reversed the inhibition by 61%, n=
9 (A). In (B) the peak Ca current traces obtained following a prepulse application in
control current (1) and in the presence of 8-OH DPAT (2) are superimposed for
comparison and show a complete restoration of the activation kinetics. Currents are
leak and capacity subtracted. Standard internal and external solutions were used. Cells
0903932 and 0903933.
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Figure 3.13: Cadmium inhibited the peak calcium current in the presence of 8-OH
DPAT. 8-OH DPAT (50 pM, 1) partially blocked the peak current by 34% and in
addition of Cd2+ (100 pM, 2) the current was reduced by 74%, n= 2. The effect of
Cd2+ was fully reversible (3) in this DR neurone. Peak Ca currents were elicited with
standard voltage pulses (lower panel). The inset shows the current that was inhibited
following Cd2+ application. Currents are leak and capacity subtracted. Standard
internal and external solutions were used. Cell 1203931.
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Figure 3.14: The inhibition of the peak calcium current by 8-OH DPAT is G-protein
mediated. Peak Ca current amplitude (#) in a DR neurone dialysed with GTP-y-S
(200 pM) is plotted against time. At the time indicated by the horizontal bar, 8-OH
DPAT (50 pM, □) was applied externally to the DR neurone, for 2 min. The
compound had no significant effect on the size of the peak current amplitude. Inset
shows two superimposed peak Ca current traces obtained in the presence of GTP-y-S
(1) and in addition of 8-OH DPAT (2). Currents are leak and capacity subtracted.
Standard internal and external solutions were used. Cell 1105931.
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Figure 3.15: "Run-down" of the peak calcium current in the presence of GTP-y-S.
Peak Ca current elicited in the presence of GTP-y-S (200 pM) with standard voltage
steps at 20° C (•) and 25° C (A) is shown in relation with time. At 20° C the
maximal peak current was observed, on average, in 11 min (n= 16) after obtaining
a whole-cell mode, rather later than in control cells (mean= 7.6 min). "Run-down"
was smaller than in control conditions, and 30 min later the peak current amplitude
decreased by 5.6%. With an increase in temperature by 5°C the current was
significantly potentiated to 159% of control and "run-down" was faster. Application
of a prepulse (*) at both 20° and 25° C additionally potentiated the peak current.
Currents are leak and capacity subtracted. GTP-y-S was included in the pipette
solution and standard external solution was used. Cell 1703931.
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Figure 3.16: Temperature-dependency of the peak calcium current in DR neurones
dialysed with GTP-y-S. Ca current evoked at 20° C in the cells dialysed with 200
pM GTP-y-S peaked, on average, at 1.02 nA (n= 16), significantly lower than in
control experiments (1.82 nA, p< 0.001), and mimicking the peak current amplitude
observed in the presence of 8-OH DPAT (0.98 nA). With a temperature step to 25° C,
the current was significantly enhanced, on average, to 1.68 nA (n= 2) and the effect
of temperature was fully reversible. In (A) superimposed peak Ca current traces are
shown at 20° and 25°C, respectively, and in (B) the current component is shown that
was potentiated with an increase in temperature. Peak currents were evoked using
standard voltage protocol (lower panel), and GTP-y-S was included in the recording
pipette. Currents are leak and capacity subtracted. Standard external solution was
used. Cell 1703932.
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Figure 3.17: Prepulse substantially relieved the inhibition of the peak calcium current
in DR neurones dialysed with GTP-y-S at 20° C. At 20° C Ca current peaked, on
average, at 1.02 nA in the presence of GTP-y-S (200 pM, 1), and application of a
prepulse (2) partially relieved the inhibition of the peak current. With the prepulse,
the current was potentiated, on average, to 1.11 nA (n= 16). Voltage pulses are
shown in the lower panel. GTP-y-S was included in the internal solution and standard
internal and external solutions were used. Currents are leak and capacity subtracted.
Cell 0804931.
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Figure 3.18: Potentiation of the peak calcium current and effect of a prepulse in DR
neurones dialysed with GTP-y-S at 25°C. At 25°C Ca current peaked, on average,
at 1.68 nA and in the presence of a prepulse was enhanced to 1.73 nA, n= 3. GTP-y-
S (200 pM) was added to the internal solution. Standard internal and external
solutions were used. Currents are leak and capacity subtracted. Voltage pulses are
shown in the lower panel. Cell 0804932.
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Figure 3.19: Voltage-dependency of calcium currents evoked in the presence of
GTP-y-S. Ca currents evoked from a holding potential of -100 mV are plotted against
various test potentials. The currents at both 20°C (•) and 25° C (■) were voltage-
dependent, activated at -40 mV and peaked at around -10 mV. Reversal potential was
at 50 mV, as in control cells. The currents elicited at both temperatures were best
differentiated at the peak potential of -10 mV, whereas at more positive potentials
they were of similar size. The curve was fitted using a cubic spline routine. Currents
are leak and capacity subtracted. Standard internal and external solutions were used.
Cell 1703933.
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Figure 3.20: "Run-down" of the peak calcium current in DR neurones dialysed with
GDP-J3-S. GDP-p-S (2 mM, •), a compound that inhibits G-protein activation, was
included in the recording pipette. Ca current peaked, on average, at 1.89 nA, n= 4,
that is similar to the peak current evoked in control DR neurones (1.82 nA). "Run¬
down" was not significantly different than in control situation and 20 min after
obtaining the maximal amplitude, the current decreased, on average, by 14%.
Currents are leak and capacity subtracted. Standard internal and external solutions
were used. Cell 1606931.
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Effect of 5-HT1A receptor activation on calcium current kinetics
In DR neurones, it was quite apparent that an application of the 5-HT1A agonist or
G-protein stimulation, resulted in a change in Ca current kinetics. Therefore, it was
challenging to examine the nature of the Ca currents modulation in various situations.
It has been shown that in many other neuronal cell types, a modulation of Ca current
by neurotransmitters also affects the current kinetics (Brown et al. 1981; Fenwick et
al. 1982; Byerly et al. 1984; Kay & Wong, 1987; Kay, 1991; Allen et al. 1993).
Calcium currents activation
To obtain a clearer picture of the effects of 5-HT1A receptor stimulation on DR
neurones, it was necessary to examine the kinetics of activation. This has been
performed by applying available mathematical functions and determining the best fit
to the Ca current activation, elicited with depolarising pulses, using the standard
voltage protocol. Activation of the current was analysed from the time of the voltage
step to the time the current peaked, following leak and capacity subtraction. Peak
current amplitudes were obtained with voltage steps from VH -100 mV to -10 mV,
for 150 ms. Single and double exponential functions and Hodgkin and Huxley
models, with the analysis of m1 - m4 fits (see Methods) were used.
In Figure 4.1 (A) the activation of Ca current in a representative control DR
neurone, at 20° C is shown, together with the best fit. In 75% of the control cells (n=
34), the best fit was a single exponential, with an activation time constant, Ta, of
2.35+0.22 ms. When the same cell was held at 25° C activation was much faster than
at 20° C. That result is, to a certain degree, discrepant with the results from other
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groups. For instance, Fenwick et al. (1982) showed that in cultured chromaffin cells,
at 20°C, the optimal fit was a sum of three components. Allen et al. (1993) suggested
that the activation of the HVA Ca current in rat magnocellular cholinergic basal
forebrain neurones could be described by a double exponential fit with the time
constants taf and Tas of 16 and 301 ms, respectively. However, the current data are
in agreement with the observations of Brown et al. (1981) in Helix aspersa neurones,
who fitted the Ca current activation using a monoexponential equation. It is possible
that the problem might be in the fact that the sensitivity of the instruments that other
groups used (Kay & Wong, 1987) was able to resolve the activation time at a
resolution of -0.1 ms, whereas the settling time of the voltage-clamp used in the
present study, was 0.5-1 ms. Therefore, it was difficult to analyse brief, fast
components of activation. In addition, Allen et al. (1993) used Ca2+ as the charge
carrier, whereas Ba2+ ions were used in the present experiments.
In a few cells, there was only a small, almost negligible, difference between a
single and double exponential fits. A good example of that is shown in Figure 4.1
(B). Both fits illustrated here have almost equal ability to fit the activation curve. In
this cell, the time constant for a single exponential fit was 2.34 ms, while T^f and Tas
were 1.32 and 3.72 ms, respectively.
Hodgkin and Huxley model was also used to examine the activation kinetics. In
control cells, the best fit was obtained with m2, and in 40% of the neurones, m1 fitted
better. This is in accord with the reports from other laboratories (Brown et al. 1983;
Byerly et al. 1984; Kay & Wong, 1987). At 20° C, the Tas for m1 to m4 were 2.55,
2.48, 2.33 and 2.26 ms, respectively.
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Effect of temperature and cadmium on activation kinetics
From a holding potential of -100 mV, a temperature dependency of the peak Ca
current was studied in the same DR neurone. Temperature was tested at 15°, 20°,
25° and 30°C, see Figure 4.2. Time constant of activation was temperature dependent
and the higher the temperature, the faster the activation. The same observation was
reported by Byerly et al. (1984) in snail neurones and VanLunteren et al. (1993) in
bullfrog sympathetic neurones. The best fit obtained at 20° C, was, as explained
above, a single exponential, but at 15°C, a double exponential function was better.
Earlier it was shown that 0.1 mM of Cd2+ blocked most of the peak current. When
the activation kinetics was analysed, it was found that Cd2+ also prolonged the
activation time. Indeed, as illustrated in Figure 4.3, in the presence of Cd2+, the
current activation was best fitted by a double exponential. Following the removal of
Cd2+ from the standard external solution, the activation kinetics was best fitted by a
single exponential. Time constants for single exponential fits for control, Cd2+ and the
current after the removal of Cd2+ were 2.33, 7.53 and 6.01 ms,
respectively.
Effect of 5-HT1A agonist on activation kinetics
There is an evidence to suggest that an application of an agonist suppresses Ca
current and simultaneously slows the activation time (Elmslie, 1992; VanLunteren et
al. 1993).
For that reason, it was important to examine the effect of 8-OH DPAT on the peak
current kinetics in DR neurones. Figure 4.4 shows traces of the activated peak current
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in control conditions, during the application of 8-OH DPAT and partial recovery. For
control cells, xa was 2.35+0.22 ms and the best fit was a single exponential.
However, perfusion of the cells with 8-OH DPAT (50 pM), produced a significant
change in the activation kinetics, n= 22, and the time constant for a single
exponential fit was 5.75+0.38 ms, i.e. a 2.5-fold increase compared to control cells.
For a double exponential fit, which was the best fit in 72% of cells tested in the
presence of 8-OH DPAT, the fast time constant, Taf, was 4.77 ms, and the slow, Tas,
6.08 ms. The m1, rather than m2 was the optimal relation for Hodgkin and Huxley
model.
Following the administration of Cd2+ (0.1 mM) in the extracellular solution, to the
cell still perfused with 8-OH DPAT (50 pM) a further increase in the activation time
constant was seen, Figure 4.5. Comparing single exponential fits, the time constant
in addition of Cd2+, increased from 5.05 to 6.40 ms. Wash-out of Cd2+ partially
restored the kinetics, n= 3.
Effect of prepulse on activation kinetics
In control cells, application of a prepulse had no effect on the peak current
amplitude. Moreover, the prepulse had no effect on activation kinetics. In the
presence of a prepulse Ta was of 2.42 ±0.08 ms, compared to 2.35+0.22 ms in control
cells. The best fit was a single exponential and m2 was the best fit for the Hodgkin
and Huxley model.
Ca current activation was almost entirely restored by a prepulse in cells bathed in
8-OH DPAT (50 pM), see Figure 4.6. The prepulse restored activation kinetics, that
was again best fitted by a single exponential and m2 was the best fit for the Hodgkin
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and Huxley model. The time constant, Ta, in the presence of 8-OH DPAT was
5.78+0.38 ms, and ta was of 2.60+0.15 ms with an addition of the prepulse. The
result was very close to the activation kinetics and ta of 2.35+0.22 ms, prior to the
8-OH DPAT administration.
Effect of GTP-y-S on activation kinetics
The effect ofGTP-y -S on the peak Ca channel current was almost identical to that
produced in the presence of 8-OH DPAT. Therefore, it was of interest to examine the
effect of GTP-y-S on the current activation. Two effects were examined: firstly, to
determine whether the activation was best fitted by a double exponential, as in the
presence of 8-OH DPAT, at 20° and 25°C, and secondly, to see whether the prepulse
restored the current activation. Figure 4.7 (A) shows that in the cells dialysed with
200 pM GTP-y-S, n= 10, at 20° C, the best fit was a double exponential. In addition,
m1 was the best in 9 out of 10 cells. The prepulse had the same effect as seen in 8-
OH DPAT cells; it completely restored the current activation, with ta of 2.64+0.09
ms, as in control cells. Single exponential fit was best in 78% cells (7/9).
Similar result was obtained at higher temperature, when DR neurones were held
at 25° C (n= 3), in the presence of GTP-y-S included in the standard intracellular
solution, see Figure 4.7 (B). In the absence of a prepulse, the activation of the current
was best fitted by a double exponential.
A prepulse restored the activation kinetics to a single exponential. It was some
what unexpected that in the presence of GTP-y-S, the peak current was best fitted
by a double exponential at 25° C, because at higher temperatures the current
activation is usually best fitted by a single exponential.
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Calcium currents inactivation
The process of inactivation of Ca current has been examined by a number of
workers (Brown et al. 1981; Chad & Eckert, 1986; Kay, 1991; Frace & Hartzell,
1993; VanLunteren et al. 1993). Kay (1991) described that the inactivation kinetics
in acutely dissociated CA 1 pyramidal neurones of guinea-pig hippocampus, was best
fitted by a sum of two exponentials, with time constants of 200 ms and 2s. He
suggested that inactivation results from a dual process of voltage- and Ca-dependent
inactivation.
Inactivation of Ca channel current has also been studied in DR neurones. As
discussed previously, inactivation was not seen in all cells and, when observed, it was
very variable. A similar observation was made by Fenwick et al. (1983) in cultured
chromaffin cells and Werz et al. (1993) in sympathetic neurones. In most DR
neurones at 20° C, under control conditions, the current amplitude at the end of a 150
ms long test pulse was not significantly smaller than the peak current, and measured
1.75 nA compared to 1.82 nA, respectively. At 25° C, the inactivation kinetics was
more apparent and the analysis was possible. The results shown here were obtained
by eliciting the peak Ca current from holding potential of -100 mV to -10 mV, where
the inactivation of the current was maximal. With the peak current elicited from VH
-60 mV, no inactivation was seen. The inactivation was analysed by fitting curves
from the time the current peaked, to the end of the test pulse.
The current kinetics were strongly temperature dependent. Earlier, it was shown
that with an increase in temperature the Ca current peaked at a higher amplitude and
the activation time was shorter. Increasing the temperature from 20° C to 25°C,
potentiated inactivation of the current in DR neurones. At 20° C, at the end of the test
pulse, the current was 3.9% smaller than the peak current, whereas at 25°C that was
15%.
Figure 4.8 shows the effect of temperature on the peak current inactivation. A
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single exponential was the best fit for inactivation at 20° C in all cells tested, n= 24.
On the other hand, an increase in inactivation, produced at 25° C, was best fitted by
both a single, n= 2, and double, n= 2, functions. This result might be in opposition
to the report by Brown et al. (1981) and Kay (1991). In CA1 hippocampal neurones,
Kay recorded that a double exponential was the best fit. He also suggested that
inactivation was strongly Ca-dependent and used 10 mM BAPTA in the recording
electrodes. In the present experiment 11 mM EGTA was used, which is weaker Ca
chelator. Werz et al. (1993) also favoured the sum of two exponentials, but measured
only the first 50 ms of inactivation of the inward current. In DR neurones, the
marked change in inactivation rate was best demonstrated by a difference in the time
constants. At 20° C, the peak current inactivated with a time constant of 203+31 ms,
whereas at 25° C that was of 47+7.6 ms, an almost 5-fold speeding up of the
inactivation.
Application of a prepulse had no effect on the inactivation time at 20° C. Single
exponential was the best fit in all cells, n= 18. The time constant in the absence of
the prepulse was 203 ms and 221 ms in its presence.
Only very few cells showed inactivation of the peak Ca current in the presence of
8-OH DPAT or GTP-y-S. Indeed, as described earlier, in a number of cells dialysed
with GTP-y-S, Ca current did not reach a peak during a 150 ms long test pulse. As
a result, the inactivation kinetics was not measured in such small number of cells.
Calcium currents deactivation
Tail currents can be used to analyse deactivation of Ca current, when the
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membrane potential is returned to its holding value. Single and double exponentials
were used to fit the current deactivation. Tail current was determined from the time
the membrane holding potential settled at -100 mV, until the current decayed fully.
In majority of the neurones tested, the tail currents were difficult to separate from
leakage currents. An excessive variability of tail currents was present from cell to
cell. For that reason, the results obtained in the presence of a prepulse, and at 25°C,
are not illustrated in this study. The other reason is, as it was described for the
activation kinetics, that we experienced a relatively slow settling time of the voltage-
clamp. In most cases, the tail currents were of very rapid nature.
Neurones were tested at 20° C exactly. In 80% of cells (12/15), the tail current was
best fitted by a single exponential. In another three cells, the best fit was a double
exponential. Some laboratories have reported the existence of an additional
component, or have used a double exponential fit (Fenwick et al. 1982; Byerly et al.
1984). In DR neurones, the time constant for the tail current was of 2.77+0.24 ms.
This is in line with the observation in sympathetic ganglion neurones by Sala (1991).
As in the analysis of the fast rate of activation in DR neurones, it was possible that
the fast component of the tail current was not detected or separated from the
capacitance artifact.
The effect of 8-OH DPAT and GTP-y-S was also studied. An impressive
observation was, that both compounds led to a prolongation of the tail current. The
tail currents were best fitted by a double exponential. Time constants, t„ for single
exponentials for 8-OH DPAT and GTP-y-S was 3.65 and 3.79 ms, respectively. The
result was significantly different than that in the control experiments, with time
constant of 2.77 ms (p< 0.01).
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Figure 4.1: Activation kinetics of the peak calcium current at 20° and 25°C. Peak
Ca current was evoked in a typical DR neurone and shown as a broken line (■••),
together with the fitted curve (—). At 20° C, the activation time constant, xa, was, on
average, of 2.35 ms (n= 34), whereas at 25° C, the activation was faster, n= 4. The
best fit for the current activation at both 20° and 25° C was a single exponential (A).
In minority of DR neurones (5.1%), both a single and double exponential showed an
equal ability to fit the activation curve, as shown in (B). Standard voltage steps were
used and currents are leak and capacity subtracted. Standard internal and external
solutions were used. SE= single exponential; DE= double exponential. Cells 2101932
(A) and 2601931 (B).
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Figure 4.2: Effect of temperature on the activation kinetics in a representative DR
neurone. Activation kinetics of the peak Ca current was temperature-dependent. At
15°C, the best fit was a double exponential, whereas at 20°, 25° and 30° C, the best
fit was obtained with single exponentials. Currents, evoked with the standard pulses,
were leak and capacity subtracted and standard internal and external solutions were
used. Two calibration bars are shown, the upper one for the current evoked at 15°C,
and the lower one for the other currents shown. Cell 2201931.
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5 ms
Figure 4.3: Effect of cadmium on the peak calcium current. Cd2+ (0.1 mM) was
applied externally, close to the DR neurone and prolonged the activation of the peak
Ca current. In the presence of Cd2+, the best fit was a double exponential, and
following wash-out of the drug the activation kinetics was best fitted by a single
exponential, as in control situation. Time constants (xa) for single exponential fits for
control current (C), current evoked in the presence of Cd2+ and following wash-out
(W) of Cd2+ were, on average, 2.33, 7.53 and 6.01 ms, respectively. Two calibration
bars for the current are shown; the upper one for the current evoked in the presence
of Cd2+, and the lower one for the other currents shown. Cell 2001931.
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Figure 4.4: 8-OH DPAT substantially prolonged the activation time of the peak
calcium current. Peak Ca current in control situation (1) activated with a time
constant of 2.35 ms and a single exponential was the best fit. Extracellularly applied
8-OH DPAT (50 pM, 2) dramatically increased the activation time by 2.5 fold. In
72% of cells the best fit for the activation of the peak Ca current in the presence of
8-OH DPAT was a double exponential with fast, ta>f, and slow, Tas, time constants
of 4.77 and 6.08 ms, respectively, n= 22. Following wash-out (W) of the drug, the
best fit was again a single exponential. Cell 0903932.
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5 ms
Figure 4.5: Effect of cadmium on the activation kinetics in the presence of 8-OH
DPAT. Cd2+ (0.1 mM) was applied externally into the vicinity of the DR neurone that
was continuously perfused with 8-OH DPAT (50 pM). A double exponential was the
best fit in the presence of both drugs. Time constants of activation during perfusion
with 8-OH DPAT (1) and with both 8-OH DPAT and Cd2+ (2) had Ta f of 4.77 and
5.05 ms, and Tas of 6.39 and 5.06 ms, respectively. The effect of Cd2+ was fully
reversible following wash-out (3). Cell 1203931.
151





3- 8-OH DPAT + prepulse
Figure 4.6: Prepulse completely restored the activation kinetics in the presence of
8-OH DPAT. Peak Ca current in control situation (1) was evoked using a standard
voltage protocol and the best fit was a single exponential. Application of 8-OH DPAT
(2) into the external solution slowed the activation of the peak current and the best
fit was a double exponential. In addition of a prepulse (3), the activation kinetics was
restored and the best fit was a single exponential. Time constants of activation in
control cells, in the presence of 8-OH DPAT and in addition of the prepulse were of
2.35, 5.78 and 2.60 ms, respectively. Cell 0903932.
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Figure 4.7: Effect of a prepulse on the activation kinetics of the peak calcium current
in the cells dialysed with GTP-y-S, at 20° and 25° C. In DR neurones intracellular
application of 200 pM GTP-y-S had similar effect on the activation kinetics as 8-OH
DPAT. The best fit was a double exponential at 20° and 25°C (1), respectively. In
addition of a prepulse (2), the activation kinetics was restored in 7/9 neurones, that
is the best fit was a single exponential with the time constant, on average, of 2.64 ms
(A), as in control cells. Similar observation was made at 25° C (B). Both fits, a single
(SE) and double (DE) exponential are superimposed over the current trace. Cells
0804931 (A) and 0804932 (B).
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Figure 4.8: Inactivation of the peak calcium current at 20° and 25° C. At 20°C
inactivation was best fitted by a single exponential in all neurones studied (n= 24),
whereas at 25° C, both a single (2/4) and double (2/4) exponentials were the best fit
in the same number of cells. The peak Ca current inactivated with t; of, on average,
203 ms at 20°C, and an increase in temperature for 5°C produced a 5-fold speeding
up of the inactivation. Cell 2201934.
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Chapter 5 Protein phosphatase inhibition and ICa2+
Effect of okadaic acid on calcium currents
The involvement of phosphorylation in the modulation of Ca currents was studied
using the okadaic acid group of compounds.
These drugs are potent natural blockers of two serine/threonine protein
phosphatases: protein phosphatase 1 (PP1) and phosphatase 2A (PP2A), (Ingebritsen
& Cohen, 1983; Bialojan & Takai, 1988; Haystead et al. 1989).
Many groups have shown that phosphorylation is a necessary step in ion channel
functioning (Armstrong & Eckert, 1987; Hescheler et al. 1988; Elmslie et al. 1993;
Frace & Hartzell, 1993). When the effect of okadaic acid (OA) was examined on the
HVA Ca current in DR neurones, the compound increased the peak Ca current and
slowed "run-down" in 80% of DR neurones tested (36 out of 45 cells). Figure 5.1
compares the time course of the increase in the peak Ca current amplitude with time
in a representative DR neurone dialysed with 1 pM OA to a control experiment, i.e.
in the absence of OA. In all experiments the peak Ca current amplitude in the
presence of protein phosphatase inhibitors was elicited with voltage pulses from VH
-100 mV to -10 mV for 150 ms, at a frequency of 0.05 Hz. Recording started 5 min
after obtaining a whole-cell mode. In the presence of OA a maximal peak amplitude
occurred, on average, in 10-18 min (mean 13.6 min, n= 45), rather later than in
control experiments (mean= 7.6 min), after establishing the whole-cell configuration.
Once the current stabilised, the average peak amplitude was 2.53+0.06 nA, 39%
higher than in control cells. This is in an agreement with the reports from Hescheler
et al. (1988) and Frace and Hartzell (1993). In their hands, OA (5-100 pM) was
applied extracellularly and potentiated the peak HVA Ca current in guinea-pig and
frog cardiomyocytes. Mironov and Lux (1991) also observed a potentiation of the
HVA Ca current, when isolated rat hippocampal neurones were bathed in OA. Werz
et al. (1993) reported that OA enhanced the peak Ca current in isolated sympathetic
ganglion neurones.
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Another, very striking, observation shown in Figure 5.1, is that OA, included in
a recording pipette, slowed "run-down". The rate of "run-down" in OA dialysed cells
was, on average, 8±0.9%, 30 min after obtaining the maximal peak amplitude. That
was significantly different than in control cells (17%), p< 0.01. It appears that OA,
by an inhibition of dephosphorylation stabilised Ca currents. This phenomenon has
also been observed in other neuronal cells (Belles et al. 1988; Hescheler et al. 1988;
Mironov & Lux, 1991; Reinhart et al. 1991; Artalejo et al. 1992b; Clark, 1993;
Elmslie et al. 1993; Werz et al. 1993).
It was described earlier that in control experiments prepulses had no significant
effect on the peak Ca current in DR neurones. However, the effect of a prepulse was
more prominent in the presence of OA. A prepulse application potentiated the current,
which on average peaked at 2.61 ±0.08 nA, n= 21, see Figure 5.2. Moreover,
additional prepulses were still able to enhance the peak current, albeit to a lesser
degree.
In another set of experiments (n= 3), OA (1 pM) was included only at the back
part of the recording pipette by "back filling", see Methods. This allows OA to reach
the cell and dialyse it more slowly by diffusion, as shown in Figure 5.3. A prolonged
increase in the size of the peak current amplitude was observed, when OA was
included in the back of the recording pipette, and the same rate of "run-down" as in
control OA experiments was recorded. The maximal peak amplitude of the HVA Ca
current was obtained some what later than in a control OA cell, see Figure 5.1. In
these neurones, the maximal peak current was observed in 11-22 min (average 16
min), whereas in control OA cells, the median time was 13.6 min. Prepulse applied
once the peak current had stabilised, potentiated the current to the same extent as in
control OA neurones.
The current-voltage relationship in a typical DR cell dialysed with OA is illustrated
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in Figure 5.4. As in control experiments, the currents were evoked from a holding
potential of -100 mV and the threshold for the current activation was around -40 mV.
Unexpectedly, the peak current amplitude was shifted to the left. Thus, there was a
very steep increase in the size of the currents positive to -30 mV, and they peaked
at around -20 mV. The same pattern was observed in all cells tested, n= 9. In the
Figure, both transient and slowly decaying components of the Ca current are plotted
and no significant inactivation of the current was observed at 20° C. OA treated cells
reversed the potential at around 50 mV, as in control cells. In cardiac myocytes
perfused with OA, Frace and Hartzell (1993) observed no shift in the peak Ca current
nor in reversal potential.
It appears that phosphorylation is strongly temperature-dependent. Current traces
obtained in the same neurone in the presence of OA, at 20° and 25° C, and evoked
by standard voltage pulses are shown in Figure 5.5. In all five experiments an
increase in temperature from 20° to 25° C enhanced the peak Ca current amplitude.
At 20° C the current peaked at 2.53+0.06 nA, and a negligible inactivation of the
current was observed. The temperature was then stepped to 25° C, and the current
peaked, on average, at 3.23+0.11 nA, that was significantly higher than at 20° C, p<
0.01. Inactivation was much stronger at the higher temperature (A). Inset (B) shows
a subtraction of the two currents, obtained at 20° and 25° C, respectively.
Effect of 8-OH DPAT in the presence of okadaic acid
Effect of the 5-HT1A agonist 8-OH DPAT was studied in DR neurones dialysed
with OA. Figure 5.6 shows a time course of the peak Ca current amplitude evoked
in the presence of 1 pM OA. Once the current had stabilised, 8-OH DPAT (50 pM)
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was applied externally to the cell during a period of time and inhibited the peak Ca
current, on average, by 31+2.6%, n= 16. The second application, 30 min later,
produced the same effect, albeit the inhibition was less. These experiments show that
OA was unable to prevent the inhibition of the peak Ca current caused by the 5-HT1A
receptor activation. Furthermore, this would suggest that phosphorylation is not
involved in the modulatory effect of 8-OH DPAT on the HVA Ca currents and does
not share the same pathway of modulation with 8-OH DPAT. This observation is
supported by the reports from other laboratories. Elmslie et al. (1993) showed that
norepinephrine partially inhibited the peak Ca current and the effect was not
prevented by an inclusion of OA in the recording pipette in bullfrog sympathetic
neurones. Hescheler et al. (1988) made similar observation in cardiomyocytes during
P-adrenergic stimulation.
The most dramatic effect observed in the experiments with 8-OH DPAT was that
of a prepulse. A prepulse applied in the presence of OA and 8-OH DPAT reduced
the inhibition of the peak Ca current caused by 8-OH DPAT by 45% and the current
peaked, on average, at 1.82+0.05 nA. However, that was not the sole effect of the
prepulse. Surprisingly, as in the DR neurones tested in the absence of OA, the
prepulse fully restored the activation kinetics, see Figure 5.7.
It was necessary to confirm that the effects described, recorded in the presence of
OA, resulted from the inhibition of protein phosphatase 1 and/or 2A. For that
purpose, other PP1 and PP2A blockers were tested using the same protocol as in the
experiments with OA. The results are presented in the following sections.
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Effect of 1-norokadaone on calcium currents
It was reported that 1-norokadaone (1-NO) has similar chemical structure to OA,
but does not inhibit PP1 and PP2A and can be used as an inactive analogue of OA
(Nishiwaki et al. 1990). 1-NO (1 pM) was included into the recording pipette and
its effect is shown in Figure 5.8. The peak Ca current was not enhanced in the
presence of the compound as in OA cells, and at 20° C the peak current was maximal
in 7-12 min, with a median of 10.3 min (n= 4), rather earlier compared to 13.6 min
in the presence of OA.
Furthermore, "run-down" was not prevented and the peak Ca current decreased by
16%, 30 min later. A prepulse application had no effect on the peak current. With an
increase in temperature to 25° C, the current amplitude was reversibly potentiated and
peaked at 2.73 and 2.72 nA, n= 2. The prepulse produced only weak and reversible
enhancement of the peak current, to 102% of control, at 25° C. Inset in the Figure
shows the peak Ca current traces obtained in another cell perfused with 1-NO at
20° C at the beginning (1) and at the end (2) of the recording. "Run-down" was not
prevented by the presence of 1-NO, as described above for okadaic acid.
Therefore, it appears that 1-norokadaone, an inactive analogue of OA, produced no
significant change in the peak Ca current amplitude or the current kinetics, when
compared to control DR neurones.
Effect of microcystin on calcium currents
Two other compounds also claimed to inhibit protein phosphatase 1 and 2A are
microcystin (MC) and calyculin-A. Therefore, it is presumed that both of them
produce similar effects as OA. The drugs were dissolved in DMF, included in the
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pipette solution and tested separately.
In Figure 5.9, MC (1 pM) dialysed the cell and changes in the peak Ca current
amplitude over a period of time are shown. The recording started 5 min after gaining
access to the cell and the maximal current amplitude was seen in 10-17 min
(median= 14 min). The peak current amplitude was potentiated, on average, to
2.62+0.08 nA (n= 9) and MC produced apparently slightly stronger enhancement of
the peak Ca current than OA. The potentiation of the peak current was significantly
larger than in control experiments, p< 0.001.
Moreover, this was not the only effect seen in the presence of MC. Fast "run¬
down" was prevented as in OA cells. The rate of "run-down" was, on average,
7+0.4%, 30 min after obtaining the maximal peak amplitude. That was significantly
less than in control cells (with a "run-down" of 17%), but only slightly different than
in OA experiments (8%). The difference observed in the effects of MC and OA
might be due to the fact that MC is a membrane impermeable substance, while OA
is not. Therefore, it could be argued that the presence of MC in the cells was at the
concentration applied, whereas OA could slowly diffuse out of the cell. The two
substances produced basically the same effect, only MC was slightly more potent.
Apparently, the same phenomenon was also observed by Frace and Hartzell (1993).
They reported that MC was more efficacious, producing a maximum Ca current
density nearly twice that of OA in frog cardiomyocytes. The group suggested that
because OA is unstable in solution, the action of OA could be blocked by its own
products of degradation.
In the Figure 5.9, an application and the effect of 8-OH DPAT on the peak Ca
current are also shown. 8-OH DPAT (50 pM) was applied into the external solution
via a lowered glass capillary with a broken tip, close to the cell. It produced a very
clear effect, that is an inhibition of the Ca current, that peaked, on average, at
1.49 ±0.08 nA.
Following a prepulse application, the inhibition of the peak Ca current was
partially relieved, as in OA dialysed neurones. With the prepulse, the current peaked,
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on average, at 1.70+0.08 nA. That result followed the pattern observed in OA cells,
suggesting again that OA and MC modulate the peak Ca current via the same
pathway.
Figure 5.10 shows current and voltage traces obtained in the same DR neurone.
The peak Ca current (A, see Figure 5.9), evoked by a voltage step from VH -100 mV
to -10 mV for 150 ms in the presence of MC, was potentiated in addition of a
prepulse (B) to 106.3% of control MC current. The second application of the prepulse
produced the same effect (data not shown).
An application of 8-OH DPAT (50 p,M) into the bath solution, i.e. to the vicinity
of the cell, reduced the peak Ca current even in the presence of MC, as described
earlier for okadaic acid. The current and voltage traces are shown in Figure 5.11. The
peak Ca current elicited in the presence of MC (1, see Figure 5.9) was depressed by
an application of 8-OH DPAT (2) by 38.2%. In addition of a prepulse (3), in the
continued presence of 8-OH DPAT, the activation kinetics was fully restored, but the
inhibition of the peak current was only partially relieved.
Effect of calyculin-A on calcium currents
Calyculin-A is another inhibitor of PP1 and PP2A and a member ofOA family of
compounds. An effect of the drug on the peak Ca current amplitude is shown in time-
dependent fashion in Figure 5.12. Calyculin-A, included in a recording pipette,
enhanced the peak amplitude of Ca current, on average, to 2.50+0.04 nA, n= 7. The
maximal peak current stabilised on average in 8-16 min from the start of the
recording and the compound also slowed the "run-down"; the inset shows that 30 min
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later the peak current was 8+0.6% smaller. During the course of recording, a prepulse
was intermittently applied and potentiated the peak Ca current to 104% of control.
This action of calyculin-A has been observed by other groups (Elmslie et al. 1993).
All three compounds, that are highly specific protein phosphatase 1 and 2A
blockers, OA, MC and calyculin A, but not 1-NO, which is an inactive analogue of
OA, increased the peak Ca current amplitude and prevented rapid "run-down" to a
certain degree. However, these compounds were unable to relieve the inhibition of
the HVA Ca current following an application of 8-OH DPAT.
Effect of GTP-y-S in the presence of okadaic acid
GTP-y-S is a non-hydrolysable analogue that fully and irreversibly activates G-
protein. In the control experiments it exhibited the effect on the peak Ca current that
was similar to the one produced by 8-OH DPAT. The two main observations were:
decrease of the peak Ca current amplitude and slowing of the activation kinetics.
Here, GTP-y-S (200 pM) was included, together with OA (1 pM), in a recording
pipette and the peak Ca current amplitude at 20° C is shown in Figure 5.13. In control
experiments, i.e. in the absence of OA, GTP-y-S significantly decreased the peak Ca
current, on average, to 1.02+0.04 nA. With an addition of OA, the current peaked
significantly higher, at 1.90+0.08 nA, p< 0.001, at 20° C. "Run-down" was slower and
30 min later, the peak Ca current decreased by only 10%.
With an increase in temperature, the current peaked at higher amplitudes and "run¬
down" was much faster. The amplitude of the peak current at 25° C, was on average
2.70+0.14 nA. That was a significant change when compared to the cells perfused
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with GTP-y-S, but not with OA. In those cells, the Ca current peaked at 1.68 nA, p<
0.001.
A prepulse potentiated the peak Ca current to 115% of control at 20°C, and the
current peaked, on average, at 2.20+0.04 nA. In subsequent applications of the
prepulses, the effect was repeatable. As expected, the action was even more
pronounced at 25° C; the prepulse enhanced the peak Ca current to 3.20+0.1 nA, n=
3. Full recovery of the peak current occurred, with a return of the temperature to
20° C.
Furthermore, when the current traces were analysed an additional effect was
observed. Apparently, the activation time in the presence of GTP-y-S was slower.
The effect on the peak Ca current amplitude and activation kinetics in DR neurones
dialysed with both GTP-y-S and OA is shown in Figure 5.14. The peak current
obtained in the presence of GTP-y-S and OA at 20° C, shows smaller peak current
amplitude and slowing of the activation kinetics, compared to control cells. However,
with an addition of the prepulse the block was substantially relieved and the
activation kinetics fastened. The changes in the current kinetics are described later.
At 25° C, the current peaked at higher amplitudes and the prepulse additionally
potentiated the peak current, see Figure 5.15. In Figure 5.16 two superimposed traces
of the peak Ca current evoked by voltage pulses at 20° and 25° C respectively, are
shown in the absence of a prepulse. For clearer presentation, the inset (B) shows a
current trace obtained when the current elicited at 20° C was subtracted from the
current evoked at 25° C.
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Effect of calcineurin inhibitors
After analysing the effects of PP1 and PP2A inhibitors on modulation of the peak
Ca current, obviously the next step was to examine the involvement of protein
phosphatase 2B (PP2B) on Ca channels.
FK 506, an immunosuppressant, has been shown to bind and inhibit calcineurin
(Liu et al. 1991; Schwaninger et al. 1993). Its effect depends on the presence of Ca2+
and FK-binding protein (FKBP). In the present experiments, FK 506 had no effect
on the peak Ca current in the absence of FKBP (data not shown). Figure 5.17 shows
a period of time in which the peak Ca current was elicited with voltage pulses from
VH -100 mV to -10 mV, every 20 s. FK 506 (0.01 pM) was dissolved in DMF and
together with FKBP-12 (1 pM) included in the recording pipette. The peak Ca
current amplitude slowly increased in size and the current was potentiated to 108%
of control, in the presence of FK 506 and FKBP, n= 3. One other observation was,
that, unlike in OA cells, "run-down" was not significantly reduced, and the peak Ca
current was 14% smaller 30 min later, similar to control experiments (17%).
However, it was important to examine whether calcineurin mediated 8-OH DPAT
inhibition of the peak Ca current. When 50 pM of 8-OH DPAT was applied into the
external solution close to the neurone, see inset, the peak current was inhibited, on
average, by 27%, as in control and OA dialysed dorsal raphe neurones. Therefore, it
appears that there is no direct link between 8-OH DPAT and protein phosphatase 2B
action on Ca channel currents.
Effect of forskolin and protein kinase inhibition
Forskolin is recognised as a stimulator of intracellular cAMP (Laurenza et al. 1989;
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Dolphin, 1992; Hartzell & Budnitz, 1992). A proposed hypothesis is that 5-HT causes
an increase in intracellular cAMP and possibly activates cAMP-dependent protein
kinase for its action on DR neurones. So, in the presence of forskolin it was to expect
that no further modulation, in addition of 8-OH DPAT, would occur.
Forskolin (10 pM) was dissolved in an anhydrous DMF and included in the pipette
solution. Figure 5.18 shows changes of the peak Ca current amplitude over time
during one representative experiment. In the presence of forskolin, the peak Ca
current was only slightly potentiated and "run-down" was 12%, 30 min later, n= 3.
Application of 8-OH DPAT (50 pM) into the external solution inhibited the peak Ca
current to the same extent as in the absence of forskolin, by 26%, as shown in Figure
5.19 (A). The same observation was reported in DRG neurones (Dolphin, 1991b),
where baclofen still inhibited Ca current in the presence of forskolin. Further on, with
the inclusion of both forskolin and OA (1 pM) in the recording pipette, the peak Ca
current was additionally potentiated but the inhibition of the peak current by the 5-
HT1A agonist (B) was not abolished, n= 3.
Another compound, that is specific in blocking protein kinase A and C, H-7, was
tested in the same fashion. With H-7 in the recording pipette, 8-OH DPAT was
applied and the peak current was inhibited, on average, by 31 % (C), as in control DR
neurones. Staurosporine is a potent, non-selective, protein kinase inhibitor (Herbert
et al. 1990). It has been shown that the drug markedly inhibited protein kinase C in
rat brain (Tamaoki et al. 1986). A similar potency was reported for its inhibition of
cAMP-dependent protein kinase from bovine heart. When staurosporine (1 pM)
dialysed DR neurones, the inhibition of the peak Ca current by the 5-HT1A agonist
was not prevented (n= 2, data not shown). The same result was reported by Yakel
(1992) in dissociated neurones from the snail Helix aspersa.
It seems that a stimulation of cAMP by forskolin modulates Ca channel currents
in DR neurones. However, it is clear that OA and 8-OH DPAT do not use the same
modulatory pathway as forskolin to exercise their action on the HVA Ca current.
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Figure 5.1: Enhancement of the peak calcium current and attenuation of "run-down"
by okadaic acid. Peak amplitude (#) of Ca current evoked with voltage steps from
VH -100 mV to -10 mV for 150 ms at 20° C is plotted against time. In the presence
of OA the peak current amplitude was maximal, on average, in 13.6 min (n= 45),
rather later than in control neurones (mean of 7.6 min). The peak current was
potentiated to 139%, compared to control experiments (p< 0.01). "Run-down" was
significantly reduced in the presence of OA, and the peak current decreased by 8%
over 30 min (compared to 17% in the absence of OA, O). Application of a prepulse
(*) additionally potentiated the peak current. OA (1 pM) was dissolved in DMF and
included in the recording pipette. Standard internal and external solutions were used.
Currents are leak and capacity subtracted. Cells 1105932 and 0902932.
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Figure 5.2: Okadaic acid produced an increase in the peak calcium current that was
additionally potentiated by a prepulse. In DR neurones dialysed with 1 pM OA, the
current peaked, on average, at 2.53 nA, n= 45, significantly higher than in control
cells (1.82 nA, p< 0.01). In addition of a prepulse, further enhancement of the peak
current was observed, and the current amplitude was 2.61 nA, n= 21. Superimposed
current traces of the peak current elicited in the presence of OA (1) and in addition
of a prepulse (2), evoked by voltage pulses (lower panel) are shown. Currents are
leak and capacity subtracted. Standard internal and external solutions were used. Cell
1105931.
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Figure 5.3: "Back filling" delayed potentiation of the peak calcium current by
okadaic acid. OA (1 pM) was included only at the back of the recording pipette, with
the tip filled by a standard recording solution. Diffusion of OA (•) into the DR
neurone was slower and maximal peak amplitude of the current was observed in 16
min (n= 3), rather later than in control OA cells (13.6 min, O). However, once the
compound dialysed the neurone, it potentiated the current and similar rate of "run¬
down" as in control OA cells was recorded (8%). A prepulse (*) additionally
enhanced the peak current. Currents are leak and capacity subtracted. Standard
internal and external solutions were used. Cells 0906931 and 1105934.
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Figure 5.4: Current-voltage relationship of calcium currents recorded in a typical DR
neurone dialysed with okadaic acid at 20°C. Ca currents were evoked by voltage
jumps from a holding potential of -100 mV to a series of depolarised test potentials
for 150 ms. The relation between the test potentials and transient (•) and slowly
decaying (□) components of the current is shown. The activation threshold was at -40
mV, the peak current was observed at around -15 mV and reversal potential at 50
mV. Note that there was almost no inactivation of the current present. OA (1 pM)
was included in the internal solution. Currents are leak and capacity subtracted. The
curve was fitted using a cubic spline routine. Standard internal and external solutions
were used. Cell 2705931.
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Figure 5.5: Temperature-dependency of the peak calcium current in the presence of
okadaic acid. Peak Ca current evoked in a typical DR neurone with standard voltage
pulses at 20° and 25° C, respectively, are shown. With an increase in temperature the
current peaked at higher amplitude, activation was speeded up and inactivation was
stronger, see text. Ca currents peaked, on average, at 2.53 nA (n= 45) and 3.23 nA
(n= 5), at 20° and 25° C, respectively (A). Both transient and decaying components
were affected by an increase in temperature, as shown in the inset (B). OA (1 pM)
was included in the recording pipette. Currents are leak and capacity subtracted.
Standard internal and external solutions were used. Cell 1606932.
171
















OA pre|iulse 8-OH DPAT
10 15 20 25 30
Time (min)
35 40 45 50
Figure 5.6: Time course of the reduction of the peak calcium current by 8-OH DPAT
in OA dialysed cells. Peak Ca current (•) was evoked over a period of time in a
typical DR neurone. The current stabilised and 50 pM 8-OH DPAT (□) was applied
(horizontal bar) externally via a broken tip glass pipette close to the cell. The drug
inhibited the peak current, on average, by 31%, n= 16 and the effect was repeatable
and fully reversible following wash-out of 8-OH DPAT. As in control cells, prepulse
(*) significantly relieved the inhibition of the peak Ca current. Currents are leak and
capacity subtracted. OA (1 pM) was included in the internal solution. Standard
internal and external solutions were used. Cell 1702942.
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Figure 5.7: Okadaic acid had no effect on the inhibition of the peak calcium current
by 8-OH DPAT. In OA (1 pM, 1) dialysed cells Ca current peaked at 2.53 nA (n=
45) and following bath application of 8-OH DPAT (50 pM, 2) significantly decreased
and peaked, on average, at 1.56 nA (n= 16, p< 0.001). A prepulse (3), applied in the
presence of both 8-OH DPAT and OA, significantly relieved the inhibition by 45%
and the mean peak current was 1.82 nA. Voltage pulses are shown in the lower panel.
OA was included in the recording pipette and standard internal and external solutions
were used. Currents are leak and capacity subtracted. Cell 2402941.
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Figure 5.8: 1-norokadaone, an inactive analogue of okadaic acid, had no effect on
the peak calcium current. 1-NO (1 pM, •) was included in the recording pipette and
the peak current was plotted against time. Maximal current amplitude was recorded
in 10.3 min, rather earlier than in control OA cells (13.6 min). "Run-down" was not
prevented and 30 min later, the peak current was 16% smaller, at 20°C (see inset).
With an increase in temperature to 25° C, the current (A) was reversibly potentiated
and peaked, on average, at 2.73 nA, compared to 3.23 nA observed in OA dialysed
neurones. Prepulse (*) produced a weak enhancement of the peak current, to 102%
of control. Currents are leak and capacity subtracted. Standard internal and external
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Figure 5.9: "Run-down" and time course of 8-OH DPAT-induced inhibition of the
peak calcium current in the presence ofmicrocystin. The recording started 5 min after
obtaining a whole-cell mode and the maximal current amplitude was observed, on
average, in 14 min. The peak amplitude was potentiated to 2.62 nA (n= 9),
significantly higher than in control cells (1.82 nA, p< 0.001). Fast "run-down" was
prevented and the peak current was decreased by 7%, 30 min later. 8-OH DPAT
(horizontal bar) inhibited the peak current, on average, by 38%. The effect was
partially relieved by a prepulse (*). MC (1 pM, •) was dissolved in DMF and
included in the internal solution and 8-OH DPAT (50 pM, □) was applied externally.
Currents are leak and capacity subtracted. Standard internal and external solutions
were used. Cell 1304931.
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Figure 5.10: Enhancement of the peak calcium current by microcystin was
additionally potentiated by a prepulse. MC (1 pM) was included in the recording
pipette and strongly potentiated the peak current, on average, to 2.62 nA (A),
compared to 1.82 nA in control and 2.53 nA in OA dialysed cells. Application of a
prepulse (B) in the presence of MC additionally increased the current by 6%.
Currents are leak and capacity subtracted. Standard voltage pulses (lower panel) and
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Figure 5.11: Microcystin had no effect on the inhibition of the peak calcium current
by 8-OH DPAT. Ca current evoked in the presence of MC peaked, on average, at
2.62 nA (1) and in addition of 8-OH DPAT the current was inhibited by 38%, and
peaked, on average, at 1.49 nA (2). Application of a prepulse (3), in a continuous
presence of MC and 8-OH DPAT substantially relieved the inhibition, similar as in
control and OA cells. Superimposed peak current traces are shown, evoked with
standard voltage jumps (lower panel). MC (1 pM) was included in the recording
solution and 8-OH DPAT (50 pM) was applied extracellularly. Currents are leak and
capacity subtracted. Standard internal and external solutions were used. Cell 1304931.
177
Chapter 5 Protein phosphatase inhibition and ICa2+
5 10 15 20 25 30 35 40
Time (min)
Figure 5.12: Effect of calyculin-A on the peak calcium current amplitude and "run¬
down". Peak Ca current evoked over a period of time in the presence of calyculin-A
(#) is shown. Maximal current amplitude was observed, on average, in 13.5 min and
the peak amplitude was potentiated, on average, to 2.50 nA, n= 7. "Run-down" was
significantly slower than in control cells, and the current decreased by 8%, 30 min
later. Application of a prepulse (*) additionally enhanced the current to 104% of
control. Inset shows two superimposed peak Ca current traces obtained at the start
(1) and the end (2) of the recording. Calyculin-A (1 pM) was dissolved in DMF and
included in the recording pipette. Currents are leak and capacity subtracted. Standard
internal and external solutions were used. Cell 0405941.
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Figure 5.13: Time course of GTP-y-S effect in DR neurones dialysed with okadaic
acid. Peak Ca current at 20° C (•) and 25°C (A) is plotted against time. With the
addition of GTP-y-S, the current in the presence of OA peaked, on average, at 1.90
nA, significantly higher than in the absence of OA (mean of 1.02 nA, p< 0.001), but
lower than in control OA cells (2.53 nA). "Run-down" was reduced and the peak
current was 10% smaller, 30 min later. The current was temperature dependent and
at 25° C peaked, on average, at 2.70 nA. Application of a prepulse (*) enhanced the
peak current to 115% of control. GTP-y-S (200 pM) and OA (1 pM) were included
in the recording solution. Currents are leak and capacity subtracted. Standard internal
and external solutions were used. Cell 1805942.
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Figure 5.14: Effect of GTP-y-S in the presence of okadaic acid at 20°C. Peak Ca
current traces are superimposed in the presence of GTP-y-S and OA (1) and in
addition of a prepulse (2). At 20° C Ca current was evoked using standard voltage
pulses (lower panel) and peaked, on average, at 1.90 nA. Application of a prepulse
partially relieved the inhibition of the peak current by 14%. With the prepulse Ca
current peaked, on average, at 2.20 nA. GTP-y-S (200 pM) and OA (1 pM) were
included in the internal solution. Currents are leak and capacity subtracted. Standard
internal and external solutions were used. Cell 2605941.
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Figure 5.15: Effect of GTP-y-S in the presence of okadaic acid at 25°C. At 25°C,
the current peaked significantly higher, at 2.70 nA, than at 20° C (1.90, p< 0.001), but
lower than in control OA cells at 25° C (3.23 nA). Application of a prepulse partially
relieved the GTP-y-S-induced inhibition by 16% and potentiated the peak current, on
average, to 3.20 nA. The peak current elicited in the presence of both GTP-y-S and
OA (1) and in addition of a prepulse (2) are shown, together with voltage pulses
(lower panel). Currents are leak and capacity subtracted. GTP-y-S (200 pM) and OA
(1 pM) were included in the recording pipette. Standard internal and external










Figure 5.16: A comparison of the peak calcium current evoked in the presence of
GTP-y-S and okadaic acid at 20° and 25°C. In (A) the peak current elicited in the
cells dialysed with GTP-y-S and OA at 20° and 25° C are superimposed, as indicated.
The peak current amplitudes were reduced compared to control OA cells, thus
mimicking the effect of 8-OH DPAT in DR neurones dialysed with OA. In (B) the
inset shows that mainly transient component of the peak current was enhanced in
most cells at 25° C. Standard voltage pulses were used (lower panel). GTP-y-S (200
pM) and OA (1 pM) were included in the recording pipette. Currents are leak and
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Figure 5.17: FK 506 up-modulated the peak calcium current and had no effect on
the 8-OH DPAT action. Peak current amplitude in the presence of FK 506 and FKBP
(•) in the recording pipette is plotted against time. The peak current was potentiated
to 108% (n= 3), compared to control experiments. "Run-down" was slightly reduced
and the peak current decreased by 14% over 30 min. Application of 8-OH DPAT led
to a significant, but incomplete reduction of the peak current (26%), similar as in
control experiments. The peak current in the presence of FK 506 (0.01 pM) and
FKBP (1 pM) and in addition of 8-OH DPAT (50 pM, *) is shown in the inset.
Currents are leak and capacity subtracted. Standard internal and external solutions
were used. Cells 0507941 and 0507943 (inset).
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Figure 5.18: Effect of forskolin on the peak calcium current. Forskolin (10 pM, •)
was dissolved in DMF and included in the recording pipette. Peak Ca current was
evoked over a period of time with standard voltage jumps. The peak current was
slightly potentiated and "run-down" in the presence of the drug was 12%, 30 min
later (n= 3), compared to 17% in control experiments. Currents are leak and capacity
subtracted. Standard internal and external solutions were used. Cell 1506941.
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Figure 5.19: Protein kinases A and C are probably not involved in the modulation
of calcium currents by 8-OH DPAT. Forskolin, a compound that stimulates
intracellular cAMP that then probably activates cAMP-dependent protein kinase,
slightly potentiated the peak Ca current compared to control DR neurones. 8-OH
DPAT (50 pM, *) was still active and the peak current was reduced, on average, by
26% (A). With addition of OA to the neurones dialysed with forskolin, the peak
current was further enhanced, and the inhibition by the 5-HT1A agonist (*) was
unaltered (B). In (C) H-7, a more specific blocker of protein kinase C, failed to
prevent the inhibition induced by 8-OH DPAT (*). The peak current was reduced,
on average, by 31%, as in control experiment. Cells 1406941, 1506943 and 0706943.
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Effect of protein phosphatase inhibition on calcium current kinetics
With an introduction of protein phosphatase 1,2A and 2B blockers intracellularly,
Ca current kinetics had different properties than in control experiments. For that
reason, okadaic acid, microcystin, calyculin-A and FK 506 have been tested and their
effect on activation, inactivation and deactivation kinetics examined. The same
methods were used, as for analysing the kinetics in control conditions, i.e. in the
absence of these compounds. Namely, mono and double exponential functions were
tested, together with Hodgkin and Huxley m1 to m4 models.
Effect of okadaic acid on activation kinetics
The HVA Ca current was activated with depolarising pulses using the standard
voltage protocol, and the peak current amplitudes were elicited with voltage steps
from VH -100 mV to -10 mV, for 150 ms every 20s.
In Figure 6.1 (A) the activation of the peak Ca current at 20° C in the presence of
OA is shown. In all DR neurones examined in the presence of OA, n= 45, it was
clear that the best fit was a single exponential. The activation time constant, ta, was
on average 2.85+0.09 ms. This is similar to the time constant obtained in control DR
neurones, where, in the absence of OA, Ta was 2.35 ms, and the best fit was also a
single exponential.
In the same cell, the activation of the peak Ca current following a prepulse
application is also shown. The prepulse evoked current that peaked to 105% of
control current, i.e. in the absence of the prepulse. Time constant of the peak Ca
current following a prepulse application was on average 2.57 ms. That is comparable
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to the control cells, where Ta, with an addition of a prepulse was 2.42 ms. In all cells
tested, a monoexponential function provided the best fit. Unfortunately, the resolution
of the instruments used in the experiments prevented the measurements of faster
activation kinetics in a number of neurones and, therefore, the activation of the peak
current in only 26% of cells (12 out of 45) was analysed.
Effect of temperature on activation kinetics
A temperature dependency was studied in the same cell, at 20° and 25° C,
respectively, as shown in Figure 6.1 (B). As described above, in the DR neurones
dialysed with OA, a single exponential was the best fit at 20° C. However, an increase
in temperature for 5°C, dramatically affected the activation kinetics. Single
exponential was still the best fit, but the activation was much faster. Regrettably, due
to the problems with the settling time of the voltage-clamp in these studies, there
were difficulties in analysing the activation kinetics of the peak current evoked at 25°
and 30° C.
At 20° C, the best fit was obtained with m2 Hodgkin and Huxley model, as in
control experiments. The time constants for m1 to m4 models were 1.52, 1.31, 1.25
and 1.22 ms, respectively.
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Effect of 5-HT1A agonist on activation kinetics
It has already been shown, that an application of 8-OH DPAT (50 pM) into the
external solution inhibited the peak Ca current in the presence, as well as in the
absence, of OA. Therefore, it was to expect that the presence of OA would not
change the activation kinetics recorded during the 8-OH DPAT application.
Figure 6.2 shows the effect before and during 8-OH DPAT (50 pM) application,
with OA (1 pM) included in the recording pipette. In OA perfused cells, at 20° C, the
time constant obtained was 2.35 ms and the best fit was monoexponential. However,
in the presence of 8-OH DPAT, the best fit was not a single exponential any more,
but, for 81% neurones tested, n= 17, that was a double exponential. In 17.6% of cells,
3 out of 17, the best fit was monoexponential. The time constant for a single
exponential in the presence of 8-OH DPAT was on average 4.87+0.30 ms and that
was almost 2-fold slower compared to control OA cells. For the double exponential
fit, a fast time constant, raf, was 3.22 ms, and a slow one, Tas, 20.6 ms. The best fit
for Hodgkin and Huxley model was m1, and not m2, as in control OA cells.
Effect of prepulse on activation kinetics
In Figure 6.2, the effect of a prepulse on the activation kinetics is also shown. The
action of the prepulse (3) on the peak Ca current activation was studied in the
presence of OA and 8-OH DPAT. In all cells tested, the prepulse restored the
activation kinetics to a single exponential fit. For Hodgkin and Huxley model, m2 was
again the best fit. The most significant observation was that the prepulse completely
restored the activation time. The time constant, ta, following the prepulse application,
was on average 3.35 ms, compared to 2.85 ms, in the cells dialysed with OA and in
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the absence of 8-OH DPAT. That was significantly different than ta obtained in the
presence of 8-OH DPAT, which was of 4.87 ms.
Effect of microcystin on activation kinetics
Effect ofmicrocystin was tested using the same protocol as employed in OA cells.
In the concentration of 1 pM, MC was included in the recording pipette and dialysed
the cells. It has been described earlier, that, in DR neurones, MC strongly potentiated
the peak Ca current and the fast "run-down" of the peak current was prevented.
Figure 6.3 shows that at 20° C, the best fit was a single exponential, as it was in
OA cells. Time constant for the DR neurones dialysed with MC, was on average of
2.76+0.04 ms, n= 9, compared to Ta of 2.85 ms obtained in OA cells. When Hodgkin
and Huxley models were analyzed, m2 was the best fit.
The effect of a standard prepulse application was then tested, and the activation
time was slightly speeded up, with ta on average of 2.70 ms.
This similarity in the results obtained in the presence of okadaic acid and in the
presence of microcystin was expected. Both of these compounds, belong to the same
family of PP1 and 2A inhibitors. The action of MC was somehow stronger, and the
reason might well lay in the fact that this compound is membrane impermeable and
does not degrade as easily as okadaic acid does (Frace & Hartzell, 1993).
Activation kinetics of the peak Ca current in DR neurones in the presence of both
MC and 8-OH DPAT was tested, as shown in Figure 6.4. In the presence of MC, Ta
was 2.76 ms. However, 8-OH DPAT increased the activation time and Ta for a single
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exponential was on average 5.41+0.04 ms, n= 6. That was a 2-fold increase,
compared to control MC cells. A double exponential was the best fit in all 6 cells
tested, together with m1 of the Hodgkin and Huxley model.
In addition of a prepulse, the activation kinetics was restored, n= 4. The time
constant was on average 2.83 ms and that was indeed very close to the time constant
in control MC cell (ta of 2.76 ms). So, the effect of the prepulse seen in OA cells,
was repeated in the presence of MC. Not unexpectedly, a single function was the best
fit, in the presence of the prepulse.
Effect of GTP-y-S on activation kinetics
It was important to study the action of GTP-y-S, because its effect on the peak Ca
current was similar to the 8-OH DPAT action. That 5-HT1A ligand produced a double
exponential activation curve and significantly increased the activation time. Both
effects were examined in the presence of GTP-y-S and OA, as shown in Figure 6.5.
The activation time increased and the time constant, ta, was on average of 3.58+0.06
ms, n= 7 at 20° C (A). That result was similar as in the presence of 8-OH DPAT and
OA, where the xa was of 4.87 ms. The best fit for all cells was a double exponential.
In addition, m1 was the best fit in 7/7 DR neurones.
A prepulse restored the activation kinetics and the best fit for 5/7 cells was a single
exponential, as shown in the same Figure. The time constant in the presence of the
prepulse was 3.21 ±0.04 ms.
To examine a temperature-dependency of the activation kinetics in the presence of
GTP-y-S and OA, the temperature was stepped from 20°C to 25°C, see Figure 6.5
(B). Unexpectedly, unlike in the cells dialysed with GTP-y-S but without OA, the
191
Chapter 6 Protein phosphatase inhibition and ICa2+ kinetics
activation was rapid and monoexponential, at 25° C (n= 3). In the presence of a
prepulse, the activation curve was also best fitted with a single exponential, n= 3.
This result suggests that OA speeded up the activation of the peak Ca current in DR
neurones in the presence of GTP-y-S. The effect of temperature was fully reversible.
The temperature was returned to 20°C, and the current kinetics restored.
Calcium currents inactivation
In this section, the changes in inactivation kinetics are described, in cells dialysed
with okadaic acid. It was observed that inactivation rate was very variable among DR
neurones and even in the same neurone. In most DR cells, the current amplitude at
the end of the test pulse (150 ms long) was not significantly different than the peak
current. At 20°C, the current peaked on average at 2.53 nA, compared to 2.46 nA,
at the end of the test pulse. Furthermore, inactivation was not recorded in all cells at
20° C, but with an increase in temperature to 25°C, inactivation was stronger and
available for analysis. Maximal inactivation of the current was evoked at potentials
around -10 mV. The same observation was reported by Frace and Hartzell (1993), in
frog cardiac myocytes. Inactivation curves were fitted with mono and double
exponentials.
As described earlier, the peak amplitude and activation kinetics of Ca current are
strongly temperature dependent. With an increase in temperature, the current peaked
at higher amplitudes and the activation time was shortened. As in control cells, in OA
perfused neurones, stepping the temperature from 20° to 25° C speeded inactivation
of the peak current. Figure 6.6 shows inactivation curves obtained in the cell dialysed
with OA at 20° and 25°C, as indicated. It is clearly shown that at the higher
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temperature, the inactivation was stronger. The difference in the rate of inactivation
was best seen when the two time constants were compared. For 20° and 25° C, the
time constants were 236 and 68 ms, respectively. That was really a dramatic effect
where the increase in temperature of 5°C, produced an almost 3.5-fold faster rate of
inactivation. The best fit at 20° C and 25° C was a single exponential in 27/29 and
4/4, respectively.
The result obtained contradicts the observation by Werz et al. (1993), who argued
that OA increased the inactivation rate in dissociated bullfrog sympathetic neurones,
compared to control cells. In control DR neurones, i.e. in the absence of OA, the time
constants of inactivation at 20° and 25° C were 203 and 47 ms, respectively, which
is, indeed, very close to the data obtained in the presence of OA. One difference
might lay in the fact that in the sympathetic ganglion neurones, Ca current is 90%
of the N-type, whereas only 40% in DR neurones. Furthermore, the group did not
indicate the temperature at which their results were obtained and that could be a
crucial difference, as shown here. They dissolved OA in DMSO, which could
possibly by itself affect inactivation kinetics. As described earlier, DMSO potentiated
the peak Ca current in DR neurones.
One other observation seen in OA cells was that a prepulse potentiated the peak
Ca current and enhanced the activation rate. Therefore, it was curious to examine,
what effect the prepulse had on inactivation of the current. However, at 20° C, the
standard prepulse application produced just short of a significant change in the
inactivation rate. Single exponential function was the best fit in all cells tested, n=
21. Time constant of the inactivation, t;, in the absence of the prepulse was on
average 236 ms, whereas, with the prepulse, was on average 189 ms.
It was impossible to assess inactivation kinetics in control DR neurones dialysed
with GTP-y-S, since in most neurones the current was not fully activated at the end
of the test pulse. In the presence of OA the current usually peaked during the test
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pulse and inactivation kinetics were analysed.
Figure 6.7 shows the inactivation curves in the presence of GTP-y-S and OA, at
20° C (A). The best fit was a double exponential. Time constant for a single
exponential was of 449 ms. That was significantly different from T; value of 236 ms
in control OA cells. With the addition of a prepulse, the inactivation kinetics was
restored, and the best fit was a single exponential. That result is close to the one
obtained in OA dialysed cells, with T, of 241 ms. Therefore, it appears, that a
prepulse has not only speeded the activation, but also restored inactivation kinetics
in the neurones dialysed with GTP-y-S.
A very similar picture was obtained at 25°C (B), where both curves were
monoexponential. Time constants, TjS, were on average of 66 and 21 ms, respectively.
It is, therefore, to conclude, that the inactivation rate was temperature-dependent and
the application of the prepulse speeded up inactivation of the Ca current in DR
neurones.
Calcium currents deactivation
As described previously, the amplitudes and kinetics of the tail current were
extremely variable. With okadaic acid dialysing DR neurones, the speed of
deactivation was even faster and caused substantial difficulties related to the data
analysis. However, some data, obtained at 20° C, is shown here. As in the cells in the
absence of OA, the best fit was a single exponential. The time constant of the tail
current was, on average, of 2.23+0.09 ms, n= 16. That was faster than in control
cells, where tt was of 2.77 ms (p< 0.01). Application of 50 pM of 8-OH DPAT in
the presence of OA had no effect on the tail current kinetics. When the cells were
dialysed with GTP-y-S and OA two different effects were seen. In 3/7 cells, t, was
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not different than in control OA cells, and measured on average 2.96 ms. On the
other hand, in 4/7 cells, tt averaged 3.80 ms, that is significantly longer than in
control OA neurones, p< 0.001. This variability illustrates the problem in analysing
fast tail current kinetics in DR neurones dialysed with OA.
A summary of the effects on the peak Ca current and activation kinetics in control
DR neurones, and in the neurones perfused with OA, microcystin, 8-OH DPAT and
GTP-y-S at different temperatures, is shown in Figures 6.8 - 6.11. It appears that 8-
OH DPAT-induced down-modulation of the peak current is G-protein mediated. OA
significantly enhanced the peak Ca current both in the presence and in the absence
of 5-HT1A receptor activation, but had no effect on the inhibitory action of 8-OH
DPAT. In the presence of OA, a prepulse additionally increased the peak current, but
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Figure 6.1: Activation of the peak calcium current in the presence of okadaic acid
at 20° and 25° C. In (A) activation of the peak Ca current in the presence of OA (1)
was best fit with a single exponential and ta was, on average, of 2.85 ms, n= 45.
Following application of a prepulse (2) the activation time was slightly faster and Ta
was of 2.57 ms, n= 12. In (B) a step in temperature to 25° C, speeded up the
activation of the peak current (n= 3). OA (1 p.M) was included in the recording
pipette and the peak current was evoked using standard voltage pulses. The activation
of the peak current is shown as a broken line (•••), and single (SE) and double (DE)
exponentials are superimposed as single lines (—), as indicated. Cells 1105932 (A)
and 1602941 (B).
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2- OA + 8-0H DPAT
3- OA + 8-OH DPAT + prepulse
Figure 6.2: 8-OH DPAT prolonged the activation time of the peak calcium current
in the presence of okadaic acid and the effect was restored by a prepulse. In DR
neurones dialysed with OA (1) Ta was of 2.85 ms and the best fit was a single
exponential. 8-OH DPAT (50 pM, 2) was applied externally to the same neurone and
the activation of the peak current was twice longer. The best fit was a double
exponential with xa f of 3.22 ms and ta>s of 20.6 ms, n= 14. However, application of
a prepulse (3) in the presence of 8-OH DPAT, completely restored the activation
kinetics. The best fit was a single exponential with Ta of 3.35 ms. OA (1 pM) was
added to the pipette solution and standard voltage steps were used. Both single (SE)
and double (DE) exponential fits are shown superimposed on the peak Ca current.
Cell 2402943.
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Figure 6.3: Activation of the peak calcium current in the presence of microcystin.
Peak Ca current evoked in the presence of microcystin (1) was best fit by a single
exponential with xa, on average, of 2.76 ms, n= 9. Application of a prepulse (2) also
produced activation of the peak current that was best fit with a single exponential,
and with similar ta of 2.70 ms. The effect is similar to that produced in OA dialysed
neurones. MC (1 pM) was included in a standard internal solution and standard
voltage pulses were used. Cell 1304932.
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3- MC + 8-OH DPAT + prepulse
Figure 6.4: 8-OH DPAT induced slowing of the activation kinetics of the peak
calcium current in the presence of microcystin, that is restored by a prepulse. At
20°C, the peak current activation in DR neurones dialysed with MC (1) was best fit
with a single exponential and ta of 2.76 ms. However, 8-OH DPAT (2) significantly
prolonged the activation time and the best fit was a double exponential, n= 6.
Addition of a prepulse fully restored the kinetics to 2.83 ms, and a single exponential
was the best fit. MC (1 p.M) was included in the recording pipette and 8-OH DPAT
(50 p.M) was applied into the standard external solution. Cell 1304931.
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Figure 6.5: Effect of GTP-y-S of the activation kinetics in the presence of okadaic
acid at 20° and 25°C. GTP-y-S significantly slowed the activation time compared
to control OA cells and in that mimicked the effect of 8-OH DPAT. At 20° C (A),
the best fit was a double exponential (n= 7, 1). With the addition of a prepulse (2),
the kinetics was fully restored and the best fit was a single exponential with time
constant of 3.21 ms, n= 5. Ln (B) the peak Ca current activation in the presence of
OA and GTP-y-S (1) and in addition of a prepulse (2) is shown at 25°C. The
activation was monoexponential in both conditions, n= 3. GTP-y-S (200 pM) and
OA (1 pM) were included in the recording pipette. Both single (SE) and double (DE)
exponentials are superimposed on the corresponding peak current traces. Standard
voltage pulses were used. Note two different calibration bars for (A) and (B). Cell
1805941.
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Figure 6.6: Inactivation of the peak calcium current in the presence of okadaic acid
at 20° and 25° C. Increase in temperature from 20° to 25°C significantly speeded the
inactivation of the peak current. The best fit at both temperatures was a single
exponential and time constants obtained at 20° and 25° C were, on average, of 236
and 68 ms, respectively (n= 27 and 4, respectively). Standard internal and external
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Figure 6.7: Inactivation of the peak calcium current in cells dialysed with okadaic
acid and GTP-y-S at 20° and 25° C. Peak Ca current in GTP-y-S dialysed DR
neurones inactivated only in the presence, but not in the absence of OA at 20° C.
Moreover, inactivation was temperature-dependent, and the higher the temperature,
the stronger was the inactivation. At 20° C (A) a double exponential (1) was the best
fit and application of a prepulse (2) restored the inactivation kinetics to a single
exponential, as in control OA cells. The best fit was a double exponential and for a
single exponential obtained in the presence of the prepulse t; was of 241 ms. At
25°C (B) inactivation was faster aand nd monoexponential (1) with of 66 ms, and
in addition of a prepulse (2) t; was of 21 ms. GTP-y-S (200 pM) and OA (1 pM)
were included in the standard internal solution. Standard external solution and voltage
jumps were used. Cell 1805942.
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Figure 6.8: Summary of the peak calcium current amplitudes in control experiments
and following the addition of 8-OH DPAT and okadaic acid at 20° C. Control Ca
current (closed column) peaked at 1.82 nA in DR neurones. 8-OH DPAT (50 pM)
decreased the peak current by 34% and this was partially reversed by a prepulse. OA
(1 |iM) significantly increased the peak Ca current by 39%, p< 0.01. In the presence
of OA, the prepulse still potentiated the peak Ca current. The depression caused by
8-OH DPAT in OA dialysed neurones was only slightly less than in control cells, i.e.
31% of the peak current was inhibited. The open columns show the effect of the
prepulse.
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Figure 6.9: Summary of the peak calcium current amplitudes in control experiments
and following the addition of GTP-y-S and okadaic acid at 20° and 25° C. Control
Ca current (closed column) peaked at 1.82 nA in DR neurones. Inclusion of GTP-y-S
(200 pM) in a pipette decreased the peak current by 53%. The effect was only
partially reversed by a prepulse. At 25° C, the peak current was 1.90 nA, compared
to 0.96 nA at 20° C. Addition of OA (1 pM) in the pipette, enhanced peak Ca current
to 1.62 nA at 20° C, and 2.70 nA at 25°C, respectively. A prepulse (open columns)
further potentiated the peak Ca current and the effect was more potent in the presence
of OA.
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Figure 6.10: Comparison of the mean activation time constants, Ta, for control, 8-OH
DPAT and GTP-y-S experiments, and the effect of prepulses. In control DR neurones
Ta was 2.35 ms (closed column). Bath application of 8-OH DPAT increased Ta to
5.75 ms, and was similar in effect to that produced when DR neurones were dialysed
with GTP-y-S, 6.21 ms. In the presence of the prepulse (open columns), ta in
control, 8-OH DPAT and GTP-y-S perfused neurones was 2.42, 2.60 and 2.64 ms,
respectively. Time constants used were best fit single exponentials.
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Figure 6.11: Summary of the rates of activation, ta, in DR neurones dialysed with
okadaic acid and microcystin. The activation time constant for OA, MC and control
cells was 2.85, 2.76 and 2.35 ms, respectively. Perfusion of the cells with 8-OH
DPAT in the presence of either OA or MC increased the activation time to 4.87 and
5.41 ms, respectively. A prepulse produced transient restoration of the activation
kinetics. In the neurones dialysed with OA and GTP-y-S, Ca currents were not fully
activated during a 150 ms long test pulses. Time constants used were best fit single
exponentials. Drug applications are shown in closed or hatched columns, and the
addition of a prepulse by open columns.
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The major finding in this study is that micromolecular concentrations of the
extracellularly applied 5-HT1A agonist 8-OH DPAT down-modulate HVA Ca channels
in dorsal raphe neurones, and suppress their gating kinetics. These effects appear to
be G-protein modulated. Furthermore, the HVA Ca current is up-regulated by
inhibition of dephosphorylation, and this modulation is enhanced in the presence of
conditioning depolarising pulses. However, the present data suggest that 8-OH DPAT
and phosphatase inhibitors use two different, but probably closely related mechanisms
for their action on the HVA current.
Properties of calcium currents in dorsal raphe neurones
High-voltage activated Ca current, evoked as the peak current was investigated in
this work. With an advantage of using a whole-cell voltage-clamp technique,
intracellular and extracellular solutions were designed to isolate Ca currents and
completely block outward sodium and potassium currents. In addition to that, high
concentration of EGTA, as an internal Ca2+ chelator, and Ba2+ as the charge carrier
were employed. Ba2+, unlike Ca2+, does not activate Ca-dependent intracellular
processes and it is more stable when tested at different temperatures. Moreover, it has
been suggested that N- and L-type Ca channels that are present in DR neurones are
slightly more permeable to barium, than to calcium ions (Hess, 1990).
Although the peak current was abolished in the presence of Cd2+, a specific Ca
channel blocker, relatively high doses of the drug were required. Fox et al. (1987)
used 20 pM of Cd2+ to fully suppress Ca current in DRG cells. Allen et al. (1993)
reported that Cd2+ in lower concentrations (< 1 pM) markedly inhibited HVA, and
in higher concentrations (1-200 pM) both HVA and LVA currents in rat forebrain
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neurones. In DR neurones the concentration of Cd2+ needed to completely abolish the
current was about 50 times higher than used by others (Fox et al. 1987b; Gross &
Macdonald, 1987; Yang et al. 1993), but similar to some (Boland & Dingledine,
1990). One possible explanation can be that perfusion of the drug was too slow and
short (cells were exposed to Cd2+ for a maximum of 10 min) or that the compound
some how "missed" the tested cell. However, this is unlikely, because other
compounds were applied in the same fashion. For example, 8-OH DPAT inhibited
the peak Ca current in 92.3% of neurones studied, which corresponds to the number
of DR neurones that possess 5-HT1A receptors (-90%). Thus, a flow artifact seems
not to present a major problem in these experiments. Another possibility is a
differential effect of Cd2+ on HVA and LVA Ca currents. Penington and Kelly (1990)
have shown at least four types of Ca currents to exist in DR neurones. Most of the
characterised current is N-type (-40%), and a smaller proportion is L-type (-0-20%)
and T-type current. Moreover, at VH -50 mV, where all T-type current is inactivated,
an application of w-CgTx and the DHP antagonist nimodipine into the bath solution,
blocked only 50% of the HVA current. Thus, -45% of the Ca current remains
unblocked (Penington et al. 1991). As described above, there is evidence to suggest
that LVA current is less sensitive to Cd2+ (Allen et al. 1993). This might indeed be
at least partial explanation for the result obtained. The small part of Ca current that
was relatively insensitive to higher concentration of Cd2+ is probably LVA current,
although this was not specifically tested in the presence of Ni2+ or amiloride.
Furthermore, it is also likely that other, still unidentified HVA Ca current type shows
lower sensitivity for Cd2+.
Voltage-activated Ca current showed a temperature-dependency in DR neurones.
With a temperature step of 5°C, as from 20° to 25° C, the current peaked
significantly higher, by 68%, and the activation kinetics was speeded up. This is
similar to the observations by McAllister-Williams (1992) in the same neurones. The
temperature-dependency was the strongest at the potentials that evoked the peak Ca
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current. At higher temperatures, a shift in the current-voltage relationship to the
hyperpolarising potentials was shown. For example, at 25° C, the peak current was
elicited with a step to around -20 mV, compared to the potential of -10 mV at 20° C.
An increase in temperature appears to shift the equilibrium of Ca channels toward
opening. This leftward shift in the voltage-dependency of Ca currents may involve
changes in a phosphorylation state of the channels, as a possible mechanism of
modulating the Ca currents. A similar shift in the current-voltage relationship has
been reported in other cell types (Nobile et al. 1990; VanLunteren et al. 1993).
Modulation of calcium currents by 5-HT1A receptor activation
Calcium channels have an important role in neurotransmission in central and
peripheral nervous system and they are found in all excitable cells so far studied.
Given the ubiquitous nature of Ca channels, it is possible that they have an essential
role in neuronal plasticity. In DR neurones, application of 8-OH DPAT led to a
significant, but incomplete suppression of the peak Ca current by 34%, and the
inhibition was relieved following a prepulse, by 60%. It is interesting that the
reduction of the peak Ca current amplitude by 8-OH DPAT was slightly less than the
depression of the current following 5-HT application (57%), that was observed in the
same cells (Penington et al. 1991). One possible explanation for lower potency of 8-
OH DPAT, compared to the effect of 5-HT is that while 5-HT is a full agonist on the
5-HT1A receptors, 8-OH DPAT, arguably, acts only as a partial agonist.
In many neuronal types N-type channel was the proposed site of action for
neurotransmitters because the transient component of Ca current was lost and that
component was DHP insensitive. For example, Koike et al. (1994) showed that 5-HT
and 8-OH DPAT blocked specifically N-type Ca current in hypothalamic neurones.
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They proposed that the N-type channel regulates release of 5-HT, by acting on 5-
HT1A receptors. Other groups have also argued that the slowing of the activation
kinetics observed in the presence of neurotransmitters results from a selective
inhibition of a rapidly inactivating N-type current, leaving a slowly activating L-type
current untouched (Wanke et al. 1987). However, in a number of different neuronal
types N-type current does not always activate rapidly, nor does L-type current
activate slowly (Jones & Elmslie, 1992). Moreover, in DR neurones the amount of
transmitter-resistant current is considerably larger than the amount of L-type current,
following application of 8-OH DPAT. Furthermore, Ciranna et al. (1993) showed that
8-OH DPAT inhibited Ca current in porcine melanotrophs. In these cells the drug
selectively inhibited L-type current. In other cells, such as in snail Helix aspersa
neurones, 5-HT potentiated Ca current (Paupardin-Tritsch et al. 1986; Hill-Venning
& Cottrell, 1992) and specifically acted on T-type current (Berger & Takahashi,
1990).
It was shown earlier that in DR neurones the current inhibited following 8-OH
DPAT application is only partially of N-type. 8-OH DPAT-induced down-modulation
of the peak Ca current is reduced by only 10% in the presence of the N-type channel
blocker co-CgTx (Penington et al. 1991). Therefore, a significant amount of the peak
Ca current that is blocked by 8-OH DPAT might be oo-CgTx and DHP insensitive
and has to be characterised. This unidentified HVA Ca current is in many ways
similar to N-type current in DR neurones. Some of the properties of this current are
that it is a high-voltage activated current, it is transient with faster inactivation rate,
the current is w-CgTx and DHP insensitive and needs negative holding potential to
reprime completely (Penington et al. 1991). Therefore, the inhibited current was
either N-type with fast inactivation time constant and less sensitive to w-CgTx, but
sensitive to 5-HT, or the channel was sensitive to 5-HT, but it was not N-type
channel. The latter hypothesis suggests that depression of the peak Ca current caused
by 8-OH DPAT may affect more than one type of Ca channels. Furthermore, this




Interesting observation is that a whole host of neurotransmitters modulate Ca
current interacting with G-proteins. In DR neurones, intracellularly applied GTP-y-S
mimicked the effect of 8-OH DPAT, both by down-modulating the peak current
amplitude and slowing of the activation kinetics.
Furthermore, 8-OH DPAT applied to the DR neurones dialysed with GTP-y-S
produced no additional effect on the peak current amplitude or activation time. A
similar modulatory pathway has already been examined in other cell types, such as
rat pituitary GH3 cells (Kleuss et al. 1991). Exogenously added G-proteins can restore
the ability of neurotransmitters to inhibit Ca currents. Such experiments have
generally suggested that G0 is more effective than G; in the restoration experiments.
It is known that there is an abundancy of G0 proteins in both central and peripheral
nervous system, and this subtype of G-proteins is limited to neuronal, neuroendocrine
and endocrine cells (Hescheler et al. 1987; Ewald et al. 1988b). For example, in DRG
neurones Campbell et al. (1993) showed that G0, but not Gj subtype was responsible
for the modulation of Ca channels by baclofen. In a rat pituitary tumour cell line that
possesses no G0, dopamine had no effect on prolactin release, whereas in another cell
line containing G0, dopamine was effective (Dolphin, 1990).
Another example that G-proteins are required for calcium currents modulation was
observed following a dialysis of DR neurones by GTP. In the absence of GTP, the
peak Ca current decreased more quickly during recordings. Furthermore, the
compound was needed for Ca channels to maintain sensitivity to modulation by 8-OH
DPAT. A similar observation was made in other cell types (Elmslie et al. 1993).
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Effect of prepulse on calcium currents amplitude and activation kinetics
A strong, conditioning depolarisation applied just prior to the test pulse had no
effect on the peak current amplitude (2% increase in the peak current) nor on the
activation kinetics (both were best fitted by a single exponential) in control DR
neurones. In the presence of 5-HT1A receptor activation a prepulse only partially
relieved the inhibition of the peak Ca current in majority of the neurones. The block
of the peak Ca current was never 100% relieved, and that was similar as observed
in other cell types (Dolphin et al. 1989; Boland & Bean, 1993).
However, a prepulse had a significant effect in restoration of the activation
kinetics. Application of the 5-HT1A agonist 8-OH DPAT or an intracellular dialysis
of DR neurones with GTP-y-S produced a slowing of activation of the peak current.
When the activation kinetics was analysed in DR neurones, a single exponential,
which was the best fit in control neurones, was replaced by a double exponential in
the presence of either 8-OH DPAT or GTP-y-S. Following application of a prepulse
to 40 mV, the activation kinetics was fully restored. A single exponential was the
best fitted, with similar time constant as in control cells.
It is possible that these two effects observed in the presence of 5-HT1A receptor
activation, that is a reduction of the current amplitude and slowing of the activation
kinetics, are two separate processes with similar time courses. Use of such two-pulse
protocol as in the present study, i.e a prepulse preceding the test pulse, clearly
illustrates that the 8-OH DPAT-induced slowing of the current activation can be
completely reversed by conditioning depolarisations. The results also demonstrate,
however, that the reversal of the current amplitude at depolarised potentials is
generally incomplete, leaving the inhibition present even at strongly depolarised
voltages. Therefore, it is possible to distinguish two components that presumably use
distinct pathways. The slowing of the activation of the current is fully reversed at
depolarised voltages, and this component is voltage-dependent. It appears that this
component subsides with time, and its contribution to the total inhibition declines
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during a depolarising pulse, see Figures 3.12, 3.17 and 3.18. The second component,
that presents a reduction of the current amplitude, is not associated with a change in
activation kinetics and is present throughout the duration of a test pulse. It is not
reversed at depolarised voltages, i.e. it is voltage-independent. Although the two
components can be separated on the basis of their voltage-dependency, they appear
to be indistinguishable in their time course for onset and recovery. In support of this
hypothesis it has been shown in a few cell types that a neurotransmitter inhibited Ca
current without changing activation kinetics. This was shown in both central (Toselli
et al. 1989; Sah, 1990) and peripheral (Forscher et al. 1986; Ewald et al. 1988b;
Bean, 1989a) neurones. The voltage-dependence of transmitter action is confined to
currents that demonstrate measurable slowing of the activation kinetics. By contrast,
currents in which the kinetic slowing could not be measured demonstrate little
voltage-dependency of neurotransmitter action (Aosaki & Kasai, 1989; Kasai, 1992).
Furthermore, some G-proteins that mediate inhibition of Ca current have also been
shown not to be associated with a slowing of the activation kinetics (Ewald et al.
1988b; Sah, 1990; Beech et al. 1992). Thus, it is possible that different G-proteins
mediate slowing of the activation kinetics and inhibition of the current amplitude. It
has already been shown that a single neurotransmitter can activate more than one
class of G-proteins. For example, following application of muscarine PTX sensitive
and PTX insensitive G-proteins are activated (Nathanson, 1987; Ashkenazi et al.
1989). Moreover, a PTX sensitive G-protein can contain different subtypes that can
specifically be activated. Ewald et al. (1989) observed differential effects of PTX
sensitive G-protein a-subunit subtypes, such as a0, ocn and ai2, following application
of neuropeptide Y and bradykinin in rat sensory cells. Diverse-Pierluissi et al. (1995)
suggested that NE-induced inhibition of voltage-independent steady-state component
of Ca current is mediated via G,, whereas slowing of the activation kinetics follows
activation of G0, in embryonic chick DRG neurones.
The mechanism of the prepulse action is not fully understood. One hypothesis
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might be that following a strong depolarisation, an "inhibitory molecule" unbinds
from the channel in a voltage-dependent fashion (Golard & Siegelbaum, 1993). In
control cells, i.e. in the absence of neurotransmitters, a majority of Ca channels reside
in a closed state from which they are "willing" to open upon depolarisation. Possibly,
addition of neurotransmitters increases the fraction of channels in the "reluctant"
mode, thus resulting in a biphasic activation curve (Bean, 1989b). A slow activation
in the presence of a transmitter shows the slow conversion of "reluctant" to "willing"
channels. It is possible that in the presence of saturating doses of neurotransmitters
a fraction of the Ca channels, which are shifted to the "reluctant" mode requires
stronger depolarising pulses to open. According to this hypothesis, large
depolarisations cause a number of "reluctant" channels to revert transiently to the
"willing" mode.
In addition, others suggested that transmitters could modulate calcium currents by
different intracellular mechanism. For instance, this process could depend on the
buffering system used, suggesting a role of internal calcium in mediating these
events. When intracellular BAPTA is low (0.1 mM) a neurotransmitter causes
inhibition of the current amplitude and slowing of the activation of the current,
whereas only slowing of the activation kinetics is present in 10 mM BAPTA
(Bernheim et al. 1991; Beech et al. 1992). In rat hypothalamic neurones 20 mM of
BAPTA completely prevented the inhibition of the current and slowing of the
activation kinetics following application of L-glutamate (Zeilhofer et al. 1993).
Qualitatively similar results were obtained with either Ca2+ or Ba2+ as the charge
carriers.
Thus, it is possible to argue that the suppression of Ca current amplitude following
5-HT1A receptor activation is probably due to a voltage-independent switch of the
"willing" Ca channels to "reluctant" mode, whereas a voltage-dependent shift is
responsible for the observed changes in the activation kinetics.
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Inactivation of calcium currents
High-voltage activated calcium current in DR neurones inactivated slowly and only
partially during voltage steps lasting 150 ms. Inactivation was the strongest at
voltages that evoked the highest Ca currents. Inactivation, as well as activation, of
the peak Ca current in DR neurones was temperature-dependent. At 20° C not all cells
exhibited inactivation and the current at the end of the test pulse was insignificantly
smaller than the peak current (1.75 nA compared to 1.82 nA, respectively). With an
increase in temperature for 5°C, as from 20° to 25° C, the inactivation was
dramatically faster, up to five times, p< 0.001. However, a great variety of
inactivation rates was observed at both 20° and 25° C. It was described earlier
(Penington et al. 1991) that co-CgTx sensitive N-type channels, that form a majority
of Ca channels in DR neurones, have excessively variable inactivation rates and
might greatly influence inactivation in the neurones, in addition with other Ca
channel types. Thus, N-type channels may be able to switch to various inactivation
states and it is possible that stronger inactivation of the peak Ca current observed at
25°C may be due to the activation of channels favouring a fast inactivation state at
higher temperature. In addition, it seems plausible that variable inactivation rates
observed in DR cells are a measure of the mixture of multiple Ca channels types
involved. In support of this view is the observation that inactivation is voltage-
dependent.
Other groups (Brown et al. 1981; Kay, 1991) observed slower inactivation of Ca
current in CA1 hippocampal neurones and Helix aspersa neurones, than in DR
neurones. This contradictory finding might result from using Ca2+ as the charge
carrier and strong buffering of internal calcium ions by BAPTA in their experiments.
In the present experiments, the weaker Ca2+ chelator EGTA was used and Ba2+ as the
charge carrier. Inactivation can also depend on different phosphorylation states of
calcium channels in these cell types. There are indications to suggest that
phosphorylation enhances voltage-dependent activation of Ca channels, and that
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inactivation is due to their dephosphorylation (Chad & Eckert, 1986).
In DR neurones, inclusion of OA in the recording pipette produced just short of
a significant change of inactivation. Time constant of inactivation in control DR
neurones was 203 ms, compared to 236 ms in the presence of the phosphatase
inhibitor. In sympathetic ganglion neurones, inactivation was stronger in the cells
perfused with OA (Werz et al. 1993). As described, by evoking high-voltage Ca
current, mostly N-type current inactivates. Thus, this difference between inactivation
rates may be in the fact that in the sympathetic ganglion neurones Ca current is 90%
of the N-type, whereas 40% in DR neurones. Moreover, Werz et al. (1993) does not
indicate the temperature at which they obtained the result, and they dissolved OA in
DMSO, which could possibly by itself modify the Ca current, see Figure 2.5.
"Run-down" of calcium currents
During whole-cell recordings a slow and irreversible decrease of Ca current
amplitude, i.e. "run-down", occurred. This presents one of the disadvantages of the
whole-cell technique.
It appears that "run-down" is a complex process that depends on at least two
events: 1. loss of the intracellular source of energy, and 2. increase in intracellular
Ca. In DR neurones, the rate of "run-down" was slower in the presence of ATP,
showing that a progressive loss of high energy compounds from the cytoplasm is
involved in the decay of the Ca current. Thus, this effect of ATP suggests
phosphorylation to be an important factor in maintaining Ca currents (Elmslie et al.
1993; Tiaho et al. 1993). Indeed, when DR neurones were dialysed with phosphatase
blockers, "run-down" was significantly smaller. For example, in the presence of OA
"run-down" was 8% 30 min later, compared to 17% in control DR neurones, p< 0.01.
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A similar phenomenon was observed in other cell types (Hescheler et al. 1988;
Reinhart et al. 1991; Werz et al. 1993), but not in all (Kameyama et al. 1986).
An increase in internal Ca concentration could also cause a decline of Ca current.
Addition of Ca chelator EGTA to the recording pipette significantly prolonged the
currents survival, whereas the cell superfusion with caffeine (which releases Ca from
sarcoplasmic reticulum and other internal stores) accelerated decay of the current
(Belles et al. 1988). Byerly and Moody (1984) showed that the presence of both ATP
and EGTA prevents fast "run-down" of Ca current more than the presence of high
dose of EGTA alone.
Phosphorylation of the cells has been shown to protect some intracellular proteins
against enzymatic hydrolysis (Belles et al. 1988). During longer recordings of Ca
current and subsequent elevation in internal Ca concentration, Ca-dependent proteases
could activate and cause proteolytic degradation of Ca channels. For instance, Chad
and Eckert (1984) have shown that leupeptin, an inhibitor of Ca-dependent proteases
prevented fast "run-down" of Ca current, however, only in the presence of
phosphorylating agents. This involvement of enzymatic mechanism in the
maintenance of Ca currents might also explain some of the temperature sensitive
features of the Ca currents in DR cells. By increasing the temperature from 20° to
25°C "run-down" was significantly faster, whereas at 15°C the current was more
sustained.
Modulation of calcium currents by protein phosphatase inhibition
Multiple phosphorylation sites on Ca channels are known to exist (Takahashi et al.
1987). However, the effect of phosphorylation on Ca channel activity is not fully
understood. In DR neurones, protein phosphatase inhibition prevented the fast "run-
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down" of the peak Ca current, potentiated the peak current and the effect was
additionally enhanced in the presence of conditioning depolarisations. These findings
suggest that phosphorylation stabilised the Ca current. In the presence of phosphatase
1 and 2A blockers a significant potentiation of the peak current occurred. Calcineurin,
on the other hand, is dependent on calcium ions intracellularly, that were well
buffered with EGTA, and it is unlikely that this phosphatase plays a major role in
regulation of Ca current in DR cells. Thus, it appears that Ca channels were already
phosphorylated to a great extent, however, additional phosphorylation was still
possible. Therefore, it is possible that at any particular time Ca current amplitude is
the product of dynamic equilibrium of phosphorylation and dephosphorylation cycle.
It is presumed that in DR cells dephosphorylation is maintained by a basally active
phosphatase and low protein kinase (PK) activity. Upon activation of PK, the
equilibrium shifts toward a phosphorylated state due to deactivation of phosphatase
activity.
Furthermore, in the presence of the phosphatase blockers, the sensitivity of the
peak current amplitude to voltage was shifted to the left (more hyperpolarising level),
suggesting a shift in voltage as a possible mechanism of enhancement of the peak
current. It has been suggested in other cell types that Ca channels can be regulated
by a voltage-dependent phosphorylation (Artalejo et al. 1992a). In chromaffin cells,
strong depolarising pulses potentiated Ca current, possibly either by activating a
protein kinase or by placing Ca channels into a conformation which is a better
substrate for a kinase. It is not clear whether phosphorylation modulates Ca channels
directly, i.e. as a result of phosphorylating its a- and/or P-subunits. There is a
possibility that phosphorylation of the P-subunit facilitates the coupling between
movement of gating charge and opening of the channel pore (Bean, 1994a). In
cardiac myocytes agents that increase cAMP cause phosphorylation primarily of the
p-subunit (Haase et al. 1993).
It appears that the role of phosphorylation is much clearer in heart muscle cells
than in neuronal tissue. Hescheler et al. (1988) observed that OA produced
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stimulatory effect on Ca currents in cardiomyocytes by suppressing
dephosphorylation, and the process resulted in enhanced phosphorylation of channel
related proteins, which in turn increased the opening probability of the channels.
Increased opening probability and decreased channel closing rates induced by
phosphorylation of Ca channels have also been shown in cell-attached patches in
single-channel recordings from isolated rabbit ventricular myocytes, with Ba2+ as
charge carrier (Ono & Fozzard, 1993).
It is shown that in DR neurones the inhibition of protein phosphatases 1, 2A and
2B has no effect on 8-OH DPAT-induced down-regulation of the peak current. The
current was still enhanced, in addition to the inhibition by 8-OH DPAT (31%),
similar to that in control cells (34%). Thus, it appears that the inhibitory effect of
neurotransmitters on Ca current is not mediated via phosphorylation mechanism. The
inhibition of the protein phosphatases does not prevent the effects of 8-OH DPAT
and GTP-y-S on Ca current. Similar observation was made in other neuronal cell
types (Frace & Hartzell, 1993; Werz et al. 1993). For instance, Elmslie et al. (1993)
showed that norepinephrine inhibited Ca current in the presence of OA. This group
also showed that AMP-PNP applied instead of ATP preserved the NE response, thus
suggesting that NE does not act by inducing phosphorylation of Ca channels. This
compound has high affinity for many ATP binding sites, but it is not a substrate for
protein kinases. They suggested that an ATP binding site needs to be occupied for
successful coupling of the adrenergic receptor and Ca channel. The possibility for its
localization include the receptor, G-protein and Ca channel, however, none of them
has been shown to bind ATP. It is possible that a novel ATP-binding protein is
involved in receptor-channel coupling.
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Role of second messengers
As described, it appears that the phosphatase inhibitors modulate Ca current by
inhibiting dephosphorylation and not via a different mechanism that do not require
phosphorylation, because their effect is lost in the absence of ATP. Furthermore, it
has not been shown that they can directly activate protein kinases. A proposed
mechanism of OA action is that the dmg inhibits protein phosphatase 1 and 2A and
that presumably leads to an activation of serine/threonine group of protein kinases
(Sassa et al. 1989). However, the exact protein kinase(s) that mediate this process are
yet to be identified. Hunter (1987) suggested that mammalian cells are able to express
over fifty different serine/threonine kinases, whose substrate phosphorylation sites
often exhibit similar primary sequences. It is expected that Ca current is under a
complex control of a network of protein kinases that interact and whose activities are
inter-dependent. Biochemical studies have shown that several protein kinases can
phosphorylate Ca channels in vitro (Sieber et al. 1987; O'Callahan & Hosey, 1988).
For example, L-type channels in cardiomyocytes possibly have two modes of
regulation. One site requires phoshorylation and its activation results in increased
opening probability of the channel in the presence of low concentration of OA (< 1
pM) and low levels of cAMP, whereas activation of the other site decreases closing
rate and requires higher levels of OA (>10 pM) and high cAMP (Ono & Fozzard,
1993).
To determine a possibility whether Ca channels could be phosphorylated at more
than one site at the same time, for instance by both PKA and another kinase (PKX)
whose activity was revealed by phosphatase inhibition, additivity between the effect
of phosphatase inhibitors and drugs that elevate cAMP was examined. Such
experiments could provide at least some vague idea of the function of protein kinases.
In the present experiments it was shown that forskolin in DR neurones increases
cAMP and potentiates Ca currents. In the presence of both forskolin and OA in the
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recording pipette, the effect on the enhancement of the peak Ca current was additive,
that is the enhancement was stronger than when OA was present alone. It is
interesting that, with a high dose of OA in the cells, cAMP-dependent stimulation of
the peak current was smaller than in the absence of phosphatase inhibition. It is
possible to suggest two hypotheses based on this observation. First, Ca channel can
be phosphorylated on two or more different phosphorylation sites simultaneously, and
phosphorylation at both sites stimulates Ca current, possibly up to a certain limit.
Secondly, the channel can be phosphorylated only at a single site, and, for example,
it might be that the applied doses of the phosphatase inhibitors did not completely
phosphorylate that site, so that elevation of cAMP results in additional
phosphorylation. In our experiments it was not possible to determine why protein
phosphatase inhibitors were unable to fully phosphorylate that site. However, in
support of the latter hypothesis is the slight difference in the efficacy of OA and MC
in elevating the peak Ca current. Moreover, there is a possibility that some other
protein phosphatase regulates the process.
Cadogan et al. (1993) showed that activation of 5-HT1A receptors by 8-OH DPAT
exhibited dual effect, i.e. it induced an increase in cAMP in rat cerebral cortex and
in rat and guinea-pig hippocampus in vivo, and inhibited forskolin-stimulated
adenylyl cyclase activity in hippocampus in vitro. It appears that this negative
coupling between 5-HT1A receptor stimulation and adenylate cyclase has only been
observed under stimulated conditions, i.e. in the presence of forskolin (Devivo &
Maayani, 1986). Forskolin has also been shown to act in a cAMP-independent
fashion (Laurenza et al. 1989). There are indications to suggest that the drug can
modulate voltage-dependent channels, for example K+ channel, and inhibit an ion
flow via nicotinic and GABA receptors (Laurenza et al. 1989).
As described, G-proteins are suggested to be involved in a regulation of Ca
channels in several ways, including a direct or membrane-delimited G-protein-Ca
channel interaction, and indirect ones that employ various second messengers. For
222
Chapter 7 Discussion
instance, NE modulates Ca current via Gs, that then activates cAMP-dependent
protein kinase in cultured heart muscle cells (Cachelin et al. 1983; Sculptoreanu et
al. 1993). There are indications to suggest PKC to underlie both potentiation
(Dosemeci et al. 1988) and inhibition of Ca currents in a number of neuronal types,
such as NE-induced modulation of Ca currents in chick DRG neurones (Rane &
Dunlap, 1986), neuropeptide Y in rat DRG cells (Rane et al. 1989), bradykinin-
induced block of Ca current in a rat DRG cell line (Boland et al. 1991) and increase
in the current following application of 5-HT in Aplysia sensory neurones (Braha et
al. 1993). Another second messenger arachidonic acid mediated the inhibition of Ca
current in Aplysia neurones, following activation of a PTX sensitive G-protein
(Brezina et al. 1987).
In contrast, in DR neurones H-7, a non-selective PKA and PKC inhibitor, and
staurosporine, that is more selective for PKC, failed to prevent 8-OH DPAT-induced
inhibition of the peak current. Phorbol esters and arachidonic acid were also
ineffective in preventing this modulatory effect (Penington et al. 1991). Secondly, it
has been shown in other cell types that transmitter-induced inhibition of Ca current
is a rapid process, unlike most known second messenger modulated events (Dolphin,
1991a). Thirdly, an application of 5-HT to the extracellular solution had no effect on
unitary Ca currents recorded with cell-attached patches (Penington et al. 1991), thus
denying the need for a freely diffusible second messenger and supporting a
membrane-delimited mechanism (Bean, 1989b; Lipscombe et al. 1989). This evidence
suggests that the action of 8-OH DPAT is mediated via a membrane bound G-protein
that can, without generating a second messenger, modulate Ca currents.
In support of the idea that no second messenger pathway is involved, it has been
shown that PKC activation does not produce the characteristic voltage-dependent
inhibition of Ca current in many cell types (Wanke et al. 1987; Plummer & Hess,
1991), furthermore, arachidonic acid had no effect in DRG cells (Dolphin et al.
1989). Extracellularly applied NE had no effect on Ca channel current in cell-attached
patches, in contrast to the experiments done in similar fashion, but with the agonist
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present in the patch pipette. The same observation was made following applications
of NE on sympathetic ganglion neurones (Lipscombe et al. 1988a), neuropeptide Y
on myenteric neurones (Himing et al. 1988b) and baclofen on DRG cells (Green &
Cottrell, 1988). However, there is evidence that NE applied from outside the patch
inhibited Ca current in chick DRG neurones (Anderson & Dunlap, 1988). Thus, it has
not been unequivocally shown in neuronal cells that the inhibition of Ca channels by
neurotransmitters occurs by direct interaction with activated G-protein, as proposed
Gs interaction occurs with Ca channels in heart and muscle cells (Yatani et al. 1987).
No method so far has provided direct evidence that in neurones a second messenger
is not required. Indeed, if the required second messenger is, for instance,
diacylglycerol or another membrane associated compound, it would not be expected
to diffuse to or from the membrane under the patch. As shown here, evidence
suggests that in spite of the fact that a PTX sensitive G-protein is involved, inhibition
of adenylyl cyclase is not essential for the response, which still occurs when the
cAMP levels are elevated above control levels. Nevertheless, the activity of Ca
channels in DR neurones, as in heart cells, is increased by cAMP-dependent
phosphorylation and forskolin is able to increase the peak Ca current in DR neurones.
Unequivocal evidence will only come from systems in which cloned receptors, G-
proteins and Ca channels are reconstituted into lipid bilayers.
Conclusions
In this study, it was shown that 5-HT1A receptor activation modulates HVA Ca
current, and the effects are probably G-protein mediated. 8-OH DPAT produced a
slowing of activation and reduction of the current amplitude in DR neurones. It is
possible that these two effects are voltage-dependent and voltage-independent,
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respectively. These effects may be mediated via different G-proteins, that are both
PTX sensitive. It is also possible that the ligand activates one G-protein type which
then activates one or more different second messengers. On the other hand, it might
be that the agonist interacts with a heterogenous collection of Ca channels, for
example more than one N-type channel each with different properties, as shown by
Williams et al. (1992) in co-CgTx sensitive N-type Ca channels in human tissue.
Functional consequences of an existence of voltage-dependent and voltage-
independent action of 8-OH DPAT in DR cells are very broad. For example, since
Ca entry via HVA channels normally occurs during a relatively short period of time,
it may well be that slowing of activation has a greater influence on the increase in
intracellular calcium, than would a direct reduction in the current amplitude
(Penington et al. 1992). The existence of multiple modulatory components could
allow fine tuning of Ca-dependent processes, during various physiological functions.
The co-existence of both voltage-dependent and voltage-independent inhibitory
mechanisms might possibly provide for time-dependent changes in cellular functions.
Kinetic-slowing component, that is voltage-dependent, would be phasic in nature,
such as in repetitive firing, and attenuated with subsequent stimulation. A reduction
in the current amplitude, that is voltage-independent, would be tonic in nature and
persist longer, even during high-frequency stimulation. Such dual mechanism of
transmitter action could be well suited for DR neurones, that are known to exhibit a
slow and regular pattern of action potentials, in addition to regulation by serotonin
release, that is probably mediated via the 5-HT1A receptor.
It is possible that modulation of Ca currents in DR neurones results from a direct
action of G-proteins on Ca channels. However, presence of a second messenger
pathway can not be excluded. Indeed, it might be an advantage to have several
modulatory pathways acting simultaneously with different time courses. One pathway
might serve and permit immediate changes in cell processes, and the other one could
possibly integrate signals over a relatively longer period of time. In that way, the
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pathways can involve various receptor subtypes, some of them closely located to the
sources of rapid transmitter release and others more diffusely spread over the cell
surface. The membrane-delimited pathway can probably affect only nearby Ca
channels, whereas the diffusible messenger pathway may act more broadly. Different
pathways may not necessarily be under the same control, and that would lead to a
greater variety of responses, and perhaps more subtle control. In support of this view
it is known that more than one pathway can be selectively activated by a single
agonist. For instance, in chick ciliary ganglion neurones somatostatin inhibited Ca
current and slowed the activation kinetics in whole-cell, but not in a perforated patch
recordings (Meriney et al. 1994). The effect observed in a whole-cell recordings is
similar to the effect of other neurotransmitters on Ca current and might present a
membrane-delimited pathway. Inhibition of Ca current with no change in activation
kinetics is mediated via a second messenger pathway involving cyclic GMP-
dependent protein kinase (cGMP-PK). This suggests that activation of the
somatostatin receptor initiates two cascades, both acting via G-proteins. This effect
can possibly occur through two different types of G-proteins or via a single G-protein
that triggers two different effectors, as demonstrated for Gs in cardiac myocytes
(Yatani et al. 1987; Mattera et al. 1989).
Protein phosphatase 1,2A and 2B inhibitors enhanced the peak Ca current in 80%
of neurones tested, and, in addition, prevented fast "run-down" of Ca current in DR
neurones. However, they had no effect on the reduction of the peak current and
slowing of the activation kinetics caused by the external application of 8-OH DPAT.
This suggests that phosphorylation is not directly involved in the modulatory effect
of 8-OH DPAT on the HVA currents in DR neurones and does not share the same
pathway of modulation with 8-OH DPAT. This fact also argues against a role for
second messengers known to modify Ca channel function via phosphorylation and/or
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